Personale

Recapiti

Orario di ricevimento

Italiano

Curriculum

Interessi

Pubblicazioni

Insegnamenti

English

Curriculum

Interest

Luca MASSACESI

Ruolo attuale:: Professore Ordinario
SSD:: MED/26 - Neurologia
Afferenza organizzativa:: Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)

Recapiti

	0557947927
	luca.massacesi(AT)unifi.it

Ulteriori Recapiti

	Dipartimento di Neuroscienze, Farmaco e Salute Bambino, Università di Firenze, Viale Pieraccini, 6 - 50139 Firenze. Dipartimento di Neuroscienze, Azienda Ospedaliero Universitaria Careggi
	055 2751697
	massacesi(AT)unifi.it
	http://www.neurofarba.unifi.it/

Luca MASSACESI

Curriculum

Curriculum Vitae

Informazioni personali
Nome		Luca Massacesi
Indirizzo		Dipartimento di Neuroscienze, Farmaco e Salute Bambino, Università di Firenze, Viale Pieraccini, 6 - 50139 Firenze Dipartimento di Neuroscienze, Azienda Ospedaliero Universitaria Careggi-Università di Firenze Largo Brambilla 3 - 50134, Firenze
Telefono		+39 05579475392
Fax		+39 0552751898
E-mail		massacesi@unifi.it
Nazionalità		Italiana
Data di nascita		30/11/1954

Posizione Attuale
Nome e indirizzo del datore di lavoro		Università di Firenze, Firenze, Italia
Tipo di azienda o settore		Dipartimento di Neuroscienze, Farmaco e Salute Bambino, Università di Firenze,
Tipo di impiego		Professore Ordinario di Neurologia

Nome e indirizzo del datore di lavoro		Azienda Ospedaliero Universitaria Careggi-Università di Firenze
Tipo di azienda o settore		Dipartimento of Neuroscienze
Tipo di impiego		Direttore
Tipo di azienda o settore		Struttura Organizzativa Dipartimentale (SOD) Neurologia II
Tipo di impiego		Direttore

Nome e indirizzo del datore di lavoro		National Institute of Health, Bethesda, MD, USA
Tipo di azienda o settore		National Institute of Neurological Disorders and Stroke, Neuroimmunology Branch,
Tipo di impiego		Visiting Scientist

Competenze principali

Neurologia Clinica, Neuroimmunologia sperimentale e clinica, Malattie infiammatorie del Sistema Nervoso, Imaging del Sistema Nervoso, Conduzione e valutazione studi clinici, Valutazione efficacia e sicurezza farmaci.

Esperienze di lavoro

• Date (da – a)		1984-1988
• Nome del datore di lavoro		Consiglio Nazionale delle Ricerche
Tipo di azienda o settore		Istituto Clinica Malattie Nervose e Mentali - Università di Firenze
Tipo di impiego		Borsista
Principali mansioni e responsabilità		Ricerca

Date (da – a)		1988-1991
Nome e indirizzo del datore di lavoro		Massachusetts General Hospital, Harvard University, Boston, Ma, USA
Tipo di azienda o settore		Neuroimmunology Unit, Dept. of Neurology
Tipo di impiego		Postdoctoral fellow.
Principali mansioni e responsabilità		Ricerca

Date (da - a)		1991-1995
Nome del datore di lavoro		ASL 10-Ospedale Careggi-Università di Firenze
Tipo di azienda o settore		SOD Neurologia Ia
Tipo di impiego		Dirigente medico I° livello
Principali mansioni e responsabilità		Attività clinica, ricerca clinica

Date (da – a)		1995-2001
Nome del datore di lavoro		-Università di Firenze - -Azienda Ospedaliero Universitaria Careggi-Università di Firenze
Tipo di azienda o settore		-Dipartimento Universitario Scienze Neurologiche e Psichiatriche -Dipartimento ad Attività Integrata (DAI) Scienze Neurologiche - SOD Neurologia Ia
Tipo di impiego		Ricercatore universitario-Dirigente medico I° livello
Principali mansioni e responsabilità		Ricerca, attività clinica

Date (da – a)		2001-2005
Nome del datore di lavoro		-Università di Firenze, Firenze -Azienda Ospedaliero Universitaria Careggi-Università di Firenze
Tipo di azienda o settore		-Dipartimento Scienze Neurologiche and Psichiatriche -Dipartimento ad Attività Integrata di Scienze Neurologiche-SOD Neurologia Ia
Tipo di impiego		Professore Associato di Neurologia-Dirigente medico I° livello
Principali mansioni e responsabilità		Ricerca, didattica, attività clinica

Date (da - a)		2005-2007
Nome del datore di lavoro		Università di Firenze, Firenze Azienda Ospedaliero Universitaria Careggi-Università di Firenze
Tipo di azienda o settore		Dipartimento Scienze Neurologiche and Psichiatriche Dipartimento ad Attività Integrata di Neuroscienze - SOD Neurologia Ia
Tipo di impiego		Professore Ordinario di Neurologia-Dirigente medico I° livello
Principali mansioni e responsabilità		Ricerca, didattica, attività clinica

Date (da – a)		2008-today
Nome del datore di lavoro		- Università di Firenze - Azienda Ospedaliero Universitaria Careggi-Università di Firenze
Tipo di azienda o settore		- Dipartimento di Neuroscienze, Farmaco e Salute Bambino -DAI Neuroscienze - SOD Neurologia IIa,
Tipo di impiego		Professore Ordinario di Neurologia Direttore SOD
Principali mansioni e responsabilità		Ricerca, didattica, attività clinica

Date (da – a)		2008-2012
Nome del datore di lavoro		Università di Firenze
Tipo di azienda o settore		Dottorato di Ricerca in Neuroscienze
Tipo di impiego		Coordinatore
Principali mansioni e responsabilità		Organizzazione attività di ricerca, formazione per la ricerca

Date (da – a)		2008-2012
Nome del datore di lavoro		Università di Firenze
Tipo di azienda o settore		Scuola di Specializzazione in Neurofisiopatologia
Tipo di impiego		Direttore
Principali mansioni e responsabilità		Didattica e tutoraggio attività assitenziale

Date (da – a)		2009-2010
Nome del datore di lavoro		National Institute of Health, Bethesda, MD, USA
Tipo di azienda o settore		NINDS, Neuroimmunology Branch
Tipo di impiego		Adjunct Scientist
Principali mansioni e responsabilità		Ricerca

Date (da – a)		2010-today
Nome del datore di lavoro		National Institute of Health, Bethesda, MD, USA
Tipo di azienda o settore		NINDS, Neuroimmunology Branch
Tipo di impiego		Visiting Scientist
Principali mansioni e responsabilità		Ricerca

Date (da – a)		2012-today
Nome del datore di lavoro		Azienda Ospedaliero Universitaria Careggi-Università di Firenze
Tipo di azienda o settore		Dipartimento di Neuroscienze
Tipo di impiego		Direttore
Principali mansioni e responsabilità		Organizzazione attività cliniche assistenziali, Governo clinico. Organizzazione attività assistenziali per supporto ad attività didattiche e di ricerca clinca

Studi e Formazione

• Data		1982
Nome e tipo di istituto di istruzione o formazione		Università di Firenze
• Principali materie / abilità professionali oggetto dello studio		Facoltà di Medicina e Chirurgia
• Qualifica conseguita		Laurea in Medicina e Chirurgia
• Livello nella classificazione nazionale		110/110 cum laude

• Data		1986
• Nome e tipo di istituto di istruzione o formazione		Università di Firenze
• Principali materie / abilità professionali oggetto dello studio		Scuola di Specializzazione in Neurologia
• Qualifica conseguita		Specializzazione in Neurologia
• Livello nella classificazione nazionale		70/70 cum laude

• Data		1990
Nome e tipo di istituto di istruzione o formazione		Università di Firenze
• Principali materie / abilità professionali oggetto dello studio		Scuola di Specializzazione in Allergologia ed Immunologia Clinica
• Qualifica conseguita		Specializzazione in Immunologia Clinica
• Livello nella classificazione nazionale		70/70 cum laude

Data		1982
Nome e tipo di istituto di istruzione o formazione		Stanford University, Palo Alto. Ca, USA.,
Tipo di azienda o settore		Neurology Department, Laboratory of Neurochemistry
Tipo di impiego		Visiting Fellow.
Principali mansioni e responsabilità		Ricerca

Data		1985
Nome e tipo di istituto di istruzione o formazione		National Institute of Health, Bethesda, Ma, USA
Tipo di azienda o settore		NINDS, Neuroimmunology Branch
Tipo di impiego		Visiting Fellow
Principali mansioni e responsabilità		Ricerca

			ULTERIORE ATTIVITA' SCIENTIFICA E DI RICERCA
1993-oggi			- Italian Multiple Sclerosis Society (AISM); member of the Scientific Committee/Research Evaluation Committee.
1994-1997			- R&D program of the del DG XII EU Commission Project Leader of the Concerted Action: "T-cell Autoimmunity in Multiple Sclerosis".
1997-1999			- Studio multicentrico italiano dell' Associazione Italiana Sclerosi Multipla (AISM): “Centralized Facility per genetic studies in Multiple Sclerosis". Coordinatore.
1999-2000			- International Federation of Multiple Sclerosis Societies: Scientific Program Committee; member of the Medical Advisory Board.
1995-2001			- Biomedical Primate Research EU Large Scale Facility, Rijswijk, The Nederland; member of the Scientific Committee.
1998-2002			- Studio clinico multicentrico italiano: “Open randomized clinical study on different doses of bIFN1a, also in association with Azathioprine, in patients with relapsing remitting multiple sclerosis”: Coordinatore scientifico nazionale.
2010-2012			- Data and Safety Monitoring Board (DSMB) of the National Institutes of Health (NIH) phase II intramural clinical study: "Investigating mechanism of action of DAC HYP (Daclizumab) in the treatment of high inflammatory multiple sclerosis": Chairman.
2006-2011			- Studio clinico multicentrico non-profit finanziato da Agenzia Italiana del Farmaco (AIFA) “Randomized controlled study of Azathioprine versus Interferon beta in relapsing-remitting multiple sclerosis”. Coordinatore scientifico nazionale.
2009-oggi			- European Medicines Agency (EMA), London, UK; Scientific Advisory Group – Neurology, member.
2009-oggi			- Agenzia Italiana del Farmaco (AIFA), Rome, Italy; Scientific Advisory Committee on Neurosciences, member.

Attività didattica presso Università di Firenze

Anno

Corso

Materia

- 2002-oggi

- 2005-oggi

- 2005-2009

- 2005-oggi

- 2005-2013

- 2009-oggi

Scuola di Scienze della Salute, CdLM in Medicina e Chirurgia

Scuola di Scienze della Salute, CdLM in Odontoiatria e Protesi Dentaria

Scuola di Scienze della Salute, CdL in Scienze Infermieristiche

Facoltà di Psicologia, Corso di Psicologia Sperimentale

Scuola di Specializzazione in Neurologia

Scuola di Specializzazione in Neurofisiopatologia

Scuola di Specializzazione in Medicina d'Urgenza

Neurologia Clinica

Neurologia Clinica;

Neurologia Clinica

- 1991-oggi

- 1995-oggi

Scuola di Scienze della Salute, Corso Medicina e Chirurgia

Dottorato di Ricerca diNeuroscienze,

Relatore Tesi:

n° = 25

Tesi: n° = 12

AFFILIAZIONE A SOCIETA' SCIENTIFICHE

- Società Italiana di Neurologia.

- European Federation of Neurological Societies

- Associazione Italiana di Neuroimmunologia.

- International Society of Neuroimmunology.

- Società Italiana di Immunologia.

REVISORE PER: Journal of Neuroimmunology, Journal Clinical Neurology and Neurosurgery, Journal of Immunology, Neurological Sciences, Intl. MS journal, Italian Multiple Sclerosis Society,Dutch Multiple Sclerosis Society, Singapore Medical Research Council, PLOs Medicine, PLOS Pathology, PLOS one, Italian Ministry of University and Research

EDITORIAL BOARD MEMBER: Multiple Sclerosis International

PUBLICATIONI

Publications on international Journal quoted in “PubMed”, National Library of

Medicine (USA).

1. Raimondi L., Banchelli Soldaini G., Buffoni F., Ignesti G., Massacesi L., Amaducci L. and Friedmann C.A. (1982). Rhein and derivatives. In vitro studies on their capacity to inhibit certain proteases. Pharmacol. Res. Comm., 14(2): 103-112.
2. Smith M.E., Somera F.P., Saldivar R., Massacesi L. and Trotter J. (1984). DNA changes in spinal cords of rats with experimental allergic encephalomyelitis.J. Neurochem., 43: 1635-1641.
3. Massacesi L., Abbamondi A.L., Sarlo F. and Amaducci L. (1987). The control of experimental allergic encephalomyelitis with retinoic acid. Further studies. Riv. Neurol. 57:166-169.
4. Massacesi L., Abbamondi A.L., Giorgi C., Sarlo F., Lolli F. and Amaducci L. (1987). Suppression of experimental allergic encephalomyelitis by retinoic acid. J. Neurol. Sciences, 80:55-64.
5. Massacesi L., Abbamondi A.L., Raimondi L., Giorgi C. and Amaducci L. (1988). Lysosomal enzymes in experimental allergic encephalomyelitis: time course and evidence of the source. Neurochem. Res., 13:165-169.
6. Theoharides TC, Lambrachthall M, Massacesi L, et al. (1990). Reduced incidence of experimental allergic encephalomyelitis (EAE) with the tricyclic sep-ch. Europ. J. Pharmacol., 183: 626-627.
7. Massacesi L., Castigli E., Vergelli M., Olivotto J., Abbamondi A.L., Sarlo F. and Amaducci L. (1991). Immunosuppressive activity of 13-cis retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J.Clin.Invest., 88:1331-1337.
8. Riskind P., Massacesi L., Doolittle T.H. and Hauser S.L. (1991).The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann. Neurol., 29: 542-547.
9. Zehetbauer B., Massacesi L., Liuzzi G. M., Vergelli M., Olivotto J., Grassi L., Riccio P. and Amaducci L. (1991). Myelin Basic Protein in lipid-bound form induces experimental allergic encephalomyelitis and demyelination in Lewis rat. Acta Neurologica 13: 121-132.
10. Massacesi L., Parritz D., Joshi N, Letvin N. and Hauser S.L.(1992). Experimental allergic encephalomyelitis in Cynomolgus Monkeys: quantitation of T-cell responses in peripheral blood. J.Clin. Invest., 90: 399-404.
11. Salvetti M and Massacesi L. (1992). Experimental allergic encephalomyelitis and multiple sclerosis: immunoregulatory mechanisms and T cell repertoires. Cell. Immunol., 142: 217-219.
12. Salvetti M., Buttinelli C., Massacesi L. and Wekerle H. (1993). New approaches to the study of T-cell autoimmunity in multiple sclerosis. J. Neuroimmunol., 47: 203-205.
13. Yu J.S., Pandey J. P., Massacesi L., Lincoln R., Usuku K., Seboun E. and Hauser S.L. (1993). Segregation of Immunoglobulin heavy Chain constant region genes in Multiple sclerosis sibling pairs. J. Neuroimmunol., 42: 113-116.
14. Lolli F., Liuzzi G.M., Vergelli M., Massacesi L., Ballerini C., Amaducci L. and Riccio P. (1993). Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. J. Neuroimmunol., 44: 69-75
15. Massacesi L., Vergelli M., Zehetbauer B., Liuzzi G.M., Olivotto J., Ballerini C., Uccelli A., Mancardi L., Riccio P. amd Amaducci L. (1993). Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form. J. Neurol. Sciences, 119: 91-98.
16. Da Vico S., Massacesi L., Amaducci L. (1993). Survey of the italian neurological output in the three years 1989-1991. It J. Neurol. Sci., 14: 595-598.
17. Genain C.P., Parritz D., Hoa Nguyen M., Massacesi L., Ioshi N., Ferrante R., Hoffman K., Moseley M., Levtin N., Hauser S. (1994). In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. J. Clinic. Invest., 94: 1339-1345.
18. Vergelli M., Mazzanti B., Ballerini C., Gran B., Amaducci L. and Massacesi L. (1995). Trasforming growth factor-beta1 inhibits the proliferation of rat astrocytes induced by serum and growth factors. J. Neurosc. Res., 40: 127-133.
19. Massacesi L., Genain C.P., Parritz D.L., Canfield D., Letvin N. and Hauser S.L. (1995). Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann. Neurol., 37: 519-530.
20. Hohlfeld R., Londei M., Massacesi L. and Salvetti M. (1995).T-cell autoimmunity in multiple sclerosis. Immunology Today (now Trends in Immunology), 16:259-261.
21. Amato M.P., Massacesi L. and Amaducci L. (1996). Clinical outcome measurements in Multiple Sclerosis trials. MS Forum. Int. MS Journal 3 n(1) : 19-27.
22. Vergelli M., Olivotto J., Castigli E., Gran B., Raimondi L., Pirisino R., Amaducci L. and Massacesi L. (1997). Immunosuppressive activity of 13-cis-retinoic acid in rats: Aspects of pharmacokinetics and pharmacodynamics. Immunopharmacol., 37: 191-197.
23. Mazzanti B. , M. Vergelli, P. Riccio, R. Martin, H.F. McFarland, G.M. Liuzzi, L. Amaducci and Massacesi L. (1998). T cell response to Myelin Basic Protein in patients with Multiple Sclerosis and healthy donors. J. Neuroimmunol., 82: 96-100.
24. Gran B., Gestri D., Sottini A., Quiròs Roldàn E., Bettinardi A., Signorini S., Primi D., Ballerini C., Taiuti R., Amaducci L. and Massacesi L. (1998). Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis. J. Neuroimmunol., 85: 22-32.
25. Cascino I., Ballerini C., Audino S., Rombolà G., Massacesi L., Colombo G., Scorza Smeraldi R., D’Alfonso S., Momigliano Richiardi P., Tosi R., Ruberti G. (1998). Fas Gene Polymorphisms are not associated with Systemic Lupus Erythematosus, Multiple Sclerosis and HIV Infection. Disease Markers, 13: 221-225.
26. Laman J.D., van Meurs M., Schellekens M.M., de Boer M., Melchers B., Massacesi L., Lassmann H., Klaassen E., ‘t Hart B. (1998). Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J. Neuroimmunol., 86: 30-45.
27. ‘t Hart B., Bauer J., Muller H.J., Melchers B., Nicolay K., Brok H., Bontrop R., Lassmann H. and Massacesi L. (1998) Histopathological characterization of magnetic resonance imaging-decectable brain white matter lesions in a primate model of multiple sclerosis. Am. J. Pathol., 153: 649-663.
28. Kappos, L; Polman, C; Pozzilli, C et al (1998). Placebo-controlled multicentre randomised trial of Interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet, 352: 1491-97.
29. Mazzucco S., Nardi E., Chelli M., Ginanneschi M., Rapi G., Papini A.M., Vergelli M., Mazzanti B., Massacesi L., Amaducci L. (1999). Synthesis of lipopeptides of the immunodominant epitope hMBP(83-99) containing amide or C-C bond linked hydrophobic chains for the study of T cell response. Letters in Peptide Sciences 6: 51-59.
30. Mazzucco S., Matà S., Vergelli M., Fioresi R., Nardi E., Mazzanti B., Chelli M., Lolli F., Ginanneschi M., Pinto F., Massacesi L. and Papini A.M. (1999). A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. Bioorg. Med. Chem. Lett. : 167-172.
31. Sabbadini M.G., Manfredi AA., Bozzolo E., Ferrario L., Rugarli C., Scorza R., Origgi L., Vanoli M., Gambini O., Vanzulli L., Croce D., Campana A., Messa C., Fazio F., Tincani A., Anzola G., Cattaneo R., Padovani A., Gasparotti R., Gerli R., Quartesan R., Piccirilli M., Farsi A., Emmi E., Domeneghetti M., Piccini C., Massacesi L., Pupi A., De Cristoforis M., Danieli M., Candela M., Fraticelli P., Bartolini M., Savolini U., Danieli G. and Passaleva A. (1999). Central Nervous system involvement in Systemic Lupus Eritematosus patients without overt neuropsychiatric manifestations. Lupus 8: 11-19.
32. D’Alfonso S., Nisticò L., Zavattari P., Marrosu M., Murru R., Lai M., Massacesi L., Ballerini C., Gestri D., Salvetti M., Ristori G., Bomprezzi R., Trojano M., Liguori M., Gambi D., Quattrone A., Fruci D., Cucca F., Momigliano Richiardi P. and Tosi R. (1999). A linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur. J Hum.Gen. 7 : 377-385.
33. Miller D.H., Molyneux P.D., Barker G.J., Mac Manus D.G., Moseley I.F., Wagner K.,and the European Study Group on Interferon-Beta1b in Secondary Progressive Multiple Sclerosis. (1999) Effect of Interferon-Beta1b on Magnetic Resonance Imaging Outcomes in Secondary Progressive Multiple Sclerosis: Results of a European Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Ann. Neurol., vol. 46, 850-859.
34. Ballerini C. Nacmias B., Rombolà G., Marcon G., Massacesi L., Sorbi S. (1999) HLA A2 Allele Is Associated with Age at Onset of Alzheimer’s Disease. Ann. Neurol., vol. 45: 397-400.
35. Mazzanti B., Hemmer B., Traggiai E., Ballerini C., McFarland H.F., Massacesi L., Martin R. and Vergelli M. (2000). Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells. J. Neurosci. Res., 59:86-93.
36. ‘t Hart B.A., van Meurs M., Brok H.P.M., Massacesi L., Bauer J., Boon L., Bontrop R.E and Laman J.D. (2000). A new primate model for multiple sclerosis in the common marmoset. Immunology Today (ora Trends in Immunology), 21: 290-297.
37. Pupi A., Sestini S., De Cristofaro M.T., Emmi L., Marchione T., Salvati G., Li Gobbi F., Massacesi L., Meldolesi U. (2000). Use of technetium-99mhexametylpropyleneamine oxime single-photon emission tomography for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behcet’s disease. Eur. J. Nucl. Med. 27(6): 700-706.
38. D’Alfonso S., Nisticò L., Bocchio D., Bomprezzi R., Marrosu M.G., Murru M.R., Lai M., Massacesi L., Ballerini C., Repice A., Solvetti M., Montesperelli C., Ristori G., Trojano M., Liguori M., Gambi D., Quattrone A., Tosi R., Momigliano-Richiardi P. (2000). An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population. J. Neurovirol. 6 (S 2):18-22.
39. Molyneux P.D., Kappos L., Polman C., Pozzilli C., Barkhof F., Filippi M., Yousry T., Hahn D., Wagner K., Ghazi M., Beckmann K., Dalhke F., Losseff N., Barker G.J., Thompson A.J., Miller D.H. and the European Study Group on Interferon beta-1b in Secondary Progressive Multiple Sclerosis (2000). The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple Sclerosis. Brain 123: 2256-2263.
40. Ballerini C., Campani D., Rombolà G., Gran B., Nacmias B., Amato M.P., Siracusa G., Bartolozzi L., Sorbi S. and Massacesi L. (2000). Association of apolipoprotein E polymophism to clinical heterogeneity of multiple sclerosis. Neurosci. Lett. 296: 174-176.
41. Papini AM, Mulinacci B, Carotenuto A, Bonetti B, Sabatino G, Peron E, Nuti F, Alcaro MC Pozo-Carrero MC, Mazzanti, B, Pazzagli m, Massacesi L, Battistini L, Chelli, M, Rovero, P, Lolli, F, Chorev M, Sawyer, TK, 2001. MS PepKit: The first diagnostic test to follow-up multiple sclerosis. Peptide Revolution: Genomics, Proteomics & Therapeutics
42. Chiarugi A., Cozzi A., Ballerini C., Massacesi L. and Moroni F. (2001). Kynurenine 3-monoxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience 102: 687 - 695.
43. Mancardi G., t’Hart B., Roccatagliata L., Brok H., Giunti D., Bontrop R., Massacesi L., Capello E. and Uccelli A. (2001.) Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J. Neurol. Sciences 184: 41-49.
44. Gestri D., Baldacci L., Taiuti R., Galli E., Maggi E., Piccinni M.P., Vergelli M. and Massacesi L. (2001). Oligoclonal T-cell repertoire in cerebrospinal fluid of patients with nervous system inflammatory diseases. J. Neurol. Neurosurg. Psych. 70: 767- 772.
45. Broadley S., Sawcer S., D'Alfonso S., Henseik A., Coraddu F., Gray J., Roxburgh R., Clayton D., Buttinelli C., Quattrone A, Trojano M., Momigliano Richiardi P. , Massacesi L. and Compston A. (2001). A genome screen for multiple sclerosis in Italian families. Genes Immun. 2: 205-10.
46. Mancardi G.L., Saccardi, R., Filippi, M., Gualandi F., Murialdo A., Inglese M., Marrosu M.G., Meucci G., Massacesi L., Lugaresi A., Pagliai F., Sormani M.P., Sardanelli F., Marmont A. and the Italian Gitmo-Neuro Intergroup on Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis (2001). Autologous hematopoietic stem cell transplantation suppresses Gadolinium-enhanced MRI activity in multiple sclerosis. Neurology 57:62-68.
47. Papini A.M., Mazzanti B., Nardi E., Traggiai E., Ballerini C., Biagioli T., Kalbacher H., Beck H., Deeg M., Chelli M., Ginanneschi M., Massacesi L., Vergelli M. (2001). Palmitoyl Derivatives of GpMBP Epitopes: T-Cell Response and Peptidases Susceptibility. J. Med. Chem 44: 3504- 3510.
48. Soldan S. S., Fogdell-Hahn A., Brennan M. B., Mittleman B. B., Ballerini C., Massacesi L., Seya T., McFarland H. F. and Jacobson S. (2001). Elevated serum and CSF levels of soluble HHV-6 cellular receptor, membrane cofactor protein (MCP; CD46), in patients with multiple sclerosis. Ann. Neurol. 50: 486-93.
49. Vergelli M., B. Mazzanti, E. Traggiai, T. Biagioli, C. Ballerini, A Parigi, G. Pellicanò, A. Konze, Massacesi L (2001). Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis. J Neurosci Res. 66:517-24.
50. Traggiai E., Biagioli T., Rosati E., Ballerini C., Mazzanti B., Ben Nun A., Massacesi L., Vergelli M. (2001). IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J. Neuroimmunol. 121:111-9.
51. Kappos L., Polman C., Pozzilli C., Thompson A., Beckmann K., Dalhke F., and the European Study Group on Interferon beta-1b in Secondary Progressive Multiple Sclerosis (2001). Final analysis of the European multicenter trial on IFNbeta-1b secondary progressive Multiple Sclerosis. Neurology 57: 1969-1975.
52. Freeman J, Thompson A., Fitzpatrick R., Hutchinson M., Miltenburger C., Beckmann K., Kappos L., Dalhke F., Polman C., Pozzilli C., and the European Study Group on Interferon beta-1b in Secondary Progressive Multiple Sclerosis (2001). IFNbeta-1b in the treatment of secondary progressive Multiple Sclerosis. Impact on quality of life. Neurology 57: 1870-1875.
53. Molyneux PD, Barker GJ, Barkhof F, Beckmann K, Dahlke F, Filippi M, Ghazi M, Hahn D, MacManus D, Polman C, Pozzilli C, Kappos L, Thompson AJ, Wagner K, Yousry T, Miller DH; European Study Group on Interferon Beta-1b in Secondary Progressive MS (2001). Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.Neurology 57: 2191-7.
54. D'Alfonso S., Mellai M., Giordano M., Pastore A., Malferrari G., Naldi P., Repice A., Liguori M., Cannoni S., Milanese C., Caputo D., Savettieri G., Momigliano-Richiardi P. and the Italian Group for the Study of Multiple Sclerosis Genetics(2002). Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene (MAG) and study of their association with multiple sclerosis. J. Neuroimmunol. 126 : 196-204.
55. Muraro, P.A., Bonanni, L., Mazzanti B., Pantalone, A., Traggiai, E., Massacesi L., Vergelli, M., Gambi, D. (2002). Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. J. Neuroimmunol. 127: 149-59.
56. Massacesi L. (2002). Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy. Clin Neurol Neurosurg 104: 177-81.
57. Ballerini C., Rosati E., Salvetti M., Ristori G., Cannoni S., Biagioli T., Massacesi L., Sorbi S., Vergelli M. (2002). PTPRC exon 4 gene mutation distribution in a Italian MS population. Neuroscience Letters 328: 325-7.
58. Buzzetti R., Pozzilli P., Di Mario U., Ballerini C., and Massacesi L. (2002). Multiple sclerosis and Type I diabetes. Diabetologia 45: 1735-6.
59. Mellai M., Giordano M., D’Alfonso S., Marchini M., Scorza R., Danieli M.G., Leone M., Ferro I., Liguori M., Trojano M., Ballerini C., Massacesi L., Cannoni S., Bomprezzi R., Momigliano-Richiardi P. (2003). Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Human Immunol. 64: 274-284.
60. Polman C, Kappos L, White R, Dahlke F, Beckmann K, Pozzilli C, Thompson A, Petkau J, Miller D; European Study Group in Interferon Beta-1b in Secondary Progressive MS (2003). Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. Neurology 60: 37-43.
61. Sormani MP, Bruzzi P, Beckmann K, Wagner K, Miller DH, Kappos L, Filippi M; European Study Group on Interferon Beta-1b in Secondary Progressive MS (2003). MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b. Neurology 60: 1462-6.
62. Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, Genin E, Vasilescu A, Bougerie H, Trojano M, Martins Silva B, Maciel P, Clerget-Darpoux F, Clanet M, Edan G, Fontaine B, Semana G. (2003) and the Portuguese and Italian Group for MS genetics. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann Neurol. 54:119-22.
63. Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF, Oturai A, Trojano M, Momigliano-Richiardi P, Cocco E, Murru R, Hillert J, Compston A and Sawcer S (2003). Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis. J Neuroimmunol. 143: 31- 38.
64. Liguori M, Sawcer S, Setakis E, Compston A, Giordano M, D'Alfonso S, Mellai M, Malferrari G, Trojano M, Livrea P, De Robertis F, Massacesi L, Repice A, Ballerini C, Biagioli T, Bomprezzi R, Cannoni S, Ristori G, Salvetti M, Grimaldi LM, Biunno I, Comi G, Leone M, Ferro I, Naldi P, Milanese C, Gellera C, Loredana LM, Savettieri G, Salemi G, Aridon P, Caputo D, Rosa Guerini F, Ferrante P, and Momigliano-Richiardi P (2003). A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. J Neuroimmunol. 143: 97-100.
65. Ballerini C, Guerini F, Rombolà G, Rosati E, Massacesi L, Ferrante P, Caputo D, Figà Talamanca L, Naldi P, Liguori M, Alizadeh M, Momigliano-Richiardi P, D’Alfonso S (2004). HLA-Multiple Sclerosis association in Continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol. 150:178 -85.
66. IngleseM, G L Mancardi, E Pagani, M A Rocca, A Murialdo, R Saccardi, G Comiand M Filippi the Italian GITMO-NEURO Intergroup on Autologous Hemotopoietic Stem Cell Transplantation (2004).Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J. Neurol. Neurosurg. Psych. 75: 643-644.
67. Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, Donelli A, Filippi M, Guerrasio A, Gualandi F, La Nasa G, Murialdo A, Pagliai F, Papineschi F, Scappini B, Marmont AM. and the Italian GITMO-NEURO Intergroup on Autologous Hemotopoietic Stem Cell Transplantation (2005). Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood. 105:2601-7.
68. MazzantiB, Biagioli T., Aldinucci A., Cavaletti G., CavalettiE., Crippa L., Oggioni N.,Sala F., Sala V., Frigo M., Rota S., Tagliabue E., Ballerini C., Massacesi L., Riccio P. and Lolli F. (2005). Effects of Pixantrone on T- and B-cell function in the course of acute rat experimental allergic encephalomyelitis. J. Neuroimmunol. 168: 111-117.
69. Capello E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, Marmont A, Uccelli A, Inglese M, Bruzzi P, Sormani MP, Cocco E, Meucci G, Massacesi L, Bertolotto A, Lugaresi A, Merelli E, Solari A, Filippi M, Mancardi GL; Italian GITMO-Neuro Intergroup on ASCT for Multiple Sclerosis (2005). Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Neurol Sci. 26: S200-3.
70. Massacesi L, Parigi A, Barilaro A, Repice AM, Pellicanò G, Konze A, Siracusa GF, Taiuti R and Amaducci L. (2005). Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated by Magnetic Resonance Imaging. Arch.Neurol.;62:1843-1847.
71. Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfo M, Pugliatti M, Sotgiu S, Solaro C, Bomprezzi R, Di Giovanni S, Figa Talamanca L, Nistico L, Fagnani C, Neale MC, Cascino I, Giorgi G, Battaglia MA, Buttinelli C, Tosi R, Salvetti M. and the Italian MS genetic collaborative group (2006). Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study. Ann Neurol.59(1):27-34.
72. The GAMES Collaborative Group, Ban M, Booth D, Heard R, Stewart G, Goris A, Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC, Brassat D, Clanet M, Cournu-Rebeix I, Fontaine B, Semana G, Goedde R, Epplen J, Weber A, Infante-Duarte C, Zipp F, Rajda C, Bencsik K, Vécsei L, Heggarty S, Graham C, Hawkins S, Liguori M, Momigliano-Richiardi P, Caputo D, Grimaldi LM, Leone M, Massacesi L, Milanese C, Salvetti M, Savettieri G, Trojano M, Bielecki B, Mycko MP, Selmaj K, Santos M, Maciel P, Pereira C, Silva A, Silva BM, Coraddu F, Marrosu MG, Akesson E, Hillert J, Datta P, Oturai A, Harbo HF, Spurkland A, Goertsches R, Villoslada P, Eraksoy M, Hensiek A, Compston A, Setakis E, Gray J, Yeo TW, Sawcer S. (2006). Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans. J. Neuroimmunol.179: 108-116.
73. Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, Carreras E, Saiz A, Löwenberg B, te Boekhorst P, GualandiF, Openshaw H, Longo G, Pagliai F, Massacesi L, Deconink E, Ouyang J, Zuazu Nagore F, Besalduch J, Lisukov I, Bonini A, Merelli E,Slavin S, Gratwohl A, Passweg J, Tyndall A, Steck A, Andolina M, Capobianco M, Diez Martin J, Lugaresi A,Meucci G, Sáez R,Clark R, Fernandez M, Fouillard L, Herstenstein B, Koza V, Cocco E, Baurmann H and Mancardi G on behalf of the Autoimmune Disease Working Party of EBMT (2006). Autologous stem cell transplantation for progressive multiple sclerosis: update of the European group for blood and marrow transplantation auto-immune diseases working party database. Mult. Sclerosis 12: 814-823.
74. Roccatagliata L, Rocca M, Valsasina P, Bonzano L, Sormani M, Saccardi R, Mancardi G, Filippi M; for the Italian GITMO-NEURO Intergroup on Autologous Stem Cell Transplantation.(2007). The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. Mult Sclerosis. 13: 1068-70.
75. Aldinucci A., Gerlini G., Fossati S., Cipriani G., Ballerini C., Biagioli T., Pimpinelli N., Borgognoni L., Massacesi L., Moroni F. and Chiarugi A. (2007). Requirement for PARP-1 activity during human dendritic cell maturation. J. Immunol. 179: 305-12.
76. D’Alfonso S., Bolognesi E., Guerini F., Barizzone N., Bocca S., Castelli L., Bergamaschi L., Agliardi C., Ferrante P., Naldi P., Leone M., Caputo D., Ballerini C., Salvetti M., Galimberti D., Massacesi L., Trojano M., Momigliano-Richiardi P. (2008). A sequence variation in the MOG gene is involved in Multiple Sclerosis susceptibility in Italy. Genes and Immun 9: 7-15.
77. Luccarini I., Ballerini C., Biagioli T., Biamonte F., Bellucci A., Rosi M.C., Grossi C., Massacesi L. and Casamenti F. (2008). Combined treatment with atorvastatin and minocycline suppresses severity of EAE. Exp. Neurol., 211: 214.
78. Mazzanti B., Aldinucci A., Biagioli T., Barilaro A., Urbani S., Dal Pozzo S., Amato MP, Siracusa GF., Crescioli C., Manuelli A., Bosi A., Saccardi R., Massacesi L. and Ballerini C. (2008). Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment. J. Neuroimmunol. 199:142-50.
79. ’t Hart B. and Massacesi L(2009). Clinical, pathological and immunological aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). J. Neuropath.Exp.Neurol. 68 (4): 341-355.
80. Bizzoco E, Lolli F, Repice A, Falcini M, Taiuti R, Siracusa GF, Amato MP, Biagioli T, Lori S, Moretti M, Vinattieri A, Nencini P, Massacesi L, Matà S. (2009). Prevalence of Neuromyelitis Optica Spectrum Disorder and Phenotype Distribution. J. Neurol. 256:1891-8
81. Aldinucci A, Biagioli T, Manuelli C, Repice A, Massacesi L, Ballerini C. (2010). Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP. J. Neuroimmunol, 218:28-35.
82. Aldinucci A, Rizzetto L, Pieri L, Nosi D, Romagnoli P, Biagioli T, Mazzanti B, Saccardi R, Beltrame L, Massacesi L, Cavalieri D, Ballerini C (2010). Inhibition of Immune Synapse by Altered Dendritic Cell Actin Distribution: A New Pathway of Mesenchymal Stem Cell Immune Regulation. J. Immunol. 185:5102-10.
83. Gaitán M, SheaC, Evangelou I, Stone R, Fenton K, Bielekova B, Massacesi L, Reich D. (2011). Evo-lution of the Blood-Brain Barrier in Newly Forming Multiple Sclerosis Lesions. Ann. Neurol. 70: 22-29.
84. Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, CerveraR, DentonC, HawkeyC, Labopin M, Mancardi G, MartinR, MooreJJ, PasswegJ, Peters C, RabusinM, RoviraM, van Laar JM & Farge D on behalf of the EBMT Autoimmune Disease, (2011). Haematopietic stem cells transplantation (HSCT) in severe autoimmune diseases: updated guidelines of the European group for bone marrow transplantation (EBMT). Bone marrow Transplantation
85. MancardiG, Sormani M, Di Gioia M, Vuolo L, Gualandi F, Amato M, Capello E, Currò D, Uccelli A, Bertolotto A, Gasperini C, Lugaresi A, Merelli E, Meucci G, Motti L, Tola M, Scarpini E, Repice A, Massacesi L, Saccardi R. (2012) Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler. J. 18: 835-842.
86. Lutterotti A, Jelcic I, Schulze C, Schippling S, Breiden P, Mazzanti B, Reinhard S, DiGioia M, Repice A, Massacesi L, Sputtek A, Salinas-Riester G, Kroeger N, Sospedra M, Saccardi R, Zander A and MartinR (2012). Gene expression and epigenetic profiling of CD34+ hematopoietic progenitor cells in multiple sclerosis patients – absence of proinflammatory signatures.Mult Scler. .
87. Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, Kraft G, Mancardi GL, Nash R, Pasquini M, Martin R, Muraro PA; European Blood and Marrow Transplantation Group; Center for International Blood and Marrow Research; HSCT in MS International Study Group (2012). A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler. Jun;18(6):825-34.
88. Zamboni P, Bertolotto A, Boldrini P, Cenni P, D'Alessandro R, D'Amico R, Del Sette M, Galeotti R, Galimberti S, Liberati A, Massacesi L, Papini D, Salvi F, Simi S, Stella A, Tesio L, Valsecchi MG, Filippini G. (2012). Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial. Trials 13: 183-196.
89. Carrai V, Donnini I, Mazzanti B, Alterini R, Amato MP, Barilaro A, Bosi A, Massacesi L, Portaccio E, Repice AM, Rotunno G and Saccardi R. (2013).Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous hematopoietic stem cells transplantarion. Clin. Neurol. and Neurosurg. 115: 1044 – 1048
90. Aldinucci A, Turco A, Biagioli T, Toma F, Bani D, Guasti D, Manuelli C, Rizzetto L, Cavalieri D, Massacesi L, Mello T, Scaini D, Bianco A, Ballerini L, Prato M, Ballerini C (2013). Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. Nano Letters 13(12):6098-105.
91. Paganini M, Biggeri A, Romoli AM, Mechi C, Ghelli E, Berti V, Pradella S, Bucciantini S, Catelan D, Saccardi R, Lombardini L, Mascalchi M, Massacesi L, Porfirio B, Di Lorenzo N, Vannelli GB, Gallina P (2014). Foetal striatal grafting slows motor and cognitive decline of Huntington’s disease. J.Neurol.Neurosurg.Psich. 85: 974-981.
92. Mascalchi M, Ginestroni A, Toschi N, Poggesi A, Cecchi P, Salvadori E,Tessa C, Cosottini M,De Stefano N, Pracucci G,Pantoni L, Inzitari D, Diciotti S and VMCI Tuscany investigators. (2014).
93. The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study. Human Brain Mapping35: 819–830.
94. Gaitan M, Maggi P, Wholer N, Leibowitch M, Sati P, Calandri B, Merkle L, Massacesi L, Silva A, Jacobson S, Rech D. (2014) Perivenular Brain lesions in a primate multiple sclerosis model at 7-tesla MRI. Mult. Scler. 20(1):64–71.
95. Maggi P, Cummings Macri S, Gaitán M, Leibovitch E, Wohler J, Knight H, Ellis M, Wu T, Silva A, Massacesi L, Jacobson S, Westmoreland S, Reich D (2014). The formation of inflammatory demyelinated lesions in cerebral white matter. Ann. Neurol. 76:594-608.
96. Massacesi L, Tramacere I, Amoroso S, Battaglia M, Benedetti MD, Filippini G, La Mantia L, Repice A M, Solari A, Tedeschi G, Milanese C (2014). Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial. PlosOne, 9(11):e113371; e-Pub, November 17 2014.
97. Bonechi E, Aldinucci A, Mazzanti B., DiGioia M, Repice A, Manuelli C, Saccardi R, Massacesi L, Ballerini C, (2014). Increased CXCL10 expression in Multiple Sclerosis MSCs and monocytes is unaffected by AHSCT. Ann Clin Transl Neurol, 1:650-8.
98. Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL, EAP Investigators (2014). Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. BMC Neurol. 14:65.
99. Gallina P, Paganini M, Lombardini L, Biggeri A, Marini M, Morelli AM, Bucciantini S, Sarchielli E, Ambrosini S, Mechi C, Romoli AM, Ghelli E, Pradella S, Urbani S, Mazzanti B, Berti V, Giordano GP, Campolo M, Dal Pozzo S, Piacentini S, Saccardi R, Massacesi L, Mascalchi M, Bosi A, Conti R, Porfirio B, Di Lorenzo N, Vannelli GB,(2014). Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana. Trapianti 18: 5-11.
100. Salvadori E1, Poggesi A1, Valenti R1, Pracucci G1, Pescini F2, Pasi M1, Nannucci S1, Marini S1, Del Bene A1, Ciolli L1, Ginestroni A3, Diciotti S4, Orlandi G5, Di Donato I6, De Stefano N6, Cosottini M7, Chiti A5, Federico A6, Dotti MT6, Bonuccelli U5, Inzitari D1, Pantoni L8; VMCI-Tuscany Study Group. VMCI-Tuscany Study Group (2015). Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: the VMCI-Tuscany Study. J Alzheimers Dis. 43: 1313-23.
101. Maggi P, Mazzoni L, Moretti M, MassacesiL (2015). SWI enhances vein detection using gadolinium in multiple sclerosis. Acta Radiologica Open. 4:2047981614560938.
102. Clausi V, Giannecchini S,Magnani E, Repice A, Mechi C, Martelli F, Azzi A, Massacesi L. (2015).Markers of JC Virus Infection in Multiple Sclerosis Patients Under Natalizumab Therapy. Neurology Neuroimmunol Neuroinflamm. 2: e58.
103. Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, Donelli A, Lugaresi A, Di Bartolomeo P, Rottoli MR, Rambaldi A, Amato MP, Massacesi L, Di Gioia M, Vuolo V, Currò D, Roccatagliata L, Filippi M, Aguglia U, Iacopino P, Farge D, and Saccardi R. (2015). Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a phase II trial. Neurology. 84(10):981-8.
104. Giovannelli I, Martelli F, Repice AM, Massacesi L, Azzi A and Giannecchini S (2015). Detection of JCPyV microRNA in Blood and urine samples of multiple sclerosis patients under natalizumab therapy. J. of Neurovirology, 21: 666-70.
105. Capobianco M, Lo Re M, Sangalli F, Moiola L, Perini P, Gallo P, Danni M, Provinciali L, Repice AM, Massacesi L, Messina S, Patti F, Laroni A, Mancardi GL, Pucci E, Calabrese M and Bertolotto A (2015). Cyclophosphamide Pulse Therapy after Natalizumab Discontinuation for Multiple Sclerosis: a multicenter study. J Mult Scler (Foster City) 2:151.
106. Maggi P, Sati P, Massacesi L. (2016). Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset. J Neuroimmunol. 304:86-92¸ Epub 2016 Oct 8.
107. Lagi F, Bartalesi F, Pecile P, Biagioli T, Caldini AL, Fanelli A, Giannazzo G, Grifoni S, Massacesi L, Bartoloni A, Rossolini GM. (2016). Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults. J Clin Microbiol. 54(7):1851-4.
108. Montanari E, Rottoli M, Maimone D, Confalonieri P, Plewnia K, Frigo M, Francia A, Pala A, Losignore NA, Ragonese P, Veneziano A; POSIDONIA study group. (2016). A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study. J Neurol Sci. 15;364:105-9.
109. Salvadori E, Poggesi A, Valenti R, Pracucci G, Pescini F, Pasi M, Nannucci S, Marini S, Del Bene A, Ciolli L, Ginestroni A, Diciotti S, Orlandi G, Di Donato I, De Stefano N, Cosottini M, Chiti A, Federico A, Dotti MT, Bonuccelli U, Inzitari D, Pantoni L; VMCI-Tuscany Study Group (2016). Operationalizing mild cognitive impairment criteria in small vessel disease: the VMCI-Tuscany Study. Alzheimers Dement. 2016 Apr;12(4):407-18.
110. Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative (2016).The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 12:714-722.
111. Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S; RENEW Study Investigators (2017). Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 16:189-199.
112. Muraro P, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R. Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group (2017). Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. JAMA Neurol. 74:459-469.
113. Forci B, Mariottini A, Mechi C, Massacesi L, Repice A. (2017).Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. Mult Scler Relat Disord. 2017 Jul;15:24-26.
114. ZamboniP, TesioL, GalimbertiS, Massacesi L, SalviF, D’AlessandroR, CenniP, GaleottiR, PapiniD,D’AmicoR, SimiS, ValsecchiMG, FilippiniG and the Brave Dreams Research Group (2017). Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurol., e-pub 18 Novembre 2017.
115. Maggi P, Absinta M, GrammaticoM, Vuolo L, EmmiG, Carlucci G, Spagni G, Barilaro A, Repice AM, Emmi L, Prisco D, Martinelli V, Scotti R, Sadeghi N, Perrotta G, Sati P, Dachy B, Reich DS, Filippi M, Massacesi L. (2018). The central vein sign differentiates multiple sclsrosis from CNS inflammatory vasculopathies. Ann Neurol, 83 (2), 283-294.

Altre pubblicazioni

1. Amaducci, L., & Massacesi, L. (1981). Modificazioni neurochimiche e prospettive di farmacologia sperimentale e clinica nella sclerosi multipla. Atti del XXII° congresso della Società Italiana di Neurologia: 197-206.

2. Cambi, F., Massacesi, L., & Amaducci, L. (1982). La sclerosi multipla malattia degli anticorpi senza senso. Aggiornamento del Medico 1 (5): 39-45.

3. Amaducci, L., Massacesi, L., Guarnieri, B.M. (1983). Neurochemical aspects of multiple sclerosis. In "New trends of multiple sclerosis research", Cazzullo, C. L., Caputo, C.L., Ghezzi, A. eds., pp. 125-130.

4. Amaducci, L., Massacesi, L., Guarnieri, B.M., & Cambi, F. (1984). Proteases, proteases inhibitors and diseases of the nervous system. In "Neuroimmunology", Behan P.O. and Spreafico F. eds., pp. 127-148. Raven Press (New York).

5. Massacesi, L., & Amaducci, L. (1986). Selective immunosuppression in multiple sclerosis, in "Virology and immunology in multiple sclerosis", Cazzullo, C.L., Caputo, D., Ghezzi, A., Zaffaroni, M. editors, pp. 147-152. Springer-Verlag (Berlin).

Massacesi, L., Abbamondi, A.L., Castigli, E., Sarlo, F., & Amaducci, L.(1987). Encefalomielite allergicasperimentale e acido retinoico. In "La neuroimmunologia clinica oggi", Annunziata, P. & Guazzi, G. eds.: 47-56, Piccin (Padova).

Massacesi, L., Abbamondi, A.L., Sarlo, F., & Amaducci, L. (1987). The control of experimental allergicencephalomyelitis with retinoic acid. Further studies. Riv. Neurol. 57:166-169.
Massacesi L., Abbamondi A.L., Castigli E. and Amaducci L. (1988). Immunosuppression inexperimental allergic encephalomyelitis. In "A multidisciplinary approach to myelin diseases", Serlupi Crescenzi, G. ed. Plenum Press (New York) pp. 251-258.

Massacesi, L., Abbamondi, A.L., Castigli, E., Sarlo, F., & Amaducci, L. (1988). Immunohistochemicalstudy of the suppressive effect of retinoic acid (RA) on experimental allergic encephalomyelitis. In "Trends in European multiple sclerosis research", Confavreux, C., Aimard, G., & Devic, M. eds. Excerpta Medica (Amsterdam), pp. 147-152.
Massacesi, L., Abbamondi, A.L., Sarlo, S., Castigli, E., Olivotto, J., Vergelli, M., & Amaducci, L. (1989). Role of astroglial cells in experimental allergic encephalomyelitis. In “Trends in neuroimmunology”, Marrosu, M.G., Cianchetti, C., & Tavolato, B. eds., Plenum Press (New York), pp. 97-102.
Massacesi, L., Sarlo, F., Abbamondi, A.L., Castigli, E., Olivotto, J., Vergelli, M., Raimondi, L., Medica, A., & Amaducci, L. (1989). Immunosuppressive activity of Retinoic Acid (RA). In “Multiple Sclerosis Research”, M.A. Battaglia ed., Elsevier Science Publishers B.V., pp. 215-224.
Massacesi, L., Sarlo, F., Castigli, E., Vergelli, M., Olivotto, J., Raimondi, L., Medica, A., & Amaducci, L. (1989). Concentration related effects of Retinoic Acid on lymphoproliferative response in EAE. In “Recent advances in multiple sclerosis therapy”, R.E. Gonsette, P. Delmotte, eds., Elsevier Science Publishers B.V., pp. 377-378.
Massacesi, L., Sarlo, F., Castigli, E., Olivotto, J., Vergelli, M., Abbamondi, A.L., & Amaducci, L. (1989). Effects of retinoic acid on passive transfer EAE. In “Recent advances in multiple sclerosis therapy”, R.E. Gonsette, P. Delmotte, eds., Elsevier Science Publishers B.V., pp. 195-198.
Zehetbauer, B., Massacesi, L., Liuzzi, G. M., Vergelli, M., Olivotto, J., Grassi, L., Riccio, P., & Amaducci, L. (1991). Myelin Basic Protein in lipid-bound form induces experimental allergic encephalomyelitis and demyelination in Lewis rat. Acta Neurologica 13: 121-132.
Vergelli, M., Sorrentino, G., & Massacesi, L. (1993). Malattie degenerative. In “Neuroimmunologia Clinica”, Bruno Tavolato ed. Il pensiero Scientifico ed. (Roma), pp. 213-228.
Massacesi, L., Amato, M.P., & Amaducci, L. (1994). Immunosuppression in Multiple Sclerosis: stateof the art and future perspectives. In "A multidisciplinary approach to myelin diseases. II", S. Salvati ed. Plenum Press (New York), pp. 255-259.
Fonda, C., Amato, M.P., Massacesi, L., Falcini, M., Bartolozzi, L., & Amaducci, L. (1995). Confronto fra RM dopo somministrazione di gadolinio, senza e dopo applicazione del “trasferimento di magnetizzazione” nella sclerosi multipla. In “Neuroradiologia”, L. Bozzao editor, Centauro (Udine), pp.273-280.
Massacesi, L. (1996). L’encefalomielite autoimmune sperimentale. In “Neurobiologia eNeuroimmunologia Clinica”, a cura di Federico A. e Annunziata P. CIC edizioni Internazionali (Roma), pp 85-93.
Amato, M.P., Massacesi L., & Amaducci L. (1996). Clinical outcome measurements in Multiple Sclerosis trials. MS Forum. Int. MS Journal 3 n(1) : 19-27.
Mazzanti, B., Traggiai, E., Hemmer, B., Martin, R., Massacesi, L., & Vergelli, M. (1999). The affinity spectrum of myelin basic protein reactive T cells. In “Advances in the immunopathogenesis of multiple sclerosis”. Gambi D., Muraro P.A.and Lugaresi A. eds. Sprinter (Milano, Italy), pp 3-10.
Vergelli, M., Massacesi, L., & McFarland, H. (2000). Immunopathogenesis of Multiple Sclerosis In “T cell autoimmunity in Multiple Sclerosis”. M. Londei ed., Landes Bioscience (Georgetown, Texas, USA), pp.133-148.
Massacesi, L. (2000). Patogenesi della sclerosi multipla: meccanismo di cronicizzazione delle lesioniinfiammatorie. In “Aspetti Immunologici e Terapeutici della Sclerosi Multipla”- C. Fieschi ed., UTET Periodici Scientifici (Milano), pp. 2-6.
Massacesi, L. (2000). Correlati biologici e di laboratorio della patologia neuroimmune. In Atti delConvegno “Impiego delle Immunoglobuline E.V. in neurologia: attualità e prospettive”.
Mancardi, G.L., Murialdo, A., Saccardi, R., Pagliai, F., Gualandi, F., Marmont, A., Inglese, M., Bruzzi, P., Sormiani, M.P., Filippi, M., Marrosu, M.G., Meucci, G., Massacesi, L., Bertolotto, A., Lugaresi, A., Morelli, E., Filippi, M. & Italian GITMO-NEURO Intergroup sul Trapiantato Autologo di cellule staminali ematopoietiche nella sclerosi multipla (2005). Il trapianto autologo di midollo osseo Intensa immunosoppressione seguita da trapianto autologo di cellule staminali in pazienti con forma grave di SM: dati clinici e RM. In L’interferone beta ed altre possibilità terapeutiche. L Durelli Ed., Excerpta Medica Elsevier (Milano), pp 97-106.
Mancardi, G.L., Saccardi, R., Murialdo, A., Pagliai, F., Gualandi, F., Marmont, A., Inglese, M., Bruzzi, P., Sormani, M.P., Marrosu, M.G., Meucci, G., Massacesi, L., Bertolotto, A. Lugaresi, A., Merelli, E. Stem Cell Therapy for Autoimmune Disease, Richard K. Burt ed.
Massacesi, L. Ed. (2013). Percorsi assistenziali del paziente con Sclerosi Multipla. Maya Idee, Verona.
Massacesi, L. (2013). Ruolo delle Agenzie regolatorie nel percorso autorizzativo dei farmacineurologici in Europa. Sclerosi Multipla news, 4 (14): 4-7.
Gallina, P,, Paganini, M,, Lombardini, L,, Biggeri, A,, Marini, M,, Morelli, A,M,, Bucciantini, S., Sarchielli,E., Ambrosini, S., Mechi, C., Romoli, A.M., Ghelli, E., Pradella, S., Urbani, S., Mazzanti, B., Berti, V., Giordano, G.P., Campolo, M., Dal Pozzo, S., Piacentini, S., Saccardi, R., Massacesi, L., Mascalchi, M., Bosi, A., Conti, R., Porfirio, B., Di Lorenzo, N., Vannelli, G.B. (2014). Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana. Trapianti, 18: 5-11.
Mechi, C., Repice, A., Di Gioia, M., Magnani, E., Vuolo, L., Bandini, G., Massacesi,L. (2014). Fingolimod therapy in a patient with idiopathic thrombocitopenic purpura. About Medicine, 11: 23-25.

Luca MASSACESI

Pubblicazioni

Legenda

Contributo su rivista |

Articolo su libro |

Libro |

Contributo in atti di convegno (proceeding) |

Brevetto |

Curatela | Altro

Altro |

Tesi di Dottorato

Mariottini A, Repice AM, Barilaro A, Massacesi L (In corso di stampa). Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance. NEUROLOGICAL SCIENCES, pp. 0-0, ISSN:1590-3478

Azzolini F, Farina A, Gastaldi M, Barilaro A, Scotti V, Falchetti G, Fainardi E, Moretti M, Massacesi L. (In corso di stampa). Leptomeningeal gadolinium enhancement in autoimmune GFAP-astrocytopathy.. NEUROLOGY, pp. 0-0, ISSN:1526-632X

Mariottini A, Bertozzi A, Marchi L, Di Cristinzi M, Mechi C,Barilaro A,Massacesi L,Repice A. (In corso di stampa). Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis. JOURNAL OF NEUROLOGY, pp. 0-0, ISSN:0340-5354 Accesso ONLINE all'editore

Lotti, Antonio; Barilaro, Alessandro; Mariottini, Alice; Vannozzi, Lorenzo; Piergentili, Marco; Fainardi, Enrico; Massacesi, Luca (2023). Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management. FRONTIERS IN NEUROLOGY, vol. 14, pp. 0-0, ISSN:1664-2295 DOI

Alice Mariottini, Antonio Lotti, Chiara Innocenti, Anna Maria Repice , Chiara Nozzoli , Riccardo Boncompagni , Enrico Fainardi , Riccardo Saccardi, Luca Massacesi (2023). Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation. EUROPEAN JOURNAL OF NEUROLOGY, vol. ..., pp. 0-0, ISSN:1351-5101 DOI Accesso ONLINE all'editore

Bertozzi, Andrea; Mariottini, Alice; Marchi, Leonardo; Cristinzi, Maria Di; Nistri, Riccardo; Damato, Valentina; Mechi, Claudia; Barilaro, Alessandro; Massacesi, Luca; Repice, Anna Maria (2023). Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience. MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol. 72, pp. 0-0, ISSN:2211-0356 DOI

Mariottini, Alice; Bulgarini, Giovanni; Cornacchini, Sara; Damato, Valentina; Saccardi, Riccardo; Massacesi, Luca (2023). Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update. BIOENGINEERING, vol. 10, pp. 0-0, ISSN:2306-5354 DOI

Beretta, Simone; Cristillo, Viviana; Camera, Giorgia; Morotti Colleoni, Carlo; Pellitteri, Gaia; Viti, Beatrice; Bianchi, Elisa; Gipponi, Stefano; Grimoldi, Maria; Valente, Mariarosaria; Guttmann, Susanna; Cotelli, Maria Sofia; Palumbo, Pasquale; Gelosa, Giorgio; Meletti, Stefano; Schenone, Cristina; Ottaviani, Donatella; Filippi, Massimo; Zini, Andrea; Basilico, Paola; Tancredi, Lucia; Cortelli, Pietro; Braga, Massimiliano; De Giuli, Valeria; Servidei, Serenella; Paolicelli, Damiano; Verde, Federico; Caproni, Stefano; Pisani, Antonio; Lo Re, Vincenzina; Massacesi, Luca; Roccatagliata, Daria Valeria; Manganotti, Paolo; Spitaleri, Daniele; Formenti, Anna; Piccoli, Marta; Marino, Silvia; Polverino, Paola; Aguglia, Umberto; Ornello, Raffaele; Perego, Elisabetta; Siciliano, Gabriele; Merlo, Paola; Capobianco, Marco; Pantoni, Leonardo; Lugaresi, Alessandra; Angelocola, Stefania; De Rosa, Anna; Sessa, Maria; Beghi, Ettore; Agostoni, Elio Clemente; Monaco, Salvatore; Padovani, Alessandro; Priori, Alberto; Silani, Vincenzo; Tedeschi, Gioacchino; Ferrarese, Carlo; Collaborators:; Andrea Pilotto, Stefano Cotti Piccinelli, Susanna Lazzari, Giulia Negro, Giulia Sofia Cereda, Roberto Infante, Ginevra Giovannelli, Claudia Cutellè, Lorenzo Tinti, Susanna Diamanti, Gaia Fanella, Nicola Rifino, Lucio Tremolizzo, Giovanni Ermanis, Fedra Kuris, Roberto Sartor, Francesco Bax, Gian Luigi Gigli, Edoardo Barvas, Mirco Volpini, Roberto Frusciante, Mariaeva Bernardi, Marinella Turla, Raffaella Valenti, Emanuele Bartolini, Lorenzo Kiferle, Silvia Pradella, Alessandro Innocenti, Ludovico Ciolli, Niccolò Orlandi, Gabriele Vandelli, Marco Mazzoli, Luana Benedetti, Matteo Pardini, Stefano Grisanti, Erica Biassoni, Corrado Cabona, Angelo Schenone, Federica Boso, Federica Agosta, Mario Orrico, Luisa Roveri, Giacomo Sferruzza, Mauro Gentile, Laura Piccolo, Elena Merli, Andrea Salmaggi, Tommaso Bocci, Roberta Ferrucci, Michelangelo Dini, Maria Guarino, Marianna Nicodemo, Sandro Beretta, Alessia Giossi, Chiara Campana, Bruno Censori, Guido Primiano, Maria Troiano, Luca Bollo, Narghes Calcagno, Francesca Trogu, Claudia Morelli, Carlo Colosimo, Chiara Di Schino, Franco Costantini, Giuseppe Cosentino, Enrico Marchioni, Federica Avorio, Giovanna Russelli, Giovanna Panarello, Giovanna Carlucci, Federica Azzolini, Antonio Lotti, Alfonso Ciccone, Giovanni Furlanis, Bruno Giometto, Giulia Bellavita, Scarano Valentina, Lorenzo Lorusso, Maria Concetta Altavista, Amelia Brigandì, Chiara Sorbera, Lucia Gatto, Simona Sacco, Raffaella Clerici, Erika Schirinzi, Enrica Bonanni, Elena Merico, Natascia Beretta, Giuseppe Gallo, Chiara Sciolla, Antonio Bertolotto, Simone Pomati, Federico Masserini, Federico Camilli, Ivan Panzera, Patrizio Cardinali, Maria Cristina Acciarri, Giovanna De Michele, Sandra Perillo, Gianluigi Rosalio Palmieri, Nunzia Cuomo, Augusta Giglio (2023). Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants. NEUROLOGY, vol. 101, pp. e892-e903, ISSN:0028-3878 DOI

Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca (2022). Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, pp. 0-0, ISSN:1351-5101 DOI

Amoriello R.; Rizzo R.; Mariottini A.; Bortolotti D.; Gentili V.; Bonechi E.; Aldinucci A.; Carnasciali A.; Peruzzi B.; Repice A.M.; Massacesi L.; Fainardi E.; Ballerini C. (2022). Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis. FRONTIERS IN NEUROLOGY, vol. 13, pp. 872396-872406, ISSN:1664-2295 DOI

Bergamaschi R.; Beghi E.; Bosetti C.; Ponzio M.; Santucci C.; Lepore V.; Mosconi P.; Aguglia U.; Amato M.P.; Ancona A.L.; Ardito B.; Avolio C.; Balgera R.; Banfi P.; Barcella V.; Barone P.; Bellantonio P.; Berardinelli A.; Bergamaschi R.; Bertora P.; Bianchi M.; Bramanti P.; Morra V.B.; Brichetto G.; Brioschi A.M.; Buccafusca M.; Bucello S.; Busillo V.; Calchetti B.; Cantello R.; Capobianco M.; Capone F.; Capone L.; Cargnelutti D.; Carrozzi M.; Cartechini E.; Cavaletti G.; Cavalla P.; Celani M.G.; Clerici R.; Clerico M.; Cocco E.; Confalonieri P.; Coniglio M.G.; Conte A.; Corea F.; Cottone S.; Crociani P.; D'Andrea F.; Danni M.C.; De Luca G.; de Pascalis D.; De Riz M.; De Robertis F.; De Rosa G.; De Stefano N.; Corte M.D.; Di Sapio A.; Docimo R.; Falcini M.; Falcone N.; Fermi S.; Ferraro E.; Ferro M.T.; Fortunato M.; Foschi M.; Gajofatto A.; Gallo A.; Gallo P.; Gatto M.; Gazzola P.; Giordano A.; Granella F.; Grasso M.F.; Grasso M.G.; Grimaldi L.M.E.; Iaffaldano P.; Imperiale D.; Inglese M.; Iodice R.; Leva S.; Luezzi V.; Lugaresi A.; Lus G.; Maimone D.; Mancinelli L.; Maniscalco G.T.; Marfia G.A.; Marini B.; Marson A.; Mascoli N.; Massacesi L.; Melani F.; Merello M.; Meucci G.; Mirabella M.; Montepietra S.; Nasuelli D.; Nicolao P.; Passantino F.; Patti F.; Peresson M.; Pesci I.; Piantadosi C.; Piras M.L.; Pizzorno M.; Plewnia K.; Pozzilli C.; Protti A.; Quatrale R.; Realmuto S.; Ribizzi G.; Rinalduzzi S.; Rini A.; Romano S.; Romeo M.; Ronzoni M.; Rossi P.; Rovaris M.; Salemi G.; Santangelo G.; Santangelo M.; Santuccio G.; Sarchielli P.; Sinisi L.; Sola P.; Solaro C.; Spitaleri D.; Strumia S.; Tassinari T.; Tonietti S.; Tortorella C.; Totaro R.; Tozzo A.; Trivelli G.; Ulivelli M.; Valentino P.; Venturi S.; Vianello M.; Zaffaroni M.; Zarbo R.; Trojano M.; Battaglia M.A.; Capobianco M.; Pugliatti M.; Ulivelli M.; Mosconi P.; Gasperini C.; Patti F.; Amato M.P.; Comi G. (2022). Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register. NEUROLOGICAL SCIENCES, vol. 43, pp. 5459-5469, ISSN:1590-1874 DOI

Antonio Farina; Silvia Falso; Sara Cornacchini; Gregorio Spagni; Gabriele Monte; Alice Mariottini; Luca Massacesi; Alessandro Barilaro; Amelia Evoli; Valentina Damato (2022). Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience. EUROPEAN JOURNAL OF NEUROLOGY, vol. 29, pp. 2505-2510, ISSN:1351-5101 DOI

Alice Mariottini, Leonardo Marchi, Chiara Innocenti, Maria Di Cristinzi, Matteo Pasca, Stefano Filippini, Alessandro Barilaro, Claudia Mechi, Arianna Fani, Benedetta Mazzanti, Tiziana Biagioli, Francesca Materozzi, Riccardo Saccardi, Luca Massacesi, Anna Maria Repice (2022). Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis.. FRONTIERS IN NEUROLOGY, vol. 40, pp. 892-898, ISSN:1664-2295 DOI Accesso ONLINE all'editore

Massacesi, Luca; Mariottini, Alice; Nicoletti, Ferdinando (2022). Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple Sclerosis. JOURNAL OF CLINICAL MEDICINE, vol. 11, pp. 0-0, ISSN:2077-0383 DOI Accesso ONLINE all'editore

Azzolini F.; Farina A.; Gastaldi M.; Barilaro A.; Scotti V.; Falchetti G.; Fainardi E.; Moretti M.; Massacesi L. (2022). Leptomeningeal Gadolinium Enhancement in Autoimmune GFAP Astrocytopathy. NEUROLOGY, vol. 98, pp. 720-722, ISSN:1526-632X DOI

Boffa, Giacomo; Signori, Alessio; Massacesi, Luca; Mariottini, Alice; Sbragia, Elvira; Cottone, Salvatore; Amato, Maria Pia; Gasperini, Claudio; Moiola, Lucia; Meletti, Stefano; Repice, Anna Maria; Morra, Vincenzo Brescia; Salemi, Giuseppe; Patti, Francesco; Filippi, Massimo; De Luca, Giovanna; Lus, Giacomo; Zaffaroni, Mauro; Sola, Patrizia; Conte, Antonella; Nistri, Riccardo; Aguglia, Umberto; Granella, Franco; Galgani, Simonetta; Caniatti, Luisa Maria; Lugaresi, Alessandra; Romano, Silvia; Iaffaldano, Pietro; Cocco, Eleonora; Saccardi, Riccardo; Angelucci, Emanuele; Trojano, Maria; Mancardi, Giovanni Luigi; Sormani, Maria Pia; Inglese, Matilde (2022). Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis. NEUROLOGY, pp. 0-0, ISSN:0028-3878 DOI

Alice Mariottini, Benedetta Forci, Elisa Gualdani, Monica Romoli, Anna Maria Repice, Alessandro Barilaro, Claudia Mechi, Luca Massacesi, Paolo Francesconi (2022). Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents. MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol. 60, pp. 0-0, ISSN:2211-0348 DOI Accesso ONLINE all'editore

Cornacchini, S; Farina, A; Contento, M; Berti, V; Biggi, M; Barilaro, A; Massacesi, L; Damato, V; Rosati, E (2022). Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report. FRONTIERS IN NEUROLOGY, vol. 13, pp. 0-0, ISSN:1664-2295 DOI

A Mariottini, C Innocenti, G Rastrelli, L Vignozzi, A Giachi, R Saccardi, L Massacesi, A Repice (2021). Impact of autologous haematopoietic stem cell transplantation on fertility in aggressive multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, vol. 28 supplement 1, pp. 384-384, ISSN:1351-5101 Accesso ONLINE all'editore

Contento, Margherita; Bertaccini, Bruno; Biggi, Martina; Magliani, Matteo; Failli, Ylenia; Rosati, Eleonora; Massacesi, Luca; Paganini, Marco (2021). Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs. EPILEPSIA, pp. 2159-2170, ISSN:0013-9580 DOI Accesso ONLINE all'editore

Amoriello, Roberta; Greiff, Victor; Aldinucci, Alessandra; Bonechi, Elena; Carnasciali, Alberto; Peruzzi, Benedetta; Repice, Anna Maria; Mariottini, Alice; Saccardi, Riccardo; Mazzanti, Benedetta; Massacesi, Luca; Ballerini, Clara (2021). The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies. FRONTIERS IN IMMUNOLOGY, vol. 11, pp. 1-19, ISSN:1664-3224 DOI Accesso ONLINE all'editore

Contento M.; Bertaccini B.; Biggi M.; Magliani M.; Failli Y.; Rosati E.; Massacesi L.; Paganini M. (2021). Response: Brightening the crystal ball: A constructive reappraisal of the postwithdrawal seizure relapse prediction model. EPILEPSIA, pp. 1-2, ISSN:0013-9580 DOI Accesso ONLINE all'editore

Pasca M, Forci B, Mariottini A, Mechi C, Barilaro A, Massacesi L, Repice AM. (2021). Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis.. MULTIPLE SCLEROSIS AND RELATED DISORDERS, pp. 0-0, ISSN:2211-0348

Cristina Tassorelli, Vincenzo Silani, Alessandro Padovani, Paolo Barone, Paolo Calabresi, Paolo Girlanda, Leopnardo Lopiano, Luca Massacesi, Salvatore Monaco, Marco Onofrj, Gioacchino Tedeschi, Alfredo Berardelli (2021). The contribution of the Italian residents in neurology to the COVID-19 crisis: admirable generosity but neurological training remains their priority. NEUROLOGICAL SCIENCES, vol. 42, pp. 4425-4431, ISSN:1590-3478 DOI Accesso ONLINE all'editore

Mariottini A.; Filippini S.; Innocenti C.; Forci B.; Mechi C.; Barilaro A.; Fani A.; Carlucci G.; Saccardi R.; Massacesi L.; Repice A.M. (2021). Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis. MULTIPLE SCLEROSIS, pp. 61-70, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi (2021). Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions. JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 429, pp. 0-0, ISSN:0022-510X DOI Accesso ONLINE all'editore

E. Sbragia, A. Mariottini, M. Capobianco, S. Martire, L. Moiola, M.P. Amato, L. Massacesi, G. Mancardi, G. Boffa, M. Inglese (2021). COVID-19 in patients with aggressive MS treated with aHSCT: a multi-center study. MULTIPLE SCLEROSIS, vol. 27, pp. 0-0, ISSN:1352-4585 Accesso ONLINE all'editore

Boffa, Massacesi L, Inglese M, Mariottini A, Capobianco M, Moiola L, Amato MP, Cottone S, Gualandi F, De Gobbi M, Greco R, Scime R, Frau J, Zimatore GB, Bertolotto A, ComiG, Uccelli A, Signori A, Angelucci E, Innocenti C, Ciceri F, Repice AM, Sormani MP, R. Saccardi R, Mancardi GL, and the Italian BMT-MS study group (2021). Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. NEUROLOGY, pp. 0-0, ISSN:0028-3878

Mariottini, A; Farina, A; Innocenti, C; Romoli, M; Zilio, I; Azzolini, F; Repice, A; Saccardi, R; Carlucci, G; Massacesi, L (2021). Neuropsychological assessment in aggressive multiple sclerosis treated with stem cell transplantation. EUROPEAN JOURNAL OF NEUROLOGY, vol. 28, pp. 362-362, ISSN:1351-5101 Accesso ONLINE all'editore

Piccini, Barbara; Ulivelli, Monica; Amato, Maria Pia; Bartalini, Sabina; Falcini, Mario; Giannini, Marta; Magnani, Eliana; Massacesi, Luca; Repice, Anna Maria; Vascotto, Marina; Grosso, Salvatore (2020). Association of celiac disease in patients with multiple sclerosis in Tuscany. REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS, vol. 112, pp. 1-9, ISSN:1130-0108 DOI

Signori A.; Boffa G.; Bovis F.; Mariottini A.; Repice A.; Inglese M.; Amato M.P.; Mancardi G.; Massacesi L.; Saccardi R.; Sormani M.P. (2020). Prevalence of disability improvement as a potential outcome for multiple sclerosis trials. MULTIPLE SCLEROSIS, pp. 1-6, ISSN:1352-4585 DOI

Maggi P.; Absinta M.; Sati P.; Perrotta G.; Massacesi L.; Dachy B.; Pot C.; Meuli R.; Reich D.S.; Filippi M.; Pasquier R.D.; Theaudin M. (2020). The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: A prospective multicenter 3T study. MULTIPLE SCLEROSIS, pp. 0-0, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Gastaldi M, Mariotto S, Giannoccaro MP, Iorio R, Zoccarato M, Nosadini M, Benedetti L, Casagrande S, Di Filippo M, Valeriani M, Ricci S, Bova S, Arbasino C, Mauri M, Versino M, Vigevano F, Papetti L, Romoli M, Lapucci C, Massa F, Sartori S,7, Zuliani L, Barilaro A, De Gaspari P, Spagni G, Evoli A, Liguori R, Ferrari S, Marchioni E, Giometto B, Massacesi L, Franciotta D. (2020). Subgroup Comparison According to Clinical Phenotype and Serostatus in Autoimmune Encephalitis: A Multicenter Retrospective Study. EUROPEAN JOURNAL OF NEUROLOGY, vol. 27, pp. 633-643, ISSN:1468-1331 DOI

Carlucci, G; Sodero, A; Buti, V; Failli, Y; Paganini, M; Massacesi, L (2020). Evaluation of cognitive and language side effects of topiramate in patients with epilepsy, and effectiveness of counseling and speech therapy interventions. EUROPEAN JOURNAL OF NEUROLOGY, vol. 27, pp. 591-591, ISSN:1351-5101 Accesso ONLINE all'editore

Mata, S; Barilaro, A; Massacesi, L; Sorbi, S (2019). POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY: AN OBSERVATIONAL STUDY. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, vol. 24, pp. S31-S31, ISSN:1085-9489

Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L (2019). Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation. EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, pp. 106-106, ISSN:1351-5101

Azzolini, F; Grammatico, M; Carlucci, G; Goanta, L; Dallagiacoma, S; Repice, AMR; Forci, B; Dipasquale, F; Marchi, L; Fainardi, E; Massacesi, L (2019). MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences. NEUROLOGY, vol. 92, pp. 0-0, ISSN:0028-3878

Azzolini, F; Grammatico, M; Carlucci, G; Goanta, L; Dallagiacoma, S; Forci, B; Barilaro, A; Repice, AM; Busto, G; Fainardi, E; Massacesi, L (2019). The Central Vein Sign identifies patients diagnosed with multiple sclerosis probably carrying different diseases and showing milder disease course. MULTIPLE SCLEROSIS, vol. 25, pp. 135-136, ISSN:1352-4585

Mariottini A, Innocenti C, Forci B, Magnani E, Mechi C, Barilaro A, Nistri R, Fani A, Saccardi R, Massacesi L, Repice AM. (2019). Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis.. EUROPEAN JOURNAL OF NEUROLOGY, pp. 0-0, ISSN:1468-1331 DOI Accesso ONLINE all'editore

Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group. Collaborators (138) Acquistapace D, Aguglia U, Amato MP, Annunziata P, Ardito B, Avolio C, Balgera R, Bandini F, Banfi P, Barone P, Bellantonio P, Bergamaschi R, Bertolotto A, Bertora P, Bombardi R, Bosco Zimatore G, Bossio RB, Bramanti P, Brescia Morra V, Brioschi AM, Bruzzone M, Buccafusca M, Busillo V, Caneve G, Caniatti LM, Capone L, Capone F, Cappellani A, Cargnelutti D, Cavaletti G, Cavalla P, Celani MG, Centonze D, Chiveri L, Clerici R, Clerico M, Cocco E, Comi G, Comi C, Coniglio MG, Cordera S, Corea F, Cortese A, Costantino G, Cottone S, Crociani P, D'Andrea F, Danni MC, De Luca G, de Pascalis D, De Robertis F, De Stefano N, Di Battista G, Di Napoli M, Falcini M, Fausto F, Ferrò MT, Florio C, Fortunato M, Frittelli C, Galgani S, Gallo P, Gatto M, Gazzola P, Geda C, Giordano A, Granella F, Grasso MG, Grimaldi LME, Imperiale D, Lo Russo L, Logullo FO, Lugaresi A, Lus G, Maccarrone G, Maimone D, Malagù S, Marconi R, Maritato P, Massacesi L, Mazzoni M, Meucci G, Mirabella M, Montepietra S, Nasuelli D, Neri W, Orefice G, Parodi S, Pasquali L, Passarella B, Patti F, Peresson M, Perla F, Pesci I, Piantadosi C, Piras ML, Pizio NR, Pozzilli C, Protti A, Pugliatti M, Quatrale R, Ragno M, Ragno M, Rezzonico M, Ribizzi G, Riva M, Ronzoni M, Rosso MG, Rottoli M, Rovaris M, Salemi G, Salvetti M, Santangelo M, Santangelo G, Santuccio G, Santuccio G, Sarchielli P, Scarpini E, Sechi GP, Severi S, Sinisi L, Sola P, Spitaleri D, Tassinari T, Tedeschi G, Tonietti S, Torri Clerici V, Totaro R, Traccis S, Trojano M, Turla M, Uccelli A, Ulivelli M, Valentino P, Valeriani M, Venturi S, Vianello M, Zaffaroni M. (2019). The Italian multiple sclerosis register.. NEUROLOGICAL SCIENCES, vol. 40, pp. 155-165, ISSN:1590-3478 DOI Accesso ONLINE all'editore

Pasca M.; Picchioni A.; Mazzeo S.; Terenzi F.; Prestipino E.; Fratangelo R.; Repice A.M.; Carlucci G.; Massacesi L.; Barilaro A. (2019). A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet. IRDR, vol. 8, pp. 275-278, ISSN:2186-3644 DOI Accesso ONLINE all'editore

Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM (2019). Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments. EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, pp. 490-490, ISSN:1351-5101

Gastaldi, M; Casagrande, S; Benedetti, L; Bova, S; Di Filippo, M; Evoli, A; Ferrari, S; Foiadelli, T; Giacomini, T; Iorio, R; Mancardi, M; Mariotto, S; Mauri, M; Massa, F; Nosadini, M; Papetti, L; Ricci, S; Sartori, S; Savasta, S; Valeriani, M; Zoccarato, M; Zuliani, L; Massacesi, L; Franciotta, D (2019). Clinico-serological features in autoimmune encephalitis: an Italian multicentre retrospective study. EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, pp. 59-60, ISSN:1351-5101

Casagrande, S; Gastaldi, M; Barilaro, A; Biagioli, T; Paganini, M; Franciotta, D; Massacesi, L (2019). The spectrum of auto-immune encephalitis: Clinical characterisation and comparison between different syndromes defined by 2016 diagnostic criteria. EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, pp. 705-705, ISSN:1351-5101

Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM (2019). Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, pp. 106-106, ISSN:1351-5101

Innocenti, C; Di Gioia, M; Amato, MP; Ciccone, N; Cutini, I; Giannini, M; Gozzini, A; Guidi, S; Mariottini, A; Massacesi, L; Nozzoli, C; Repice, A; Maria, RG; Saccardi, R (2019). Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen. BONE MARROW TRANSPLANTATION, vol. 54, pp. 174-175, ISSN:0268-3369

Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM (2019). Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study. MULTIPLE SCLEROSIS, vol. 25, pp. 340-341, ISSN:1352-4585

Coles, A; Berkovich, R; Carraro, M; Compston, DAS; Al Malik, Y; Fernandez, O; Ionete, C; Massacesi, L; Meuth, SG; Mitsikostas, D; Pardo, G; Simm, RF; Steingo, B; Choudhry, Z; Daizadeh, N; Traboulsee, A (2019). Long-term efficacy and safety of Alemtuzumab in patients with RRMS: 12-year follow-up of the CAMMS223 study. MULTIPLE SCLEROSIS, vol. 25, pp. 320-321, ISSN:1352-4585

Montalban, X; Barone, D; Broadley, S; Dive, D; Hupperts, RM; Lycke, J; Massacesi, L; Naismith, RT; Nakamura, K; Pandey, K; Schippling, S; Vermersch, P; Wiendl, H; Chung, L; Daizadeh, N; Afsar, S; Van Wijmeersch, B (2019). Alemtuzumab improves outcomes in RRMS patients who switched from SC IFNB-1a: 6-year follow-up of CARE-MS I Patients (TOPAZ Study). EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, pp. 678-678, ISSN:1351-5101

Azzolini, F; Grammatico, M; Filippini, S; Carlucci, G; Repice, AM; Forci, B; Dallagiacoma, S; Busto, G; Fainardi, E; Massacesi, L (2019). MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination. EUROPEAN JOURNAL OF NEUROLOGY, vol. 26, pp. 473-474, ISSN:1351-5101

Van Wijmeersch, B; Barone, D; Broadley, S; Dive, D; Hupperts, RMM; Lycke, J; Massacesi, L; Montalban, X; Naismith, RT; Pandey, K; Schippling, S; Vermersch, P; Chung, L; Daizadeh, N; Rodriguez, CE; Nakamura, K; Wiendl, H (2018). Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study). MULTIPLE SCLEROSIS, vol. 24, pp. 488-489, ISSN:1352-4585

Grammatico, M; Carlucci, G; Dallagiacoma, S; Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L (2018). The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination. EUROPEAN JOURNAL OF NEUROLOGY, vol. 25, pp. 437-437, ISSN:1351-5101

Maria Pia, Amato ; Alfredsson, Lars; Aloisi, Francesca; Ascherio, Alberto; Baldin, Elisa; Bjørnevik, Kjetil; Comabella, Manuel; Correale, Jorge; Cortese, Marianna; Derfuss, Tobias; D’Hooghe, Marie; Ghezzi, Angelo; Gold, Julian; Hellwig, Kerstin; Hemmer, Bernhard; Koch-Henricksen, Nils; Gould, Annette Langer; Liblau, Roland; Linker, Ralf; Lolli, Francesco; Lucas, Robyn; Lünemann, Jan; Magyari, Melinda; Massacesi, Luca; Miller, Ariel; Miller, David H; Montalban, Xavier; Monteyne, Philippe; Mowry, Ellen; Münz, Christian; Nielsen, Nete M; Olsson, Tomas; Oreja-Guevara, Celia; Otero, Susana; Pugliatti, Maura; Reingold, Stephen; Riise, Trond; Robertson, Neil; Salvetti, Marco; Sidhom, Youssef; Smolders, Joost; Sørensen, Per Soelberg; Sollid, Ludvig; Steiner, Israel; Stenager, Egon; Sundstrom, Peter; Taylor, Bruce V; Tremlett, Helen; Trojano, Maria; Uccelli, Antonio; Waubant, Emmanuelle; Wekerle, Hartmut (2018). Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop. MULTIPLE SCLEROSIS JOURNAL, EXPERIMENTAL, TRANSLATIONAL AND CLINICAL, vol. 1, pp. 1-14, ISSN:2055-2173 DOI Accesso ONLINE all'editore

Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators. Collaborators (171) Bartholomé E, D'Hooghe M, Pandolfo M, Van Wijmeersch B, Bhan V, Blevins G, Brunet D, Devonshire V, Duquette P, Freedman M, Grand'Maison F, Jacques F, Lapierre Y, Lee L, Morrow S, Yeung M, Dufek M, Havrdová EK, Kanovsky P, Stetkarova I, Talabova M, Frederiksen J, Kant M, Petersen T, Ravnborg M, Sellebjerg F, Airas L, Elovaara I, Eralinna JP, Sarasoja T, Al Khedr A, Brassat D, Brochet B, Camu W, Debouverie M, Laplaud D, Lebrun Frenay C, Pelletier J, Vermersch P, Vukusi S, Baum K, Berthele A, Faiss J, Flachenecker P, Hohlfeld R, Krumbholz M, Lassek C, Maeurer M, Meuth S, Ziemssen T, Hardiman O, McGuigan C, Achiron A, Karussis D, Bergamaschi R, Morra VB, Comi G, Cottone S, Grimaldi L, Mancardi GL, Massacesi L, Nocentini U, Salvetti M, Scarpini E, Sola P, Tedeschi G, Trojano M, Zaffaroni M, Frequin S, Hupperts R, Killestein J, Schrijver H, Van Dijl R, van Munster E, Czarnecki M, Drozdowski W, Fryze W, Hertmanowska H, Ilkowski J, Kaminska A, Klodowska-Duda G, Maciejowski M, Motta E, Podemski R, Potemkowski A, Rog T, Selmaj K, Stelmasiak Z, Stepien A, Tutaj A, Zaborski J, Boyko A, Chefranova Z, Evdoshenko E, Khabirov F, Sivertseva S, Yakupov E, Alvarez Cermeño JC, Escartin A, Fernandez OF, Garcia-Merino A, Hernandez Perez MA, Ayuso GI, Lallana JM, Gairin XM, Oreja-Guevara C, Saiz Hinarejos A, Gunnarsson M, Lycke J, Martin C, Piehl F, Roshanisefat H, Sundstrom P, Duddy M, Gran B, Harrower T, Hobart J, Kapoor R, Lee M, Mattison P, Nicholas R, Pearson O, Rashid W, Rog D, Sharrack B, Silber E, Turner B, Williams A, Woolmore J, Young C, Bandari D, Berger J, Camac A, Cohan S, Conway J, Edwards K, Fabian M, Florin J, Freedman S, Garwacki D, Goldman M, Harrison D, Herrman C, Huang D, Javed A, Jeffery D, Kamin S, Katsamakis G, Khatri B, Langer-Gould A, Lynch S, Mattson D, Miller T, Miravalle A, Moses H, Muley S, Napier J, Nielsen A, Pachner A, Pardo G, Picone M, Robertson D, Royal W, Sheppard C, Thrower B, Twyman C, Waubant E, Wendt J, Yadav V, Zabad R, Zarelli G. (2018). Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.. THE LANCET NEUROLOGY, vol. 17, pp. 405-415, ISSN:1828-6607 DOI Accesso ONLINE all'editore

Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch LJ, Leocani L, Freedman MS, Plant GT, Preiningerova JL, Ziemssen F, Massacesi L, Chai Y, Xu L; RENEW Study Investigators (2018). Predictors of response to opicinumab in acute optic neuritis. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, vol. 5, pp. 1154-1162, ISSN:2328-9503 DOI Accesso ONLINE all'editore

Zamboni, P; Tesio, L; Galimberti, S; Massacesi, L; Salvi, F; D'Alessandro, R; Cenni, P; Galeotti, R; Papini, D; D'Amico, R; Simi, S; Valsecchi, Mg; Filippini, G; Brave Dreams Research Group, (2018). Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial.. JAMA NEUROLOGY, vol. 75, pp. 35-43, ISSN:2168-6157 DOI Accesso ONLINE all'editore

Maggi, P; Zellini, F; Passeri, A; Barilaro, A; Massacesi, L (2018). Natural history of brain inflammatory lesions in multiple sclerosis: a FLAIR and T1w post contrast MRI volumetric analysis. EUROPEAN JOURNAL OF NEUROLOGY, vol. 25, pp. 345-345, ISSN:1351-5101

Aldinucci, A; Rizzo, R; Bonechi, E; Fainardi, E; Bortolotti, D; Mariottini, A; Mechi, C; Repice, AM; Massacesi, L; Ballerini, C (2018). Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg. EUROPEAN JOURNAL OF NEUROLOGY, vol. 25, pp. 350-350, ISSN:1351-5101

Innocenti, C; Amato, MP; Barilaro, A; Bianchini, G; Capobianco, T; Calia, MA; Ceschini, R; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Mariottini, A; Massacesi, L; Nozzoli, C; Repice, A; Rossolini, G; Saccardi, R (2018). Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis. BONE MARROW TRANSPLANTATION, vol. 53, pp. 210-210, ISSN:0268-3369

Pradella, S; Paganini, M; Barilaro, A; Casagrande, S; Biagioli, T; Franciotta, D; Massacesi, L (2018). Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy. EUROPEAN JOURNAL OF NEUROLOGY, vol. 25, pp. 554-554, ISSN:1351-5101

Massacesi, L (2018). Challenges for modern MS therapy on back-ground of pathogenesis. EUROPEAN JOURNAL OF NEUROLOGY, vol. 25, pp. 12-12, ISSN:1351-5101

D'Amore, Angelica; Tessa, Alessandra; Casali, Carlo; Dotti, Maria Teresa; Filla, Alessandro; Silvestri, Gabriella; Antenora, Antonella; Astrea, Guja; Barghigiani, Melissa; Battini, Roberta; Battisti, Carla; Bruno, Irene; Cereda, Cristina; Dato, Clemente; Di Iorio, Giuseppe; Donadio, Vincenzo; Felicori, Monica; Fini, Nicola; Fiorillo, Chiara; Gallone, Salvatore; Gemignani, Federica; Gigli, Gian Luigi; Graziano, Claudio; Guerrini, Renzo; Gurrieri, Fiorella; Kariminejad, Ariana; Lieto, Maria; Marques LourenḈo, Charles; Malandrini, Alessandro; Mandich, Paola; Marcotulli, Christian; Mari, Francesco; Massacesi, Luca; Melone, Maria A B; Mignarri, Andrea; Milone, Roberta; Musumeci, Olimpia; Pegoraro, Elena; Perna, Alessia; Petrucci, Antonio; Pini, Antonella; Pochiero, Francesca; Pons, Maria Roser; Ricca, Ivana; Rossi, Salvatore; Seri, Marco; Stanzial, Franco; Tinelli, Francesca; Toscano, Antonio; Valente, Mariarosaria; Federico, Antonio; Rubegni, Anna; Santorelli, Filippo Maria (2018). Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study. FRONTIERS IN NEUROLOGY, vol. 9, pp. 0-0, ISSN:1664-2295 DOI

Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L. (2018). Central vein sign differentiates MS from CNS inflammatory vasculopathies.. ANNALS OF NEUROLOGY, vol. 83, pp. 283-294, ISSN:0364-5134 DOI Accesso ONLINE all'editore

Muraro, P.A.; Pasquini, ; M, .; Atkins, ; Hl, H.L.; Bowen, ; Jd, J.D.; Farge, ; D, .; Fassas, ; A, .; Freedman, ; Ms, M.S.; Georges, ; Ge, G.E.; Gualandi, ; F, .; Hamerschlak, ; N, .; Havrdova, ; E, .; Kimiskidis, ; Vk, V.K.; Kozak, ; T, .; Mancardi, ; Gl, G.L.; Massacesi, ; L, .; Moraes, ; Da, D.A.; Nash, ; Ra, R.A.; Pavletic, ; S, .; Ouyang, ; J, .; Rovira, ; M, .; Saiz, ; A, .; Simoes, ; B, .; Trněný, ; M, .; Zhu, ; L, .; Badoglio, ; M, .; Zhong, ; X, .; Sormani, ; Mp, M.P.; Saccardi, (2017). Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.. JAMA NEUROLOGY, vol. 74, pp. 459-469, ISSN:2168-6149 DOI Accesso ONLINE all'editore

Cadavid, D.; Balcer, L.; Galetta, S; Aktas, O; Ziemssen, T; Vanopdenbosch, L; Frederiksen, J; Skeen, M; Jaffe, G.J.; Butzkueven, H; Ziemssen, F; Massacesi, L; Chai, Y; Xu, L; Freeman (2017). Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.. LANCET NEUROLOGY, vol. 16, pp. 189-199, ISSN:1474-4422 DOI Accesso ONLINE all'editore

Maggi, Pietro; Sati, Pascal; Massacesi, Luca (2017). Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset.. JOURNAL OF NEUROIMMUNOLOGY, vol. 304, pp. 86-92, ISSN:0165-5728 DOI Accesso ONLINE all'editore

Aldinucci, A (Aldinucci, A.); Bonechi, E (Bonechi, E.); Barilaro, A (Barilaro, A.); Repice, A (Repice, A.); Biagioli, T (Biagioli, T.); Massacesi, L (Massacesi, L.); Emmi, G (Emmi, G.); D'elios, MM (D'elios, M. M.); Ballerini, C (Ballerini, C.) (2017). MMP9 index as possible diagnostic marker of Neuro-Behcet's disease. In: 3rd Congress of the European-Academy-of-Neurology, WILEY, pp. 335-335.

M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L. (2017). Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis.. MULTIPLE SCLEROSIS, vol. 23, pp. 432-432, ISSN:1352-4585

Franciotta D, Gastaldi M, Sala A, Andreetta F, Rinaldi E, Ruggieri M, Leante R, Costa G, Biagioli T, Massacesi L, Bazzigaluppi E, Fazio R, Mariotto S, Ferrari S, Galloni E, Perini F, Zardini E, Zuliani L, Zoccarato M, Giometto B, Bertolotto A. (2017). Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD).. NEUROLOGICAL SCIENCES, vol. 38, pp. 231-236, ISSN:1590-1874 DOI Accesso ONLINE all'editore

Forci, B; Mariottini, A; Mechi, C; Massacesi, L; Repice, A. (2017). Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports.. MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol. 15, pp. 24-26, ISSN:2211-0348 DOI Accesso ONLINE all'editore

Mariottini, A; Forci, B; Magnani, E; Massacesi, L; Repice, A (2017). Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports. MULTIPLE SCLEROSIS, vol. 23, pp. 923-924, ISSN:1352-4585

Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L (2017). Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience. MULTIPLE SCLEROSIS, vol. 23, pp. 307-308, ISSN:1352-4585

Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L; Repice, A (2017). Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments. MULTIPLE SCLEROSIS, vol. 23, pp. 874-874, ISSN:1352-4585

M., Grammatico; Dallagiacoma, S.; Lorenzoni, L.; Carlucci, G.; Repice, A. M.; Mechi, C.; Magnani, E.; Vuolo, L.; Fainardi, E.; Massacesi, L. (2017). Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis.. EUROPEAN JOURNAL OF NEUROLOGY, vol. 24, pp. 575-575, ISSN:1351-5101 Accesso ONLINE all'editore

Sati, P.; Oh, J.; Constable, R.T.; Evangelou, N.; Guttmann, C.R.G.; Henry, R.G.; Klawiter, E.C.; Mainero, C.; Massacesi, L.; Mcfarland, H.; Nelson, F.; Ontaneda, D.; Rauscher, A.; Rooney, W.D.; Samaraweera, A.P.R.; Shinohara, R.T.; Sobel, R.A.; Solomon, A.J.; Treaba, C.A.; Wuerfel, J.; Zivadinov, R.; Sicotte, N.L.; Pelletier, D.; Reich, D.S (2016). The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.. NATURE REVIEWS. NEUROLOGY, vol. 12, pp. 714-722, ISSN:1759-4758 DOI Accesso ONLINE all'editore

Innocenti, C; Barilaro, A; Fani, A; Mariottini, A; Massacesi, L; Repice, AM; Saccardi, R (2016). Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis. BONE MARROW TRANSPLANTATION, vol. 51, pp. S290-S290, ISSN:0268-3369

Saccardi, R; Repice, AM; Innocenti, C; Mariottini, A; Amato, MP; Guidi, S; Fani, A; Nistri, R; Giannini, M; Portaccio, E; Barilaro, A; Nozzoli, C; Gozzini, A; Massacesi, L (2016). Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience. MULTIPLE SCLEROSIS, vol. 22, pp. 376-377, ISSN:1352-4585

Massacesi, L (2016). Evaluation by brain MRI of white matter perivenular lesions in inflammatory micro-angiopatic ischemia and in demyelinating multiple sclerosis lesions. EUROPEAN JOURNAL OF NEUROLOGY, vol. 23, pp. 86-86, ISSN:1351-5101

Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A.; Magnani, E.; Spagni, G.; Prisco, D.; Silvestri, E.; Barilaro, A.; Sati, P.; Reich, D.; Massacesi, L. (2016). MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases.. MULTIPLE SCLEROSIS, vol. 22, pp. 403-404, ISSN:1352-4585 Accesso ONLINE all'editore

Montanari, E.; Rottoli, M.; Maimone, D.; Confalonieri, P.; Plewnia, K.; Frigo, M.; Francia, A.; Pala, A.; Losignore, N. A.; Ragonese, P.; Veneziano, A.; Traccis, S.; Bosco, G.; Dotta, M.; Severi, S.; Ragno, M.; Candeago, R. M.; Feleppa, M.; Stecchi, S.; Bosco, D.; Tola, M. R.; Massacesi, L.; Costantino, G.; Solaro, C. M.; Serrati, C.; Totaro, R.; Coniglio, M. G.; Scarpini, E.; Zuliani, C.; Perla, F.; Ticca, A.; Cottone, S.; Iudice, A.; Koudriavteva, T.; Di Battista, G.; Gasperini, C.; Perin, C.; Meola, G.; Pugliatti, M.; Bandini, F.; Cavalla, P.; Posteraro, F.; Consoli, D. (2016). A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study. JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 364, pp. 105-109, ISSN:0022-510X DOI Accesso ONLINE all'editore

Salvadori E.; Poggesi A.; Valenti R.; Pracucci G.; Pescini F.; Pasi M.; Nannucci S.; Marini S.; Del Bene A.; Ciolli L.; Ginestroni A.; Diciotti S.; Orlandi G.; Di Donato I.; De Stefano N.; Cosottini M.; Chiti A.; Federico A.; Dotti M.T.; Bonuccelli U.; Inzitari D.; Pantoni L.; Abbate R.; Boddi M.; Cesari F.; Coppo M.; Giusti B.; Gori A.M.; Mascalchi M.; Cecchi P.; Pagni C.; Siciliano G.; Tognoni G.; Formichi P.; Gambetti C.; Giorgio A.; Rossi F.; Stromillo L.; Zicari E.; Zolo P.; Tiezzi A.; Bertini E.; Brotini S.; Guidi L.; Lombardi M.; Mugnai S.; Notarelli A.; Bracco L.; Cadelo M.; Cisbani R.; Gabbani L.; Gori G.; Lambertucci L.; Massacesi L.; Mossello E.; Paganini M.; Piccininni M.; Pinto F.; Pozzi C.; Sorbi S.; Zaccara G.; Borgogni T.; Mancuso M.; Marconi R.; Mazzoni M.; Vista M.; Meucci G.; Bellini G.; Gabrielli L.; Frittelli C.; Galli R.; Gambaccini G.; Bartolini S.; Biagini C.; Caleri V.; Vanni P.; Calvani D.; Giorgi C.; Magnolfi S.; Palumbo P.; Valente C.; Rossi A.; Tassi R.; Boschi S.; Baldacci F. (2016). Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study. ALZHEIMER'S & DEMENTIA, vol. 12, pp. 0-0, ISSN:1552-5260 DOI Accesso ONLINE all'editore

Massacesi, L; Grammatico, M; Vuolo, L; Barilaro, A; Benedetti, MD; La Mantia, L; Milanese, C; Repice, AM; Solari, A; Tedeschi, G; Filippini, G (2016). Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, vol. 23, pp. 405-405, ISSN:1351-5101

Massacesi, L (2016). Perivenular Distribution of White Matter Lesions Evaluated by MRI Can Differentiate MS Lesions from Inflammatory Small Vessel Diseases. NEUROLOGY, vol. 86, pp. 121-121, ISSN:0028-3878

Innocenti, C; Barilaro, A; Fani, A; Mariottini, A; Massacesi, L; Repice, AM; Saccardi, R (2016). Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports. BONE MARROW TRANSPLANTATION, vol. 51, pp. S601-S601, ISSN:0268-3369

Saccardi, R; Barilaro, A; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Innocenti, C; Mariottini, A; Nozzoli, C; Portaccio, E; Repice, AM; Amato, MP; Massacesi, L (2016). intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience. BONE MARROW TRANSPLANTATION, vol. 51, pp. S495-S495, ISSN:0268-3369

Maggi, P; Zellini, F; Barilaro, A; Passeri, A; Massacesi, L (2016). Time Course of Multiple Sclerosis Lesions Visualized with MRI: Insight into Focal Pathology. NEUROLOGY, vol. 86, pp. 569-569, ISSN:0028-3878

Lagi, Filippo; Bartalesi, Filippo; Pecile, Patrizia; Biagioli, Tiziana; Caldini, Anna Lucia; Fanelli, Alessandra; Giannazzo, Giuseppe; Grifoni, Stefano; Massacesi, Luca; Bartoloni, Alessandro; Rossolini, Gian Maria (2016). Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults. JOURNAL OF CLINICAL MICROBIOLOGY, vol. 54, pp. 1851-1854, ISSN:0095-1137 DOI Accesso ONLINE all'editore

Maggi, P; Mazzoni, L; Moretti, M; Massacesi, L (2015). Gadolinium improves susceptibility weighted imaging vein detection in multiple sclerosis white matter contrast enhancing lesions.. ACTA RADIOLOGICA OPEN, pp. 0-0, ISSN:2058-4601

Maggi, P; Mazzoni, Ln; Moretti, M; Grammatico, M; Chiti, S; Massacesi, L. (2015). SWI enhances vein detection using gadolinium in multiple sclerosis.. ACTA RADIOLOGICA, vol. 4, pp. 0-0, ISSN:0284-1851 DOI Accesso ONLINE all'editore

Giovannelli, I; Martelli, F; Repice, A; Massacesi, L; Azzi, A; Giannecchini, S. (2015). Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy.. JOURNAL OF NEUROVIROLOGY, vol. 21, pp. 0-0, ISSN:1355-0284 DOI Accesso ONLINE all'editore

Capobianco, Marco; Re, Marianna Lo; Sangalli, Francesca; Moiola, Lucia; Perini, Paola; Gallo, Paolo; Danni, Maura; Provinciali, Leandro; Repice, Annamaria; Massacesi, Luca; Messina, Silvia; Patti, Francesco; Laroni, Alice; Mancardi, Gian Luigi; Pucci, Eugenio; Calabrese, Massimiliano; Bertolotto, Antonio (2015). Cyclophosphamide Pulse Therapy after Natalizumab Discontinuation for Multiple Sclerosis: a multicenter study.. JOURNAL OF MULTIPLE SCLEROSIS, vol. 2, pp. 0-0, ISSN:2376-0389 DOI Accesso ONLINE all'editore

Capobianco, M.; Lo Re, M.; Sangalli, F.; Moiola, L.; Comi, G.; Perini, P.; Gallo, P.; Danni, M.; Provinciali, L.; Repice, A.; Massacesi, L.; Patti, F.; Messina, S.; Laroni, A.; Mancardi, G. L.; Calabrese, M.; Monaco, S.; Pucci, E.; Giuliani, G.; Bertolotto, A. (2015). Cyclophosphamide pulses therapy after natalizumab discontinuation in Multiple Sclerosis patients. EUROPEAN JOURNAL OF NEUROLOGY, vol. 22, pp. 0-0, ISSN:1468-1331 Accesso ONLINE all'editore

Kurukulasuriya, N.; Fernandez, O.; Balcer, L.; Galetta, S.; Aktas, O.; Ziemssen, T.; Vanopdenbosch, L.; Butzkueven, H.; Ziemssen, F.; Massacesi, L.; Chai, Y.; Xu, L.; Freeman, S.; Cadavid, D. (2015). Efficacy for remyelination and safety of anti-lingo-1 monoclonal antibody (biib033) in acute optic neuritis: results from the renew study. JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 357, pp. e14-e15, ISSN:0022-510X DOI

Clausi, V; Giannecchini, S; Magnani, E; Repice, A; Mechi, C; Martelli, F; Azzi, A; Massacesi, L. (2015). Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.. NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION, vol. 2, pp. 1-4, ISSN:2332-7812 DOI Accesso ONLINE all'editore

Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; Grammatico Di Tullio, M.; Silvestri, E.; Barilaro, A.; Prisco, D.; Emmi, L.; Massacesi, L. (2015). Imaging perivenular distribution can differentiate MS from CNS vasculitis.. MULTIPLE SCLEROSIS, vol. 21, pp. 471-471, ISSN:1352-4585 Accesso ONLINE all'editore

Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, Donelli A, Lugaresi A, Di Bartolomeo P, Rottoli MR, Rambaldi A, Amato MP, Massacesi L, Di Gioia M, Vuolo L, Currò D, Roccatagliata L, Filippi M, Aguglia U, Iacopino P, Farge D, Saccardi R; (2015). Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: a phase II trial.. NEUROLOGY, vol. 84, pp. 981-988, ISSN:0028-3878 DOI Accesso ONLINE all'editore

Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; M., Grammatico; Prisco, D.; Silvestri, E.; Barilaro, A.; Emmi, L.; Massacesi, L. (2015). Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies.. EUROPEAN JOURNAL OF NEUROLOGY, vol. 22, pp. 216-216, ISSN:1468-1331 DOI Accesso ONLINE all'editore

Cadavid, D; Balcer, L; Galetta, S; Aktas, O; Ziemssen, T; Vanopdenbosch, L; Butzkueven, H; Ziemssen, F; Massacesi, L; Chai, Y; Xu, L; Freeman, S (2015). Evidence of remyelination with the anti-LINGO-1 monoclonal antibody BIIB033 after acute optic neuritis. NEUROLOGY, vol. 85, pp. E46-E46, ISSN:0028-3878

Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L (2015). Leptomeningeal enhancement analysis in diagnostic clinical setting. MULTIPLE SCLEROSIS, vol. 21, pp. 210-210, ISSN:1352-4585

Vuolo, L; Dewey, B; Sati, P; Massacesi, L; Reich, DS (2015). Efficiency of FLAIR* at 1.5T, 3T, and 7T for detecting perivenular lesions in multiple sclerosis (MS). MULTIPLE SCLEROSIS, vol. 21, pp. 210-210, ISSN:1352-4585

Bandieri, L; Vuolo, L; Repice, AM; Grammatico, M; Mechi, C; Massacesi, L (2015). Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume. EUROPEAN JOURNAL OF NEUROLOGY, vol. 22, pp. 303-303, ISSN:1351-5101

Mariottini, A; Innocenti, C; Repice, AM; Fani, A; Massacesi, L; Saccardi, R (2015). Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis. MULTIPLE SCLEROSIS, vol. 21, pp. 768-769, ISSN:1352-4585

Muraro, PA; Pasquini, M; Atkins, H; Bowen, J; Farge, D; Fassas, A; Freedman, MS; Georges, GE; Gualandi, F; Hamerschlak, N; Havrdova, E; Kimiskidis, VK; Kozak, T; Mancardi, GL; Massacesi, L; Moraes, D; Nash, RA; Pavletic, S; Ouyang, J; Rovira, M; Saiz, A; Simoes, B; Trneny, M; Zhu, L; Zhong, X; Badoglio, M; Sormani, MP; Saccardi, R (2015). Long term outcomes after autologous hematopoietic stem cell transplantation for treatment of MS. MULTIPLE SCLEROSIS, vol. 21, pp. 63-64, ISSN:1352-4585

Laroni A.; Brogi D.; Morra V.B.; Guidi L.; Pozzilli C.; Comi G.; Lugaresi A.; Turrini R.; Raimondi D.; Uccelli A.; Mancardi G.L.; Amato M.P.; Appendino L.; Ardito B.; Avolio C.; Bandini F.; Batocchi A.P.; Bellantonio P.; Benedetti M.D.; Bergamaschi R.; Bortolon F.; Bosco A.; Buccafusca M.; Cargnelutti D.; Cavalla P.; Cavallo R.; Centonze D.; Coniglio M.G.; Costantino G.; Cottone S.; Danni M.C.; De Robertis F.; Deotto L.; Dotta M.; Di Battista G.; Filippi M.M.; Florio C.; Francia A.; Galgani S.; Gallo P.; Ghezzi A.; Giometto B.; Giuliani G.; Grimaldi L.M.E.; Guidotti M.; Iudice A.; Lenzi G.L.; Lorusso L.; Lus G.; Maimone D.; Malentacchi G.M.; Mantegazza R.E.; Massacesi L.; Melato M.; Millefiorini E.; Montanari E.; Patti F.; Perrone P.S.M.; Protti A.; Provera P.; Quattrone A.; Rasi F.; Rosati G.; Rovaris M.; Saccà F.; Salemi G.; Sarchielli P.; Scarpini E.A.; Schoenhuber R.; Serrati C.; Sinisi L.; Sola P.; Spitaleri D.L.A.; Tedeschi G.; Tezzon F.; Tinebra Asti M.C.; Tola M.R.; Totaro R.; Trojano M.; Ulivelli M.; Vecchio M.M.; Zimatore G.B. (2014). Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.. BMC NEUROLOGY, vol. 14, pp. 0-0, ISSN:1471-2377 DOI Accesso ONLINE all'editore

Massacesi L; Tramacere I; Amoroso S; Battaglia M; Benedetti MD; Filippini G; La Mantia L; Repice A M; Solari A; Tedeschi G; Milanese C (2014). Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.. PLOS ONE, vol. 9 (11), pp. 113371-113380, ISSN:1932-6203 DOI Accesso ONLINE all'editore

María I Gaitán; Pietro Maggi; Jillian Wohler; Emily Leibovitch; Pascal Sati; Ismael L Calandri; Hellmut Merkle; Luca Massacesi; Afonso C Silva; Steven Jacobson; Daniel S Reich. (2014). Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging.. MULTIPLE SCLEROSIS, vol. 20, pp. 64-71, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Di Gioia, M; Innocenti, C; Donnini, I; Nozzoli, C; Bosi, A; Guidi, S; Rigacci, L; Repice, A; Massacesi, L; Portaccio, E; Amato, MP; Saccardi, R (2014). CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY. BONE MARROW TRANSPLANTATION, vol. 49, pp. S248-S249, ISSN:0268-3369

Maggi P.; Cummings Macri S.; Gaitán M.; Leibovitch E.; Wohler J.; Knight H.; Ellis M.; Wu T.; Silva A.; Massacesi L.; Jacobson S.; Westmoreland S.; Reich D. (2014). The formation of inflammatory demyelinated lesions in cerebral white matter.. ANNALS OF NEUROLOGY, vol. 76 (4), pp. 594-608, ISSN:0364-5134 DOI Accesso ONLINE all'editore

M Paganini; A Biggeri; AM Romoli; C Mechi; E Ghelli; V Berti; S Pradella; S Bucciantini; D Catelan; R Saccardi; L Lombardini; M Mascalchi; L Massacesi; B Porfirio; N Di Lorenzo; GB Vannelli; P Gallina (2014). Fetal striatal grafting slows motor and cognitive decline of Huntington's disease. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, vol. 85, pp. 974-981, ISSN:0022-3050 DOI

Elena Bonechi;Alessandra Aldinucci;Benedetta Mazzanti;Massimo di Gioia;Anna Maria Repice;Cinzia Manuelli;Riccardo Saccardi;Luca Massacesi;Clara Ballerini (2014). Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, vol. 1 (9), pp. 650-658, ISSN:2328-9503 DOI

Gallina P; Paganini M; Lombardini L; Biggeri A; Marini M; Morelli AM; Bucciantini S; Sarchielli E; Ambrosini S; Mechi C; Romoli AM; Ghelli E; Pradella S; Urbani S; Mazzanti B; Berti V; Giordano GP; Campolo M; Dal Pozzo S; Piacentini S; Saccardi R; Massacesi L; Mascalchi M; Bosi A; Conti R; Porfirio B; Di Lorenzo N; Vannelli GB (2014). Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana. TRAPIANTI, vol. 18, pp. 5-11, ISSN:1590-072X

Massacesi L. (2013). Il ruolo delle Agenzie regolatorie nel percorso autorizzativo dei farmaci neurologici in Europa.. Pisa: Primula Multimedia SrL

Massacesi L. (2013). Percorsi assistenziali del paziente con Sclerosi Multipla.. Verona: Maya Idee, ISBN:9788895958439

Valentina Carrai; Irene Donnini; Benedetta Mazzanti; Renato Alterini; Maria Pia Amato; Alessandro Barilaro; Alberto Bosi; Luca Massacesi; Emilio Portaccio; Anna Maria Repice; Giada Rotunno; Riccardo Saccardi. (2013). Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation. CLINICAL NEUROLOGY AND NEUROSURGERY, vol. 115, pp. 1044-1048, ISSN:0303-8467 DOI Accesso ONLINE all'editore

Massacesi, L; Tramacere, I; Benedetti, MD; Filippini, G; Lamantia, L; Solari, A; Amoroso, S; Battaglia, M; Tedeschi, G; Milanese, C (2013). Direct Comparison of Azathioprine and beta Interferon Efficacy in Multiple Sclerosis. NEUROLOGY, vol. 80, pp. 1200-1200, ISSN:0028-3878

Maggi, P; Macri, SMC; Gaitan, MI; Leibovitch, E; Wholer, JE; Wu, T; Silva, A; Massacesi, L; Jacobson, S; Westmoreland, S; Reich, DS (2013). The formation of inflammatory demyelinating lesions: MRI and pathology in a primate model of multiple sclerosis. MULTIPLE SCLEROSIS, vol. 19, pp. 427-428, ISSN:1352-4585

Simone Giannecchini ; Irene Giovannelli; Valeria Clausi; Anna Repice; Luca Massacesi; Alberta Azzi (2013). Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC.. In: 41° congresso nazionale della Società Italiana di Microbiologia, Riccione, 16-18 Ottobre 2013, SIM, pp. 97-97.

Mazzanti, B; Aldinucci, A; Bonechi, E; Boieri, M; Di Gioia, M; Repice, A; Donnini, I; Massacesi, L; Saccardi, R; Ballerini, C (2013). Mesenchymal Stem Cells and Autoimmune Diseases: The Case of Multiple Sclerosis. NEUROLOGY, vol. 80, pp. 5178-5178, ISSN:0028-3878

Giambene, B; Di Tullio, MG; Massacesi, L; Menchini, U (2013). Retinal Nerve Fiber Layer Thickness As Prognostic Indicator For The Conversion To Clinically Definite Multiple Sclerosis In Clinically Isolated Syndrome With Acute Retrobulbar Optic Neuritis. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 54, pp. 2348-2348, ISSN:0146-0404

Galante, A; Bonechi, E; Mariottini, A; Aldinucci, A; Biagioli, T; Mechi, C; Repice, A; Massacesi, L; Ballerini, C (2013). CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions. MULTIPLE SCLEROSIS, vol. 19, pp. 152-152, ISSN:1352-4585

Alessandra Aldinucci; Antonio Turco; Tiziana Biagioli; Francesca Maria Toma; Daniele Bani; Daniele Guasti; Cinzia Manuelli; Lisa Rizzetto; Duccio Cavalieri; Luca Massacesi; Tommaso Mello; Denis Scaini; Alberto Bianco; Laura Ballerini; Maurizio Prato; Clara Ballerini. (2013). Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale.. NANO LETTERS, vol. 13, pp. 6098-6105, ISSN:1530-6984 DOI Accesso ONLINE all'editore

Mancardi, G.L.; Sormani, M.P.; Di Gioia, M.; Vuolo, L.; Gualandi, F.; Amato, M.P.; Capello, E.; Currò, D.; Uccelli, A.; Bertolotto, A.; Gasperini, C.; Lugaresi, A.; Merelli, E.; Meucci, G.; Motti, L.; Tola, M.R.; Scarpini, E.; Repice, A.M.; Massacesi, L.; Saccardi, R. (2012). Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience. MULTIPLE SCLEROSIS, vol. 18, pp. 835-842, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Gian Luigi Mancardi ;Maria Pia Sormani; Massimo Di Gioia; Luisa Vuolo ;Francesca Gualandi; Maria Pia Amato; Elisabetta Capello; Daniela Currò ; Antonio Uccelli; Antonio Bertolotto; Claudio Gasperini; Alessandra Lugaresi ; Elisa Merelli; Giuseppe Meucci; Luisa Motti; Maria Rosaria Tola; Elio Scarpini; Anna Repice A;Massacesi L;Riccardo Saccardi; Alberto Bosi; The Italian BMT Study Group (2012). Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.. MULTIPLE SCLEROSIS, vol. 18, pp. 835-842, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Lutterotti A; Jelcić I; Schulze C; Schippling S; Breiden P; Mazzanti B; Reinhardt S; Di Gioia M; Repice A; Massacesi L; Sputtek A; Salinas-Riester G; Kroeger N; Sospedra M; Saccardi R; Zander A; Martin R.; Bosi A. (2012). No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.. MULTIPLE SCLEROSIS, vol. 18 (8), pp. 1188-1192, ISSN:1352-4585 DOI Accesso ONLINE all'editore

Clausi, V.; Martelli, F.; Repice, A.; Mechi, C.; Magnani, E.; Massacesi, Luca; Azzi, Alberta; Giannecchini, Simone (2012). Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy.. MULTIPLE SCLEROSIS, vol. 18, pp. 467-467, ISSN:1352-4585

Valeria, Clausi; Francesco, Martelli; Anna, Repice; Claudia, Mechi; Eliana, Magnani; Massacesi, Luca; Azzi, Alberta; Giannecchini, Simone (2012). Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy.. MULTIPLE SCLEROSIS, vol. 18, pp. 467-467, ISSN:1352-4585

Paolo Zamboni; Antonio Bertolotto; Paolo Boldrini; Patrizia Cenni; Roberto D’Alessandro; Roberto D’Amico; Massimo Del Sette; Roberto Galeotti; Stefania Galimberti; Alessandro Liberati; Luca Massacesi; Donato Papini; Fabrizio Salvi; Silvana Simi; Andrea Stella; Luigi Tesio; Maria Grazia Valsecchi; Graziella Filippini; (2012). Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial. TRIALS, vol. 13, pp. 183-195, ISSN:1745-6215 DOI Accesso ONLINE all'editore

Massacesi, L; Tramacere, I; Benedetti, MD; Filippini, G; La Mantia, L; Solari, A; Milanese, C (2012). Non-inferiority of azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomised trial. MULTIPLE SCLEROSIS, vol. 18, pp. 187-188, ISSN:1352-4585

Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rambaldi, A; Rottoli, M; Amato, MP; Massacesi, L; Di Gioia, M; Vuolo, L; Curro, D; Roccatagliata, L; Capello, E; Uccelli, A; Iacopino, P; Aguglia, U; Filippi, M; Saccardi, R (2012). Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial. MULTIPLE SCLEROSIS, vol. 18, pp. 209-209, ISSN:1352-4585

Maggi, P; Leibovitch, E; Gaitan, MI; Wholer, J; Nair, G; Massacesi, L; Jacobson, S; Silva, A; Reich, DS (2012). Blood Brain Barrier Changes Prior to Lesion Formation in a Primate Model of Multiple Sclerosis. ANNALS OF NEUROLOGY, vol. 72, pp. S114-S114, ISSN:0364-5134

Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rottoli, M; Rambaldi, A; Amato, MP; Massacesi, L; Vuolo, L; Curro, D; Roccatagliata, L; Filippi, M; Russo, C; Iacopino, P; Saccardi, R (2012). Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis. BONE MARROW TRANSPLANTATION, vol. 47, pp. S83-S83, ISSN:0268-3369

Maggi, P; Sati, P; Macri, S; Leibovitch, E; Absinta, M; Massacesi, L; Westmoreland, S; Jacobson, S; Silva, A; Reich, DS (2012). Biological origin of MR phase contrast in white matter lesions at 7T. MULTIPLE SCLEROSIS, vol. 18, pp. 150-150, ISSN:1352-4585

Maggi, P; Sati, P; Leibovitch, E; Gaitan, MI; Wholer, J; Macri, S; Massacesi, L; Westmoreland, S; Jacobson, S; Silva, A; Reich, DS (2012). Phase Imaging in Marmoset EAE at 7T Demonstrates Heterogeneity within Focal Lesions. ANNALS OF NEUROLOGY, vol. 72, pp. S115-S115, ISSN:0364-5134

Carrai V; Donnini I; Mazzanti B; Alterini R; Amato MP; Barilaro A;Bosi A; Massacesi L; Portaccio E; Repice AM; Rotunno G Saccardi R. (2012). Immunohistochemistry analsis of bone marrow biopies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation.. CLINICAL NEUROLOGY AND NEUROSURGERY, pp. 0-0, ISSN:0303-8467

Saccardi, R; Donnini, I; Repice, A; Maggi, P; Di Gioia, M; Andreoli, E; Bosi, A; Guidi, S; Gozzini, A; Massacesi, L; Amato, MP; Nozzoli, C (2011). CMV and EBV reactivation in autologous haemopoietic stem cell transplantation for severe multiple sclerosis. BONE MARROW TRANSPLANTATION, vol. 46, pp. S378-S379, ISSN:0268-3369

Snowden JA; Saccardi R; Allez M; Ardizzone S; Arnold R; Cervera R; Denton C; Hawkey C; Labopin M; Mancardi G; Martin R; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; van Laar JM; Farge D; on behalf of the EBMT Autoimmune Disease Working Party (ADWP) and Paediatric Diseases Working Party (PDWP); Massacesi L. (2011). Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.. BONE MARROW TRANSPLANTATION, vol. 47(6), pp. 1-21, ISSN:0268-3369 DOI

Gaitán MI; Shea CD; Evangelou IE; Stone RD; Fenton KM; Bielekova B; Massacesi L; Reich DS. (2011). Evolution of the Blood-Brain Barrier in Newly Forming Multiple Sclerosis Lesions.. ANNALS OF NEUROLOGY, vol. 70(1), pp. 22-29, ISSN:1531-8249 DOI

Gaitan, MI; Maggi, P; Wohler, J; Sati, P; Silva, AC; Massacesi, L; Jacobson, S; Reich, DS (2011). 7T MRI reveals the perivascular distribution of lesions in an animal model of multiple sclerosis. MULTIPLE SCLEROSIS, vol. 17, pp. S376-S376, ISSN:1352-4585

Massacesi, L; Filippini, G; Benedetti, D; La Mantia, L; Solari, A; Milanese, C (2011). Randomised controlled direct comparison of azathioprine and beta interferons efficacy in relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS, vol. 17, pp. S429-S430, ISSN:1352-4585

Gaitan, MI; Shea, CD; Evangelou, IE; Stone, RD; Fenton, KM; Bielekova, B; Massacesi, L; Reich, DS (2011). In Vivo Blood-Brain Barrier Evolution of Newly Forming Multiple Sclerosis Lesions. NEUROLOGY, vol. 76, pp. A358-A358, ISSN:0028-3878

Di Gioia, M; Guidi, S; Bosi, A; Amato, MP; Portaccio, E; Repice, A; Barilaro, A; Massacesi, L; Saccardi, R (2011). HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility. BONE MARROW TRANSPLANTATION, vol. 46, pp. S379-S379, ISSN:0268-3369

Maggi, P; Gaitan, MI; Wohler, J; Liu, J; Senseney, J; Shea, C; Massacesi, L; Jacobson, S; Silva, A; Reich, DS (2011). Early blood-brain-barrier permeability changes in the normal-appearing white matter of a marmoset model of MS. MULTIPLE SCLEROSIS, vol. 17, pp. S103-S103, ISSN:1352-4585

Aldinucci A; Biagioli T; Manuelli C; Repice A; Massacesi L; Ballerini C. (2010). Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP.. JOURNAL OF NEUROIMMUNOLOGY, vol. 218(1-2), pp. 28-35, ISSN:0165-5728 DOI Accesso ONLINE all'editore

Aldinucci A; Rizzetto L; Pieri L; Nosi D; Romagnoli P; Biagioli T; Mazzanti B; Saccardi R; Beltrame L; Massacesi L; Cavalieri D; Ballerini C. (2010). Inhibition of Immune Synapse by Altered Dendritic CellActin Distribution: A New Pathway of Mesenchymal StemCell Immune Regulation.. JOURNAL OF IMMUNOLOGY, vol. 185(9), pp. 5102-5110, ISSN:0022-1767 DOI

Ballerini, C; Galante, A; Biagioli, T; Repice, A; Barilaro, A; Aldinucci, A; Massacesi, L (2010). Antigen Driven T-Cell Response in CSF of Multiple Sclerosis Patients. ANNALS OF NEUROLOGY, vol. 68, pp. S57-S58, ISSN:0364-5134

Aldinucci, A; Mazzanti, B; Galante, A; Dal Pozzo, S; Saccardi, R; Massacesi, L; Ballerini, C (2010). DIFFERENCES IN MSCS IP-10 PRODUCTION BETWEEN MS PATIENTS AND HEALTHY DONORS. BONE MARROW TRANSPLANTATION, vol. 45, pp. S20-S20, ISSN:0268-3369

A. Aldinucci; T. Biagioli; B. Mazzanti; L. Pieri; P. Romagnoli; R. Saccardi; D. Cavalieri; L. Massacesi; C. Ballerini (2010). MSCs shift DCs from immunogenic to tolerogenic through contact induced cytoskeleton modifications.. BONE MARROW TRANSPLANTATION, vol. 45 (Suppl. 1), pp. S20-S20, ISSN:0268-3369

Freedman, M; Amato, MP; Atkins, H; Carreras, E; Fassas, A; Griffith, LM; Kerr, D; Martin, R; Massacesi, L; Muraro, P; Nash, R; Pasquini, M; Saccardi, R; Sormani, MP; Mancardi, G (2010). Panel Session Report: Multiple Sclerosis. BONE MARROW TRANSPLANTATION, vol. 45, pp. S8-S10, ISSN:0268-3369

Mazzanti, B; Cuzzola, M; Di Gioia, M; Fedele, R; Massara, E; Cannata, MC; Dal Pozzo, S; Ballerini, C; Aldinucci, A; Amato, MP; Massacesi, L; Bosi, A; Saccardi, R; Iacopino, P (2010). GENE EXPRESSION ANALYSIS OF PBMNC FROM MS PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (HSCT). BONE MARROW TRANSPLANTATION, vol. 45, pp. S22-S22, ISSN:0268-3369

Sati, P; Silva, AC; Gaitan, MI; Wohler, JE; Evangelou, IE; Massacesi, L; Jacobson, S; Reich, DS (2010). In-Vivo Myelin Water Imaging using T2*Decay at 7T. ANNALS OF NEUROLOGY, vol. 68, pp. S34-S34, ISSN:0364-5134

Massacesi, L (2009). Evolution of immune system aberration instigates early treatment of active MS. EUROPEAN JOURNAL OF NEUROLOGY, vol. 16, pp. 14-14, ISSN:1351-5101

’t Hart B.; Massacesi L. (2009). Clinical, pathological and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, vol. 68 (4), pp. 341-355, ISSN:0022-3069 DOI Accesso ONLINE all'editore

E. Bizzoco; F. Lolli; AM Repice; B. Hakiki; M. Falcini; A. Barilaro; R. Taiuti; G. Siracusa; M.P. Amato; T. Biagioli; S. Lori; M. Moretti; A. Vinattieri; P. Nencini; L. Massacesi; S. Matà (2009). Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.. JOURNAL OF NEUROLOGY, vol. 11, pp. 1891-1898, ISSN:0340-5354 DOI Accesso ONLINE all'editore

Caleri, F; Repice, A; Zellini, F; Barilaro, A; De Cristofaro, MT; Pupi, A; Massacesi, L (2009). Cerebral perfusion abnormalities in multiple sclerosis patients with markers of systemic autoimmunity. EUROPEAN JOURNAL OF NEUROLOGY, vol. 16, pp. 267-267, ISSN:1351-5101

Mazzanti, B; Aldinucci, A; Biagioli, T; Barilaro, A; Crescioli, C; Saccardi, R; Massacesi, L; Ballerini, C (2009). Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology. EUROPEAN JOURNAL OF NEUROLOGY, vol. 16, pp. 250-250, ISSN:1351-5101

Repice, AM; Di Gioia, M; Barilaro, A; Saccardi, R; Donnini, I; Guidi, S; Zellini, F; Massacesi, L (2009). Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience. EUROPEAN JOURNAL OF NEUROLOGY, vol. 16, pp. 267-267, ISSN:1351-5101

Aldinucci, A; Biagioli, T; Manuelli, C; Barilaro, A; Massacesi, L; Ballerini, C (2009). Modulating DC from immunogenic to tolerogenic responses: a novel mechanism of azathioprine (AZA). EUROPEAN JOURNAL OF NEUROLOGY, vol. 16, pp. 250-250, ISSN:1351-5101

A. Aldinucci; T. Biagioli; L. Pieri; P. Romagnoli; B. Mazzanti; R. Saccardi; L. Massacesi; C. Ballerini (2009). MSCs-DCs interaction: a cell-cell contact mechanism inducing tolerance.. BONE MARROW TRANSPLANTATION, vol. 43 (Suppl. 1), pp. S19-S19, ISSN:0268-3369

DALFONSO S; BOLOGNESI E; GUERINI F; BARIZZONE N; BOCCA S; CASTELLI L; BERGAMASCHI L; AGLIARDI C; FERRANTE P; NALDI P; LEONE M; CAPUTO D; BALLERINI C; SALVETTI M; GALIMBERTI D; MASSACESI L; TROJANO M; MOMIGLIANO-RICHIARDI P; FERRANTE D. (2008). A sequence variation in the MOG gene is involved in Multiple Sclerosis susceptibility in Italy.. GENES AND IMMUNITY, vol. 9, pp. 7-15, ISSN:1466-4879 DOI

I. Luccarini; C. Ballerini; T. Biagioli; F. Biamonti; A. Bellucci; MC. Rosi; C. Grossi; L. Massacesi; F. Casamenti (2008). Combined treatment with atorvastatin and minocycline suppresses severity of EAE. EXPERIMENTAL NEUROLOGY, vol. 211, pp. 214-226, ISSN:0014-4886 DOI

Farina, C; Di Dario, M; Di Stefano, AL; Ballerini, C; Biagioli, T; Franciotta, D; Mantegazza, R; Confalonieri, P; Massacesi, L; Bergamaschi, R; La Mantia, L; Milanese, C; Medico, E (2008). Blood gene signatures in clinically isogated syndromes and multiple sclerosis. NEUROLOGY, vol. 70, pp. A384-A384, ISSN:0028-3878

A. Aldinucci; T. Biagioli; L. Pieri; P. Romagnoli; B. Mazzanti; R. Saccardi; L. Massacesi; C. Ballerini (2008). MSCs-DCs interactions: An intimate cell-cell contact.. JOURNAL OF NEUROIMMUNOLOGY, vol. 203, pp. 250-250, ISSN:0165-5728

Mazzanti B; Aldinucci A; Biagioli T; Barilaro A; Urbani S; Dal Pozzo S; Amato MP; Siracusa G; Crescioli C; Manuelli C; Bosi A; Saccardi R; Massacesi L; Ballerini C. (2008). Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment. JOURNAL OF NEUROIMMUNOLOGY, vol. 199, pp. 142-150, ISSN:0165-5728 DOI

ALDINUCCI A; GERLINI G; FOSSATI S; CIPRIANI G; BALLERINI C; BIAGIOLI T; PIMPINELLI N; BORGOGNONI L; MASSACESI L; MORONI F; CHIARUGI A. (2007). A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.. JOURNAL OF IMMUNOLOGY, vol. 179(1), pp. 305-312, ISSN:0022-1767

ROCCATAGLIATA L; ROCCA M; VALSASINA P; BONZANO L; SORMANI M; SACCARDI R; MANCARDI G; FILIPPI M; FOR THE ITALIAN GITMO-NEURO INTERGROUP ON AUTOLOGOUS STEM CELL TRANSPLANTATION; MASSACESI L. (2007). The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.. MULTIPLE SCLEROSIS, vol. 13, pp. 1068-1070, ISSN:1352-4585 DOI

G.L. Mancardi; R. Saccardi; A. Murialdo; F. Pagliai; F. Gualandi; A. Marmont; M. Inglese; P. Bruzzi; M.P. Sormani; M.G. Marrosu; G. Meucci; L. Massacesi; A. Bertolotto; A. Lugaresi; E. Merelli; M. Filippi. (2007). Intense Immunosuppression Followed by Autologous Stem Cell Transplantation in Severe Multiple Sclerosis Cases: MRI and Clinical Data.. In: R. K. Burt. Stem Cell Therapy for Autoimmune Disease, pp. *-*, *: Landes Bioscience.

RISTORI G; CANNONI S; STAZI MA; VANACORE N; COTICHINI R; ALFO M; PUGLIATTI M; SOTGIU S; SOLARO C; BOMPREZZI R; DI GIOVANNI S; FIGA TALAMANCA L; NISTICO L; FAGNANI C; NEALE MC; CASCINO I; GIORGI G; BATTAGLIA MA; BUTTINELLI C; TOSI R; SALVETTI M; THE ITALIAN MS GENETIC COLLABORATIVE GROUP; MASSACESI L; (2006). Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study.. ANNALS OF NEUROLOGY, vol. 59(1), pp. 27-34, ISSN:0364-5134 DOI

SACCARDI R, KOZAK T, BOCELLI-TYNDALL C, FASSAS A, KAZIS A, HAVRDOVA E, CARRERAS E, SAIZ A, LOWENBERG B, TE BOEKHORST P; GUALANDI F, OPENSHAW H, LONGO G, PAGLIAI F, MASSACESI L, DECONINK E, OUYANG J, ZUAZU NAGORE F, BESALDUCH J, LISUKOV IA, BONINI A, MERELLI E, SLAVIN S, GRATWOHL A, PASSWEG J, TYNDALL A, STECK AJ, ANDOLINA M, CAPOBIANCO M, DIEZ MARTIN J, LUGARESI A, MEUCCI G, SAEZ RA, CLARK RE, FERNANDEZ MN, FOUILLARD L, HERSTENSTEIN B, KOZA V, COCCO E, BAURMANN H, MANCARDI GL, ON BEHALF OF THE AUTOIMMUNE DISEASES WORKING PARTY OF EBMT (2006). Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation auto immune diseases working party database.. MULTIPLE SCLEROSIS, vol. 12(6), pp. 814-823, ISSN:1352-4585 DOI

Games Collaborative Group; Ban M; Booth D; Heard R; Stewart G; Goris A; Vandenbroeck K; Dubois B; Laaksonen M; Ilonen J; Alizadeh M; Edan G; Babron MC; Brassat D; Clanet M; Cournu-Rebeix I; Fontaine B; Semana G; Goedde R; Epplen J; Weber A; Infante-Duarte C; Zipp F; Rajda C; Bencsik K; Vécsei L; Heggarty S; Graham C; Hawkins S; Liguori M; Momigliano-Richiardi P; Caputo D; Grimaldi LM; Leone M; Massacesi L; Milanese C; Salvetti M; Savettieri G; Trojano M; Bielecki B; Mycko MP; Selmaj K; Santos M; Maciel P; Pereira C; Silva A; Silva BM; Coraddu F; Marrosu MG; Akesson E; Hillert J; Datta P; Oturai A; Harbo HF; Spurkland A; Goertsches R; Villoslada P; Eraksoy M; Hensiek A; Compston A; Setakis E; Gray J; Yeo TW; Sawcer S. (2006). LINKAGE DISEQUILIBRIUM SCREENING FOR MULTIPLE SCLEROSIS IMPLICATES JAG1 AND POU2AF1 AS SUSCEPTIBILITY GENES IN EUROPEANS.. JOURNAL OF NEUROIMMUNOLOGY, vol. 179, pp. 108-116, ISSN:0165-5728, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598:

MAZZANTI B; BIAGIOLI T; ALDINUCCI A; CAVALETTI G; CAVALLETTI E; OGGIONI N; FRIGO M; ROTA S; TAGLIABUE E; BALLERINI C; MASSACESI L; RICCIO P; LOLLI F; (2005). Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis.. JOURNAL OF NEUROIMMUNOLOGY, vol. 168, pp. 111-117, ISSN:0165-5728 DOI

G. L. Mancardi; A. Murialdo; R. Saccardi; F. Pagliai; F. Gualandi; A. Marmont; M. Inglese; P. Bruzzi; M. P. Sormiani; M. Filippi; M. G. Marrosu; G. Meucci; L. Massacesi; A. Bertolotto; A. Lugaresi; E. Morelli; M. Filippi; Italian GITMO-NEURO Intergroup (2005). Il trapianto autologo di midollo osseo Intensa immunosoppressione seguita da trapianto autologo di cellule staminali in pazienti con forma grave di SM: dati clinici e RM. In L’interferone beta ed altre possibilità terapeutiche.. In: L. Durelli. Trapiantato Autologo di cellule staminali ematopoietiche nella sclerosi multipla, pp. 97-106, Milano: Excerpta Medica Elsevier.

MASSACESI L; PARIGI A; BARILARO A; REPICE AM; PELLICANO' G; KONZE A; SIRACUSA GF; TAIUTI R; AMADUCCI L; (2005). Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated by Magnetic Resonance Imaging.. ARCHIVES OF NEUROLOGY, vol. 62, pp. 1843-1847, ISSN:0003-9942, American Medical Association:515 North State Street:Chicago, IL 60610:(800)262-2350, (312)464-2518, EMAIL: ama-subs@ama-assn.org, INTERNET: http://www.ama-assn.org, Fax: (312)464-5600:

SACCARDI R; MANCARDI GL; SOLARI A; BOSI A; BRUZZI P; DI BARTOLOMEO P; DONELLI A; FILIPPI M; GUERRASIO A; GUALANDI F; LA NASA G; MURIALDO A; PAGLIAI F; PAPINESCHI F; SCAPPINI B; MARMONT AM; AND THE ITALIAN GITMO-NEURO INTERGROUP ON AUTOLOGOUS HEMOTOPOIETIC STEM CELL TRANSPLANTATION; L. MASSACESI (2005). Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.. BLOOD, vol. 105, pp. 2601-2607, ISSN:0006-4971

CAPELLO E; SACCARDI R; MURIALDO A; GUALANDI F; PAGLIAI F; BACIGALUPO A; MARMONT A; UCCELLI A; INGLESE M; BRUZZI P; SORMANI MP; COCCO E; MEUCCI G; MASSACESI L; BERTOLOTTO A; LUGARESI A; MERELLI E; SOLARI A; FILIPPI M; MANCARDI GL; ITALIAN GITMO-NEURO INTERGROUP ON ASCT FOR MULTIPLE SCLEROSIS. (2005). Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.. NEUROLOGICAL SCIENCES, vol. 26, pp. 200S-203S, ISSN:1590-3478, Springer-Verlag Italia Srl:via Decembrio 28, 20137 Milan Italy:011 39 2 5425971, EMAIL: riccardi@springer.it, Fax: 011 39 2 55193360:

Massacesi L; Parigi A; Barilaro A; Repice AM; Pellicanò G; Konze A; Siracusa GF; Taiuti R; Amaducci L; (2005). Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated using Magnetic Resonance Imaging.. ARCHIVES OF NEUROLOGY, vol. 62(12), pp. 1843-1847, ISSN:0003-9942 DOI

Massacesi, L; Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G (2004). Comparision of Azathioprine and Interferon beta 1a efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis. NEUROLOGY, vol. 62, pp. A290-A291, ISSN:0028-3878

Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L (2004). Azathioprine versus interferon-beta-1a s.c.: efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis. MULTIPLE SCLEROSIS, vol. 10, pp. S261-S262, ISSN:1352-4585

A.M. Papini; B. Mulinacci; A. Carotenuto; B. Bonetti; G. Sabatino; E. Peroni; F. Nuti; M.C. Alcaro; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; L. Battistini; M. Chelli; P. Rovero; F. Lolli; (2004). MS PepKit: The first diagnostic test to follow-up multiple sclerosis. In: 18th American Peptide Symposium, BOSTON, MA, JUL 19-23, 2003, American Peptide Society, pp. 942-944, ISBN:0-9715560-1-6 Accesso ONLINE all'editore

Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L (2004). Azathioprine and interferon beta1a relative efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, vol. 11, pp. 126-127, ISSN:1351-5101

Repice, A; Barilaro, A; Parigi, A; Taiuti, B; Pellicano, G; Meucci, G; Fioretti, C; Valleriani, A; Onesti, E; Prosperini, L; Pozzilli, C; Massacesi, L (2004). Azathioprine-interferon beta 1a s.c. association in relapsing-remitting multiple sclerosis: compliance and efficacy in prevention of new brain lesions. MULTIPLE SCLEROSIS, vol. 10, pp. S262-S262, ISSN:1352-4585

A.M. Papini; B. Mulinacci; A. Carotenuto; B. Bonetti; G. Sabatino; E. Peroni; F. Nuti; M.C. Alcaro; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; L. Battistini; M. Chelli; P. Rovero; F. Lolli. (2004). MS PepKit. The First Diagnostic Test to Follow-up Multiple Sclerosis. In: M. Chorev, T.K. Sawyer. Peptide Revolution: Genomics, Proteomics & Therapeutics, pp. 942-944, San Diego, CA, USA: American Peptide Society, ISBN:9780971556010.

Barilaro, A; Zellini, F; Caleri, F; Passeri, A; Gasperini, C; Pozzilli, C; Massacesi, L (2004). Kinetic of brain MRI gadolinium enhancing lesions in multiple sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, vol. 11, pp. 20-20, ISSN:1351-5101

Barilaro, A; Zellini, F; Caleri, F; Passeri, A; Gasperini, C; Pozzilli, C; Massacesi, L (2004). In vivo dynamic neuropathology of brain new lesions in multiple sclerosis. JOURNAL OF NEUROIMMUNOLOGY, vol. 154, pp. 189-189, ISSN:0165-5728

Olivito, B; Biagioli, T; Aldinucci, A; Ballerini, C; Massacesi, L (2004). T-cell oligoclonality in CNS inflammation. JOURNAL OF NEUROIMMUNOLOGY, vol. 154, pp. 225-225, ISSN:0165-5728

BALLERINI C; GUERINI F; ROMBOLA' G; ROSATI E; MASSACESI L; FERRANTE P; CAPUTO D; FIGA' TALAMANCA L; NALDI P; LIGUORI M; ALIZADEH M; MOMIGLIANO-RICHIARDI P; D'ALFONSO S. (2004). HLA-Multiple Sclerosis association in Continental Italy and correlation with disease prevalence in Europe.. JOURNAL OF NEUROIMMUNOLOGY, vol. 150, pp. 178-185, ISSN:0165-5728, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598:

Barilaro, A; Repice, A; Parigi, A; Taiuti, R; Pellicano, G; Massacesi, L (2004). Direct comparison of Azathioprine and Interferon beta 1a efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis. JOURNAL OF NEUROIMMUNOLOGY, vol. 154, pp. 215-215, ISSN:0165-5728

Aldinucci, A; Mazzanti, B; Biagioli, T; Parigi, A; Ballerini, C; Massacesi, L (2004). Azathioprine suppressive activity on T cells: insight of a novel action mechanism. JOURNAL OF NEUROIMMUNOLOGY, vol. 154, pp. 214-214, ISSN:0165-5728

M. INGLESE; G. L. MANCARDI; E. PAGANI; M. A. ROCCA; A. MURIALDO; R. SACCARDI; G. COMI; M. FILIPPI; THE ITALIAN GITMO-NEURO INTERGROUP ON AUTOLOGOUS HEMOTOPOIETIC STEM CELL TRANSPLANTATION; L. MASSACESI (2004). Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation.. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, vol. 75, pp. 643-644, ISSN:0022-3050, BMJ / British Medical Journal Publishing Group:PO Box 299, London WC1H 9TD United Kingdom:011 44 20 73836270, EMAIL: subscriptions@bmjgroup.com, INTERNET: http://www.bmjpg.com/bmj, Fax: 011 44 20 73836402:

Peroni, E; Lolli, F; Mazzanti, B; Pazzagli, M; Bonetti, B; Massacesi, L; Chelli, M; Rovero, P; Papini, AM. (2003). Towards a therapeutic apheresis in multiple sclerosis based on a glycopeptide antigen able to isolate specific autoantibodies. PEPTIDE SCIENCES, vol. 71, pp. 311-311, ISSN:0006-3525 Accesso ONLINE all'editore

A. M. Papini; B. Mulinacci; E. Peroni; F. Nuti; G. Sabatino; M.C. Pozo-Carrero; B. Mazzanti; M. Pazzagli; L. Massacesi; M. Chelli; P. Rovero; F. Lolli (2003). MS PepKit: the first diagnostic test based on CSF114(Glc), a glycopeptide to follow-up Multiple Sclerosis.. BIOPOLYMERS, vol. 71, pp. 298-298, ISSN:0006-3525 DOI Accesso ONLINE all'editore

AKESSON E; CORADDU F; MARROSU M.G; MASSACESI L; HENSIEK A; HARBO H.F; OTURAI A; TROJANO M; MOMIGLIANO-RICHIARDI P; COCCO E; MURRU R; HILLERT J; COMPSTON A; SAWCER S; (2003). Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis.. JOURNAL OF NEUROIMMUNOLOGY, vol. 143, pp. 31-38, ISSN:0165-5728, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598: DOI

ALIZADEH M; BABRON MC; BIREBENT B; MATSUDA F; QUELVENNEC E; LIBLAU R; COURNU-REBEIX I; MOMIGLIANO-RICHIARDI P; SEQUEIROS J; YAOUANQ J; GENIN E; VASILESCU A; BOUGERIE H; TROJANO M; MARTINS SILVA B; MACIEL P; CLERGET-DARPOUX F; CLANET M; EDAN G; FONTAINE B; THE ITALIAN GROUP FOR MS GENETICS; L. MASSACESI (2003). Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.. ANNALS OF NEUROLOGY, vol. 54, pp. 119-122, ISSN:0364-5134, -attuale: WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030 -Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

A.M. Papini, B. Mulinacci, E. Peroni, F. Nuti, G. Sabatino, M.C. Pozo-Carrero, B. Mazzanti, M. Pazzagli, L. Massacesi, M. Chelli, P. Rovero, F. Lolli (2003). MS PepKit, the first diagnostic test based on CSF114(Glc) a glycopeptide to follow-up Multiple Sclerosis.. BIOPOLYMERS, vol. 71, pp. 401-401, ISSN:0006-3525 DOI Accesso ONLINE all'editore

MELLAI M; GIORDANO M; D'ALFONSO S; MARCHINI M; SCORZA R; DANIELI M.G; LEONE M; FERRO I; LIGUORI M; TROJANO M; BALLERINI C; MASSACESI L; CANNONI S; BOMPREZZI R; MOMIGLIANO-RICHIARDI P; (2003). Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.. HUMAN IMMUNOLOGY, vol. 64, pp. 274-284, ISSN:0198-8859, Elsevier Science Incorporated / NY Journals:Madison Square Station, PO Box 882:New York, NY 10159:(212)633-3730, EMAIL: usinfo-f@elsevier.com, INTERNET: http://www.elsevier.com, Fax: (212)633-3680: DOI

SORMANI MP; BRUZZI P; BECKMANN K; WAGNER K; MILLER DH; KAPPOS L; FILIPPI M; EUROPEAN STUDY GROUP ON INTERFERON BETA-1B IN SECONDARY PROGRESSIVE MS; L. MASSACESI; (2003). MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b.. NEUROLOGY, vol. 60, pp. 1462-1466, ISSN:0028-3878, Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

POLMAN C; KAPPOS L; WHITE R; DAHLKE F; BECKMANN K; POZZILLI C; THOMPSON A; PETKAU J; MILLER D; EUROPEAN STUDY GROUP IN INTERFERON BETA-1B IN SECONDARY PROGRESSIVE MS; MASSACESI L; (2003). Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b.. NEUROLOGY, vol. 60, pp. 37-43, ISSN:0028-3878, Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

E. Peroni; F. Lolli; B. Mazzanti; M. Pazzagli; B. Bonetti; L. Massacesi; M. Chelli; P. Rovero; A. M. Papini (2003). Towards a therapeutic apheresis in Multiple Sclerosis based on a glycopeptide antigen able to isolate specific autoantibodies.. BIOPOLYMERS, vol. 71, pp. 277-277, ISSN:0006-3525 DOI Accesso ONLINE all'editore

LIGUORI M; SAWCER S; SETAKIS E; COMPSTON A; GIORDANO M; D'ALFONSO S; MELLAI M; MALFERRARI G; TROJANO M; LIVREA P; DE ROBERTIS F; MASSACESI L; REPICE A; BALLERINI C; BIAGIOLI T; BOMPREZZI R; CANNONI S; RISTORI G; SALVETTI M; GRIMALDI L.M; BIUNNO I; COMI G; LEONE M; FERRO I; NALDI P; MILANESE C; GELLERA C; LOREDANA L.M; SAVETTIERI G; SALEMI G; ARIDON P; CAPUTO D; ROSA GUERINI F; FERRANTE P; MOMIGLIANO-RICHIARDI P; (2003). A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population.. JOURNAL OF NEUROIMMUNOLOGY, vol. 143, pp. 97-100, ISSN:0165-5728 DOI

Ballerini C; Rosati E; Salvetti M; Ristori G; Cannoni S; Biagioli T; Massacesi L; Sorbi S; Vergelli M (2002). Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population. NEUROSCIENCE LETTERS, vol. 328, pp. 325-327, ISSN:0304-3940

BUZZETTI R; POZZILLI P; DI MARIO U; BALLERINI C; MASSACESI L; (2002). Multiple sclerosis and Type I diabetes.. DIABETOLOGIA, vol. 45, pp. 1735-1736, ISSN:0012-186X, Springer Verlag Germany:Tiergartenstrasse 17, D 69121 Heidelberg Germany:011 49 6221 3450, EMAIL: g.braun@springer.de, INTERNET: http://www.springer.de, Fax: 011 49 6221 345229: DOI

D'ALFONSO S; MELLAI M; GIORDANO M; PASTORE A; MALFERRARI G; NALDI P; REPICE A; LIGUORI M; CANNONI S; MILANESE C; CAPUTO D; SAVETTIERI G; MOMIGLIANO-RICHIARDI P; THE ITALIAN GROUP FOR THE STUDY OF MULTIPLE SCLEROSIS GENETICS; MASSACESI L; (2002). Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene (MAG) and study of their association with multiple sclerosis.. JOURNAL OF NEUROIMMUNOLOGY, vol. 126, pp. 196-204, ISSN:0165-5728, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598: DOI

MASSACESI L; (2002). Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy.. CLINICAL NEUROLOGY AND NEUROSURGERY, vol. 104, pp. 177-181, ISSN:0303-8467, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598: DOI

BALLERINI C; ROSATI E; SALVETTI M; RISTORI G; CANNONI S; BIAGIOLI T; MASSACESI L; SORBI S; VERGELLI M; (2002). Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population.. NEUROSCIENCE LETTERS, vol. 328, pp. 325-327, ISSN:0304-3940, Elsevier Science Ireland Limited:PO Box 85, Limerick Ireland:011 353 61 709600, 011 353 61 61944, EMAIL: usinfo-f@elsevier.com, INTERNET: http://www.elsevier.com, Fax: 011 353 61 709114: DOI

MURARO P.A; BONANNI L; MAZZANTI B; PANTALONE A; TRAGGIAI E; MASSACESI L; VERGELLI M; GAMBI D; (2002). Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS.. JOURNAL OF NEUROIMMUNOLOGY, vol. 127, pp. 149-159, ISSN:0165-5728, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598: DOI

A.M. PAPINI; E. NARDI; B. MAZZANTI; T. BIAGIOLI; C. BALLERINI; E. TRAGGIAI; M. CHELLI; M. GINANNESCHI; H. KALBACHER; M. DEEG; L. MASSACESI; M. VERGELLI (2001). EFFECT OF LIPOCONJUGATION ON MBP PEPTIDE EPITOPES FOR CD4+ T CELL RESPONSIVENESS. In: JEAN MARTINEZ, JEAN-ALAIN FEHRENTZ. PEPTIDES 2000, pp. 69-70, PARIS: Editions EDK, ISBN:9782842540487.

Gestri D; Baldacci L; Taiuti R; Galli E; Maggi E; Piccinni MP; Vergelli M; Massacesi L (2001). Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system.. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, vol. 70, pp. 767-772, ISSN:0022-3050

SOLDAN S.S; FOGDELL-HAHN A; BRENNAN M.B; MITTLEMAN B.B; BALLERINI C; MASSACESI L; SEYA T; MCFARLAND H.F; JACOBSON S; (2001). Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein (MCP; CD46), in patients with multiple sclerosis.. ANNALS OF NEUROLOGY, vol. 50, pp. 486-493, ISSN:0364-5134, -attuale: WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030 -Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

BROADLEY S; SAWCER S; D'ALFONSO S; HENSIEK A; CORADDU F; GRAY J; ROXBURGH R; CLAYTON D; BUTTINELLI C; QUATTRONE A; TROJANO M; MASSACESI L; COMPSTON A; (2001). A genome screen for multiple sclerosis in Italian families.. GENES AND IMMUNITY, vol. 2, pp. 205-210, ISSN:1466-4879, Nature Publishing Group:Brunel Road Houndmills, Basingstoke RG21 6XS United Kingdom:011 44 20 78334000, EMAIL: institutions@natureny.com, INTERNET: http://www.nature.com, Fax: 011 44 20 78434640: DOI

MANCARDI G.L; SACCARDI R; FILIPPI M; GUALANDI F; MURIALDO A; INGLESE M; MARROSU M.G; MEUCCI G; MASSACESI L; LUGARESI A; PAGLIAI F; SORMANI M.P; SARDANELLI F; MARMONT A; Italian GITMO-NEURO Intergroup on Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis; (2001). Autologous hematopoietic stem cell transplantation suppresses Gadolinium-enhanced MRI activity in multiple sclerosis.. NEUROLOGY, vol. 57, pp. 62-68, ISSN:0028-3878, Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

E. NARDI; E. MASTRANGELO; S. MATÀ; B. MAZZANTI; V. ZIPOLI; M. CHELLI; M. GINANNESCHI; L. MASSACESI; M. VERGELLI; F. LOLLI; F. PINTO; A.M. PAPINI (2001). Study of the Role of the Glycosyl Moiety in Autoantibody Recognition in Multiple Sclerosis.. In: MARTINEZ J.; FEHRENTZ J.-A.. Peptides 2000, pp. 895-896, PARIS: Editions EDK, ISBN:9782842540487.

PAPINI A.M.; MAZZANTI B.; NARDI E.; TRAGGIAI E.; BALLERINI C.; BIAGIOLI T.; KALBACHER H.; BECH H.; DEEG M.; CHELLI M.; GINANNESCHI M.; MASSACESI L.; VERGELLI M.; (2001). Palmitoyl Derivatives of GpMBP Epitopes: T-Cell Response and Peptidases Susceptibility.. JOURNAL OF MEDICINAL CHEMISTRY, vol. 44, pp. 3504-3510, ISSN:0022-2623 DOI

KAPPOS L; POLMAN C; POZZILLI C; THOMPSON A; BECKMANN K; DAHLKE F; THE EUROPEAN STUDY GROUP ON INTERFERON BETA-1B IN SECONDARY-PROGRESSIVE MULTIPLE SCLEROSIS; MASSACESI L; (2001). Final analysis of the European multicenter trial on IFNbeta-1b secondary progressive Multiple Sclerosis.. NEUROLOGY, vol. 57, pp. 1969-1975, ISSN:0028-3878, Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

TRAGGIAI E; BIAGIOLI T; ROSATI E; BALLERINI C; MAZZANTI B; BEN NUN A; MASSACESI L; VERGELLI M; (2001). IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J. Neuroimmunol.. JOURNAL OF NEUROIMMUNOLOGY, vol. 121, pp. 111-119, ISSN:0165-5728, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598: DOI

CHIARUGI A; COZZI A; BALLERINI C; MASSACESI L; F. MORONI (2001). Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.. NEUROSCIENCE, vol. 102, pp. 687-695, ISSN:0306-4522, Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010:

FREEMAN JA; THOMPSON AJ; FITZPATRICK R; HUTCHINSON M; MILTENBURGER C; BECKMANN K; DAHLKE F; KAPPOS L; POLMAN C; POZZILLI C; THE EUROPEAN STUDY GROUP ON INTERFERON BETA-1B IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; MASSACESI L; (2001). IFNbeta-1b in the treatment of secondary progressive Multiple Sclerosis: impact on quality of life.. NEUROLOGY, vol. 57, pp. 1870-1875, ISSN:0028-3878, Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

MOLYNEUX PD; BARKER GJ; BARKHOF F; BECKMANN K; DAHLKE F; FILIPPI M; GHAZI M; HAHN D; MACMANUS D; POLMAN C; POZZILLI C; KAPPOS L; THOMPSON AJ; WAGNER K; YOUSRY T; MILLER DH; EUROPEAN STUDY GROUP ON INTERFERON BETA-B IN SECONDARY PROGRESSIVE MS; MASSACESI L; (2001). Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.. NEUROLOGY, vol. 57, pp. 2191-2197, ISSN:0028-3878, Lippincott, Williams & Wilkins:530 Walnut Street:Philadelphia, PA 19106:(800)638-3030, (301)223-2300, EMAIL: orders@lww.com, INTERNET: http://www.lww.com, Fax: (301)223-2320, (301)223-2320: DOI

Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L; (2001). Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis.. JOURNAL OF NEUROSCIENCE RESEARCH, vol. 66, pp. 517-524, ISSN:0360-4012, John Wiley & Sons Incorporated:Customer Service, 111 River Street:Hoboken, NJ 07030:(800)225-5945, (201)748-6000, EMAIL: societyinfo@wiley.com, INTERNET: http://www.wiley.com, Fax: (212)748-6551: DOI

MANCARDI G; HART B; ROCCATAGLIATA L; BROK H; GIUNTI D; BONTROP R; MASSACESI L; CAPELLO E; UCCELLI A; (2001). Demyelination and axonal damage in a non-human primate model of multiple sclerosis.. JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 184, pp. 41-49, ISSN:0022-510X, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598: DOI

A. PUPI; SESTINI S; EMMI L; MARCHIONE T; SALVATI G; GOBBI FL; MASSACESI L; MELDOLESI U (2000). Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behcet's disease.. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, vol. 27, pp. 700-706, ISSN:0340-6997, Springer Verlag Germany:Tiergartenstrasse 17, D 69121 Heidelberg Germany:011 49 6221 3450, EMAIL: g.braun@springer.de, INTERNET: http://www.springer.de, Fax: 011 49 6221 345229: DOI

D'Alfonso S; Nisticò L; Bocchio D; Bomprezzi R; Marrosu MG; Murru MR; Lai M; Massacesi L; Ballerini C; Repice A; Salvetti M; Montesperelli C; Ristori G; Trojano M; Liguori M; Gambi D; Quattrone A; Tosi R; Momigliano-Richiardi P. (2000). An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population.. JOURNAL OF NEUROVIROLOGY, vol. 6 (S 2), pp. 18-22, ISSN:1355-0284, Taylor & Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL: madeline.sims@tandf.co.uk, info@tandf.co.uk, INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245:

C. Ballerini; D. Campani; G. Rombolà; B. Gran; B. Nacmias; M. P. Amato; G. Siracusa; L. Bartolozzi; S. Sorbi; L. Massacesi (2000). Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis.. NEUROSCIENCE LETTERS, vol. 296, pp. 174-176, ISSN:0304-3940

'T HART B.A.; VAN MEURS M.; BROK H.P.M.; MASSACESI L; BAUER J.; BOON L.; BONTROP R.E.; LAMAN J.D.; (2000). A new primate model for multiple sclerosis in the common marmoset.. IMMUNOLOGY TODAY, vol. 21, pp. 290-297, ISSN:0167-5699, Elsevier Trends Journals:An Imprint of Elsevier Science Limited, The Boulevard, Langford Lane, Kidlington, Oxford 0X5 1GB United Kingdom:011 44 1865 843000, 011 44 1865 843699, Fax: 011 44 1865 843010: DOI

PUPI A; SESTINI S; DE CRISTOFARO M.T; EMMI L; MARCHIONE T; SALVATI G; LI GOBBI F; MASSACESI L; MELDOLESI U; (2000). Use of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet’s disease.. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, vol. 27(6), pp. 700-706, ISSN:0340-6997, Springer Verlag Germany:Tiergartenstrasse 17, D 69121 Heidelberg Germany:011 49 6221 3450, EMAIL: g.braun@springer.de, INTERNET: http://www.springer.de, Fax: 011 49 6221 345229:

MOLYNEUX P.D; KAPPOS L; POLMAN C; POZZILLI C; BARKHOF F; FILIPPI M; YOUSRY T; HAHN D; WAGNER K; GHAZI M; BECKMANN K; DAHLKE F; LOSSEFF N; BARKER G.J; THOMPSON A.J; MILLER D.H; THE EUROPEAN STUDY GROUP ON INTERFERON BETA-1B IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; MASSACESI L; (2000). The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple Sclerosis.. BRAIN, vol. 123, pp. 2256-2263, ISSN:0006-8950, Oxford University Press:Journals Department, Great Clarendon Street, Oxford OX2 6DP United Kingdom:011 44 1865 556767, EMAIL: jnlorders@oup.co.uk, INTERNET: http://www.oup.co.uk, Fax: 011 44 1865 267485: DOI

A.M. PAPINI; E. NARDI; S. MAZZUCCO; B. MAZZANTI; E. TRAGGIAI; C. BALLERINI; H. KALBACHER; H. BECK; M. CHELLI; M. GINANNESCHI; L. MASSACESI; M. VERGELLI (2000). LIPOPHILIC MODIFICATIONS OF PEPTIDE EPITOPES: T-CELL RESPONSE AND SUSCEPTIBILITY TO PEPTIDASES. In: GREGG B. FIELDS, JAMES P. TAM, GEORGE BARANY. PEPTIDES FOR THE NEW MILLENIUM, pp. 697-698, Dordrecht/Boston/London, The Netherlands: Kluwer/Escom academic publishers.

MAZZANTI B.; HEMMER B.; TRAGGIAI E.; BALLERINI C.; MCFARLAND H.F.; MASSACESI L.; MARTIN R.; VERGELLI M.; (2000). Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells.. JOURNAL OF NEUROSCIENCE RESEARCH, vol. 59, pp. 86-93, ISSN:0360-4012, John Wiley & Sons Incorporated:Customer Service, 111 River Street:Hoboken, NJ 07030:(800)225-5945, (201)748-6000, EMAIL: societyinfo@wiley.com, INTERNET: http://www.wiley.com, Fax: (212)748-6551: DOI

MAZZUCCO S; MAT S; VERGELLI M; FIORESI R; NARDI E; MAZZANTI B; CHELLI M; LOLLI F; GINANNESCHI M; PINTO F; L. MASSACESI; PAPINI A.M (1999). A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases.. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 9 (2), pp. 167-172, ISSN:0960-894X DOI Accesso ONLINE all'editore

Mazzucco, S; Matà, S; Vergelli, M; Fioresi, R; Nardi, E; Mazzanti, B; Chelli, M; Lolli, F; Ginanneschi, M; Pinto, F; Massacesi, L; Papini, A M (1999). A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 9, pp. 167-172, ISSN:0960-894X DOI

Sabbadini MG; Manfredi AA; Bozzolo E; Ferrario L; Rugarli C; Scorza R; Origgi L; Vanoli M; Gambini O; Vanzulli L; Croce D; Campana A; Messa C; Fazio F; Tincani A; Anzola G; Cattaneo R; Padovani A; Gasparotti R; Gerli R; Quartesan R; Piccirilli M; Farsi A; Emmi E; Passaleva A;Pupi A; Massacesi L (1999). Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.. LUPUS, vol. 8, pp. 11-19, ISSN:0961-2033 DOI Accesso ONLINE all'editore

B. Mazzanti; E. Traggiai; B. Hemmer; R. Martin; L. Massacesi; M. Vergelli (1999). The affinity spectrum of myelin basic protein reactive T cells.. In: Gambi D., Muraro P.A., Lugaresi A.. Advances in the immunopathogenesis of multiple sclerosis, pp. 3-10, Milano: Springer Milan, ISBN:9788847000674. DOI Accesso ONLINE all'editore

MILLER D.H; MOLYNEUX P.D; BARKER G.J; MAC MANUS D.G; MOSELEY I.F; WAGNER K; EUROPEAN STUDY GROUP ON INTERFERON-; B IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; L. MASSACESI (1999). Effect of Interferon-β1b on Magnetic Resonance Imaging Outcomes in Secondary Progressive Multiple Sclerosis: Results of a European Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.. ANNALS OF NEUROLOGY, vol. 46, pp. 850-859, ISSN:0364-5134 DOI Accesso ONLINE all'editore

S. MAZZUCCO; R. FIORESI; S. MATÀ; M. VERGELLI; M. CHELLI; F. LOLLI; M. GINANNESCHI; F. PINTO; B. MAZZANTI; L. MASSACESI; G. RAPI; A. PAPINI (1999). Glycopeptides of hMOG(30-50) Detect Antibody Response in Multiple Sclerosis and other Neurological Diseases.. In: BAJUSZ S.; HUDECZ F.. Peptides 1998, pp. 46-47, BUDAPEST: Akadèmiai Kiadò.

A.M. PAPINI; S. MAZZUCCO; D. PINZANI; M. BIONDI; M. CHELLI; M. GINANNESCHI; G. RAPI; B. MAZZANTI; M. VERGELLI; L. MASSACESI; L. AMADUCCI (1999). Lipoderivatives of an immunodominant epitope of myelin basic protein increased T cell responsiveness in Lewis rats.. In: TAM J.P.; KAUMAYA P.T.P.. Peptides: Frontiers of Peptide Science, pp. 700-702, DORDRECHT/BOSTON/LONDON: Kluwer/Escom Academic Publishers, ISBN:9780792351603.

S. MAZZUCCO; E. NARDI; M. CHELLI; M. GINANNESCHI; G. RAPI; A.M. PAPINI; M. VERGELLI; B. MAZZANTI; L. MASSACESI; L. AMADUCCI (1999). SYNTHESIS OF LIPOPEPTIDES OF THE IMMUNODOMINANT EPITOPE HMBP(83-99) CONTAINING AMIDE OR C-C BOND LINKED HYDROPHOBIC CHAINS FOR THE STUDY OF T CELL RESPONSE. LETTERS IN PEPTIDE SCIENCE, vol. 6(1), pp. 51-59, ISSN:0929-5666

BALLERINI C; B. NACMIAS; ROMBOLA G; MARCON G; MASSACESI L; SORBI S. (1999). HLA A2 allele is associated with age at onset of Alzheimer's disease.. ANNALS OF NEUROLOGY, vol. 45, pp. 397-400, ISSN:0364-5134

S. Mata; F. Lolli; S. Mazzucco; A. M. Papini; R. Fioresi; L. Massacesi; M. Vergelli (1999). Antibodies to a glycoderivative of Myelin Oligodendrocyte Glycoprotein (MOG) peptide 30-50 in multiple sclerosis.. NEUROLOGY, vol. 52(6) S2, pp. A401-A401, ISSN:0028-3878

DALFONSO S; NISTIC L; ZAVATTARI P; MARROSU M; MURRU R; LAI M; L. MASSACESI; BALLERINI C; GESTRI D; SALVETTI M; RISTORI G; BOMPREZZI R; TROJANO M; LIGUORI M; GAMBI D; QUATTRONE A; FRUCI D; CUCCA F; MOMIGLIANO RICHIARDI P; TOSI R (1999). A linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families.. EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 7, pp. 377-385, ISSN:1018-4813 DOI Accesso ONLINE all'editore

A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI (1998). [Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients.. In: 10th International Congress of Immunology, New Delhi, India, November 1-6, 1998, Monduzzi Editore, International Proceedings Division Bologna, pp. 1239-1244, ISBN:9788832311013

GRAN B.; MASSACESI L.; SOTTINI A.; QUIRÒS-ROLDAN E.; BETTINARDI A.; SIGNORINI S.; PRIMI D.; BALLERINI C.; TAIUTI R.; AMADUCCI L.; L. MASSACESI (1998). Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis.. JOURNAL OF NEUROIMMUNOLOGY, vol. 85, pp. 22-32, ISSN:0165-5728, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598:

EUROPEAN STUDY GROUP ON INTERFERON BETA-B IN SECONDARY PROGRESSIVE MS; L. MASSACESI (1998). Placebo-controlled multicentre randomised trial of Interferon beta-1b in treatment of secondary progressive multiple sclerosis.. THE LANCET, vol. 352, pp. 1491-1497, ISSN:0140-6736 DOI Accesso ONLINE all'editore

CASCINO I; BALLERINI C; AUDINO S; ROMBOL G; L. MASSACESI; COLOMBO G; SCORZA SMERALDI R; DALFONSO S; MOMIGLIANO RICHIARDI P; TOSI R; RUBERTI G (1998). Fas Gene Polymorphisms are not associated with Systemic Lupus Erythematosus, Multiple Sclerosis and HIV Infection.. DISEASE MARKERS, vol. 13, pp. 221-225, ISSN:0278-0240 Accesso ONLINE all'editore

LAMAN J.D; VAN MEURS M; SCHELLEKENS M.M; DE BOER M; MELCHERS B; L. MASSACESI; LASSMANN H; KLAASSEN E; T HART B (1998). Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).. JOURNAL OF NEUROIMMUNOLOGY, vol. 86, pp. 30-45, ISSN:0165-5728 DOI Accesso ONLINE all'editore

T HART B; BAUER J; MULLER H.J; MELCHERS B; NICOLAY K; BROK H; BONTROP R; LASSMANN H; L. MASSACESI (1998). Histopathological characterization of magnetic resonance imaging-decectable brain white matter lesions in a primate model of multiple sclerosis.. THE AMERICAN JOURNAL OF PATHOLOGY, vol. 153, pp. 649-663, ISSN:0002-9440 DOI Accesso ONLINE all'editore

VERGELLI, M., OLIVOTTO, J., CASTIGLI, E., GRAN B., A; RAIMONDI, L.; R. PIRISINO; AMADUCCI, L.; MASSACESI, L. (1997). Immunosuppressive activity of 13-cis-retinoic acid in rats: aspects of pharmacokinetics and pharmacodynamics.. IMMUNOPHARMACOLOGY, vol. 37, pp. 191-197, ISSN:0162-3109, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598:

L. Massacesi (1996). L’encefalomielite autoimmune sperimentale.. In: A. Federico, P. Annunziata. Neurobiologia e Neuroimmunologia Clinica, pp. 85-93, Roma: CIC edizioni Internazionali.

L. MASSACESI; GENAIN C.P; PARRITZ D.L; CANFIELD D; LETVIN N. AND HAUSER S.L (1995). Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.. ANNALS OF NEUROLOGY, vol. 37, pp. 519-530, ISSN:0364-5134 DOI Accesso ONLINE all'editore

D.CAMPANI;L.MASSACESI;A.BONELLI;M.BATTAGLIA;L.AMADUCCI (1995). COLLECTION OF NERVOUS TISSUE FOR BRAIN BANTS: ETHICAL AND LEGAL ISSUE. In: E.B.B.N. AND XXXI CONGRES OF I.A.N., PAVIA, 21-24 GIUGNO 1995, .., vol. ABSTRACT E.B.B.N. AND XXXI CONGRES OF I.A.N., pp. 36-36.

HOHLFELD R; LONDEI M; L. MASSACESI; SALVETTI M (1995). T-cell autoimmunity in multiple sclerosis.. IMMUNOLOGY TODAY, vol. 16, pp. 259-261, ISSN:0167-5699 DOI Accesso ONLINE all'editore

GENAIN C.P; PARRITZ D; HOA NGUYEN M; L. MASSACESI; IOSHI N; FERRANTE R; HOFFMAN K; MOSELEY M; LEVTIN N; HAUSER S (1994). In healthy primates, circulating autoreactive T-cells mediate autoimmune disease.. THE JOURNAL OF CLINICAL INVESTIGATION, vol. 94, pp. 1339-1345, ISSN:0021-9738 DOI Accesso ONLINE all'editore

L. Massacesi; M.P. Amato; L. Amaducci (1994). Immunosuppression in multiple sclerosis state of art and future perspectives. In: L. Massacesi, M.P. Amato, L. Amaducci. A multidisciplinary approach to myelin diseases II, pp. 255-259, New York: Salviati, Plenum Press.

L. Massacesi; MP. Amato; L. Amaducci (1994). Immunosuppression in multiple sclerosis: state of the art and future perspectives. In: A multidisciplinary approach to myelin diseases II. New York: S. Salvati

DA VICO S; L. MASSACESI; AMADUCCI L (1993). Survey of the italian neurological output in the three years 1989-1991.. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, vol. 14, pp. 595-598, ISSN:0392-0461 DOI Accesso ONLINE all'editore

LOLLI F; LIUZZI G.M; VERGELLI M; L. MASSACESI; BALLERINI C; AMADUCCI L; RICCIO P (1993). Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis.. JOURNAL OF NEUROIMMUNOLOGY, vol. 44, pp. 69-75, ISSN:0165-5728 DOI Accesso ONLINE all'editore

Massacesi, L.; Vergelli, M; Zehetbauer, B; Liuzzi, G.M; Olivotto, J; Ballerini, C; Uccelli, A; Mancardi, L; Riccio, P; Amaducci, L (1993). Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form.. JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 119, pp. 91-98, ISSN:0022-510X DOI Accesso ONLINE all'editore

YU J.S; PANDEY J. P; L. MASSACESI; LINCOLN R; USUKU K; SEBOUN E; HAUSER S.L (1993). Segregation of Immunoglobulin heavy Chain constant region genes in Multiple sclerosis sibling pairs.. JOURNAL OF NEUROIMMUNOLOGY, vol. 42, pp. 113-116, ISSN:0165-5728 DOI Accesso ONLINE all'editore

SALVETTI M; BUTTINELLI C; L. MASSACESI; WEKERLE H (1993). New approaches to the study of T-cell autoimmunity in multiple sclerosis.. JOURNAL OF NEUROIMMUNOLOGY, vol. 47, pp. 203-205, ISSN:0165-5728 DOI Accesso ONLINE all'editore

SALVETTI M; L. MASSACESI (1992). Experimental allergic encephalomyelitis and multiple sclerosis: immunoregulatory mechanisms and T cell repertoires.. CELLULAR IMMUNOLOGY, vol. 142, pp. 217-219, ISSN:0008-8749 DOI Accesso ONLINE all'editore

L. MASSACESI; PARRITZ D; JOSHI N; LETVIN N; HAUSER S.L (1992). Experimental allergic encephalomyelitis in Cynomolgus Monkeys: quantitation of T-cell responses in peripheral blood.. THE JOURNAL OF CLINICAL INVESTIGATION, vol. 90, pp. 399-404, ISSN:0021-9738 DOI Accesso ONLINE all'editore

L. MASSACESI; CASTIGLI E; VERGELLI M; OLIVOTTO J; ABBAMONDI A.L; SARLO F; AMADUCCI L (1991). Immunosuppressive activity of 13-cis retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats.. THE JOURNAL OF CLINICAL INVESTIGATION, vol. 88, pp. 1331-1337, ISSN:0021-9738 DOI Accesso ONLINE all'editore

RISKIND P; L. MASSACESI; DOOLITTLE T.H; HAUSER S.L (1991). The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine.. ANNALS OF NEUROLOGY, vol. 29, pp. 542-547, ISSN:0364-5134 Accesso ONLINE all'editore

L. MASSACESI; ABBAMONDI A.L; RAIMONDI L; GIORGI C; AMADUCCI L (1988). Lysosomal enzymes in experimental allergic encephalomyelitis: time course and evidence of the source.. NEUROCHEMICAL RESEARCH, vol. 13, pp. 165-169, ISSN:0364-3190 DOI Accesso ONLINE all'editore

MASSACESI L; ABBAMONDI AL; GIORGI C; SARLO F; F. LOLLI; AMADUCCI L. (1987). Suppression of experimental allergic encephalomyelitis by retinoic acid.. JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 80, pp. 55-64, ISSN:0022-510X, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598:

L. MASSACESI; ABBAMONDI A.L; GIORGI C; SARLO F; LOLLI F; AMADUCCI L (1987). Suppression of experimental allergic encephalomyelitis by retinoic acid.. JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 80, pp. 55-64, ISSN:0022-510X DOI Accesso ONLINE all'editore

SMITH M.E; SOMERA F.P; SALDIVAR R; L. MASSACESI; TROTTER J (1984). DNA changes in spinal cords of rats with experimental allergic encephalomyelitis.. JOURNAL OF NEUROCHEMISTRY, vol. 43, pp. 1635-1641, ISSN:0022-3042 DOI Accesso ONLINE all'editore

Raimondi L, Banchelli Soldaini G, Buffoni F, Ignesti G, Massacesi L, Amaducci L, Friedmann CA. (1982). Rhein and derivates. In vitro studies on their capacity to inhibit certain proteases.. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, vol. 14, pp. 103-112, ISSN:0031-6989

F. Cambi; L. Massacesi; L. Amaducci (1982). La sclerosi multipla malattia degli anticorpi senza senso.. AGGIORNAMENTO MEDICO, vol. 5, pp. 39-45, ISSN:0392-3002

Luca MASSACESI

Curriculum

curriculum vitae

Personal information

Name		Luca Massacesi
Address		Dept. of Neurosciences, Drugs and Child Health, University of Florence, Viale Pieraccini, 6 - 50139 Florence, Italy Department of Neurosciences, Careggi University Hospital - University of Florence, Largo Brambilla 3 - 50134, Florence, Italy.
Telephone		+39 0552751697
Fax		+39 0552751898
E-mail		massacesi@unifi.it
Nationality		italian
Date of birth		30.11.1954

Current Position
• Name and address of employer		Florence University, Florence, Italy
• Type of business or sector		Dept. of Neurosciences, Drugs and Child Health
• Occupation or position held		Full Professor of Neurology
• Main activities and responsibilities		Research, Teaching, Clinical care

• Name and address of employer		Careggi University Hospital-University of Florence
• Type of business or sector		Dept. of Neurosciences
• Occupation or position held		Director
• Main activities and responsibilities		Management of clinical/ research activities, Clinical Governance
• Type of business or sector		IInd Neurology Division,
• Occupation or position held		Director
• Main activities and responsibilities		Patient clinical care, Clinical management, Teaching, Research,

Expertise

· Principal areas of expertise

Clinical neurology, neuroimmunology, inflammatory diseases of the nervous system, imaging of the nervous system

Work experience

• Dates (from – to)		1984-1988
• Name and address of employer		University of Florence, Florence, Italy
• Type of business or sector		Dept. of Neurology
• Occupation or position held		National Research Council research fellow
• Main activities and responsibilities		Research

• Dates (from – to)		1988-1991
• Name and address of employer		Massachusetts General Hospital, Harvard University, Boston, Ma, USA
• Type of business or sector		Neuroimmunology Unit, Dept. of Neurology
• Occupation or position held		postdoctoral fellow.
• Main activities and responsibilities		research

• Dates (from – to)		1991-2007
• Name and address of employer		Careggi University Hospital, Florence, Italy
• Type of business or sector		Ist NeurologyDivision
• Occupation or position held		Staff neurologist
• Main activities and responsibilities		Patients clinical care

• Dates (from – to)		1995-2001
• Name and address of employer		Florence University, Florence, Italy
• Type of business or sector		Dept. of Neurological and Psichiatric Sciences
• Occupation or position held		Assistant Professor of Neurology
• Main activities and responsibilities		Research and patient clinical care

• Dates (from – to)		2001-2005
• Name and address of employer		Florence University, Florence, Italy
• Type of business or sector		Dept. of Neurological And Psichiatric Sciences
• Occupation or position held		Associated Professor in Neurology
• Main activities and responsibilities		Teaching, Research, patient clinical care

• Dates (from – to)		2005-today
• Name and address of employer		Florence University, Florence, Italy
• Type of business or sector		Dept. of Neurosciences Drugs and Child Health
• Occupation or position held		Full Professor of Neurology
• Main activities and responsibilities		Teaching, Research, patient clinical care

• Dates (from – to)		2008-today
• Name and address of employer		Dept. of Neurosciences, Careggi University Hospital-University of Florence, Florence, Italy,
• Type of business or sector		IInd Neurology Division,
• Occupation or position held		Director
• Main activities and responsibilities		Clinical care, Clinical management, Teaching, Research,

• Dates (from – to)		2008-2012
• Name and address of employer		Florence University, Florence, Italy
• Type of business or sector		PHD Program in Neurosciences
• Occupation or position held		Coordinator
• Main activities and responsibilities		Research organization, research supervision

• Dates (from – to)		2008-2012
• Name and address of employer		Florence University, Florence, Italy
• Type of business or sector		Resident Program in Neurophysiopathology
• Occupation or position held		Director
• Main activities and responsibilities		Teaching and tutoring residents, patient clinical care, management

• Dates (from – to)		2009-2010
• Name and address of employer		National Institute of Health, Bethesda, MD, USA
• Type of business or sector		NINDS, Neuroimmunology Branch
• Occupation or position held		Adjunct Scientist
• Main activities and responsibilities		research

• Dates (from – to)		2010-today
• Name and address of employer		National Institute of Health, Bethesda, MD, USA
• Type of business or sector		NINDS, Neuroimmunology Branch
• Occupation or position held		Visiting Scientist
• Main activities and responsibilities		research

• Dates (from – to)		2012-today
• Name and address of employer		Careggi University Hospital-University of Florence, Florence, Italy
• Type of business or sector		Dept. of Neurosciences
• Occupation or position held		Director
• Main activities and responsibilities		Management of clinical and research activities

Education and training

• Date		1982
• Name and type of organization providing education and training		University of Florence
• Principal subjects/occupational skills covered		School of Medicine and Surgery
• Title of qualification awarded		Medical degree
• Level in national classification		110/110 cum laude

• Date		1986
• Name and type of organization providing education and training		University of Florence
• Principal subjects/occupational skills covered		Resident program in Clinical Neurology
• Title of qualification awarded		Specialization in Neurology
• Level in national classification		70/70 cum laude

• Date		1990
• Name and type of organization providing education and training		University of Florence
• Principal subjects/occupational skills covered		Resident program in Clinical Immunology
• Title of qualification awarded		Specialization in Clinical Immunology
• Level in national classification		70/70 cum laude

• Date		1982
• • Name and type of organization providing education and training		Stanford University, Palo Alto. Ca, USA.,
• Type of business or sector		Neurology Department, Laboratory of Neurochemistry
• Occupation or position held		visiting fellow.
• Main activities and responsibilities		research

• Date		1985
• • Name and type of organization providing education and training		National Institute of Health, Bethesda, Ma, USA
• Type of business or sector		NINDS, Neuroimmunology Branch
Occupation or position held		visiting fellow
• Main activities and responsibilities		research

Additional information

• Dates (from – to)		ORGANIZATION AND COORDINATION OF RESEARCH GROUPS.
1994-1997,		Project Leader of the international project "Concerted Action on T-cell Autoimmunity in Multiple Sclerosis". R&D program of the del General Directorate XII of the European Union Commission.
1997-1999		Coordinator of the italian multicentric project funded by the Associazione Italiana Sclerosi Multipla (AISM) entitled “Centralized Facility per genetic studies in Multiple Sclerosis.
1998-2001		Scientific Coordinator of the study entitled “Open randomized clinical study on different doses of bIFN1a, also in association with Azathioprine, in patients with relapsing remitting multiple sclerosis”.
2006-2011		Coordinator of the multicentric Randomized Controlled Trial funded by the Italian Drug Agency (AIFA) “Randomized controlled study of Azathioprine versus Interferon beta in relapsing-remitting multiple sclerosis”.

			FURTHER SCIENTIFIC ACTIVITIES
1993-today			- Italian Multiple Sclerosis Society (AISM); member of the Scientific Committee and of the Research Evaluation Committee.
1994-1997			- "Concerted Action on T-cell Autoimmunity in Multiple Sclerosis" R&D program of the del DG XII EU Commission, Project Leader.
1999-2000			- International Federation of Multiple Sclerosis Societies Scientific Program Committee; member of the Medical Advisory Board.
1995-2001			- Biomedical Primate Research EU Large Scale Facility, Rijswijk, The Nederland; member of the Scientific Committee.
2009-today			- European Medicines Agency (EMA), London, UK; Scientific Advisory Group – Neurology, member.
2009-today			- Italian Medicines Agency (AIFA), Rome, Italy; Scientific Advisory Committee on Neurosciences, member.
2010-2012			- National Institutes of Health, Bethesda MD, USA. Data and Safety monitoring board (DSMB) of the phase II intramural clinical study: Investigating mechanism of action of DAC HYP (Daclizumab) in the treatment of high inflammatory multiple sclerosis: Chairman

CURRENT TEACHING ACTIVITY AT FLORENCE UNIVERSITY

Course Subject

- 2002-today, School of Medicine: Clinical Neurology;

- 2005-today, School of Dentistry: Clinical Neurology;

- 2005-today, School of Nursing: Clinical Neurology;

- 2005-2009, Faculty of Experimental. Psycology: Clinical Neurology;

- 2005-today, Resident Program in Neurology: Clinical Neurology;

- 2005-2013, Resident Program in Neurophysiopathology: Clinical Neurology;

- 2009-today, Resident Program in Emergency Medicine: Clinical Neurology;

- 1991-today, School of Medicine, mentor of 25 Thesis dissertations;

- 1995-today,PhD program in Neurosciences, Supervisor of 12 PhD dissertations.

AFFILIATIONS TO SCIENTIFIC SOCIETIES

- Società Italiana di Neurologia.

- European Federation of Neurological Societies

- Associazione Italiana di Neuroimmunologia.

- International Society of Neuroimmunology.

- Società Italiana di Immunologia.

REVIEWER FOR

Journal of Neuroimmunology,

Journal Clinical Neurology and Neurosurgery,

Journal of Immunology,

Neurological Sciences,

Intl. MS journal,

Italian Multiple Sclerosis Society,

Dutch Multiple Sclerosis Society,

Singapore Medical Research Council

PLOs Medicine

PLOS Pathology

Italian Ministry of University and Research

Multiple Sclerosis International, member of the editorial board

ANNEXES

PUBLICATIONS

Publications on international Journal quoted in “PubMed”, National Library of Medicine (USA).

1. Raimondi L., Banchelli Soldaini G., Buffoni F., Ignesti G., Massacesi L., Amaducci L. and Friedmann C.A. (1982). Rhein and derivatives. In vitro studies on their capacity to inhibit certain proteases. Pharmacol. Res. Comm., 14(2): 103-112.
2. Smith M.E., Somera F.P., Saldivar R., Massacesi L. and Trotter J. (1984). DNA changes in spinal cords of rats with experimental allergic encephalomyelitis.J. Neurochem., 43: 1635-1641.
3. Massacesi L., Abbamondi A.L., Sarlo F. and Amaducci L. (1987). The control of experimental allergic encephalomyelitis with retinoic acid. Further studies. Riv. Neurol. 57:166-169.
4. Massacesi L., Abbamondi A.L., Giorgi C., Sarlo F., Lolli F. and Amaducci L. (1987). Suppression of experimental allergic encephalomyelitis by retinoic acid. J. Neurol. Sciences, 80:55-64.
5. Massacesi L., Abbamondi A.L., Raimondi L., Giorgi C. and Amaducci L. (1988). Lysosomal enzymes in experimental allergic encephalomyelitis: time course and evidence of the source. Neurochem. Res., 13:165-169.
6. Theoharides TC, Lambrachthall M, Massacesi L, et al. (1990). Reduced incidence of experimental allergic encephalomyelitis (EAE) with the tricyclic sep-ch. Europ. J. Pharmacol., 183: 626-627.
7. Massacesi L., Castigli E., Vergelli M., Olivotto J., Abbamondi A.L., Sarlo F. and Amaducci L. (1991). Immunosuppressive activity of 13-cis retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J.Clin.Invest., 88:1331-1337.
8. Riskind P., Massacesi L., Doolittle T.H. and Hauser S.L. (1991).The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann. Neurol., 29: 542-547.
9. Zehetbauer B., Massacesi L., Liuzzi G. M., Vergelli M., Olivotto J., Grassi L., Riccio P. and Amaducci L. (1991). Myelin Basic Protein in lipid-bound form induces experimental allergic encephalomyelitis and demyelination in Lewis rat. Acta Neurologica 13: 121-132.
10. Massacesi L., Parritz D., Joshi N, Letvin N. and Hauser S.L.(1992). Experimental allergic encephalomyelitis in Cynomolgus Monkeys: quantitation of T-cell responses in peripheral blood. J.Clin. Invest., 90: 399-404.
11. Salvetti M and Massacesi L. (1992). Experimental allergic encephalomyelitis and multiple sclerosis: immunoregulatory mechanisms and T cell repertoires. Cell. Immunol., 142: 217-219.
12. Salvetti M., Buttinelli C., Massacesi L. and Wekerle H. (1993). New approaches to the study of T-cell autoimmunity in multiple sclerosis. J. Neuroimmunol., 47: 203-205.
13. Yu J.S., Pandey J. P., Massacesi L., Lincoln R., Usuku K., Seboun E. and Hauser S.L. (1993). Segregation of Immunoglobulin heavy Chain constant region genes in Multiple sclerosis sibling pairs. J. Neuroimmunol., 42: 113-116.
14. Lolli F., Liuzzi G.M., Vergelli M., Massacesi L., Ballerini C., Amaducci L. and Riccio P. (1993). Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. J. Neuroimmunol., 44: 69-75
15. Massacesi L., Vergelli M., Zehetbauer B., Liuzzi G.M., Olivotto J., Ballerini C., Uccelli A., Mancardi L., Riccio P. amd Amaducci L. (1993). Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form. J. Neurol. Sciences, 119: 91-98.
16. Da Vico S., Massacesi L., Amaducci L. (1993). Survey of the italian neurological output in the three years 1989-1991. It J. Neurol. Sci., 14: 595-598.
17. Genain C.P., Parritz D., Hoa Nguyen M., Massacesi L., Ioshi N., Ferrante R., Hoffman K., Moseley M., Levtin N., Hauser S. (1994). In healthy primates, circulating autoreactive T-cells mediate autoimmune disease. J. Clinic. Invest., 94: 1339-1345.
18. Vergelli M., Mazzanti B., Ballerini C., Gran B., Amaducci L. and Massacesi L. (1995). Trasforming growth factor-beta1 inhibits the proliferation of rat astrocytes induced by serum and growth factors. J. Neurosc. Res., 40: 127-133.
19. Massacesi L., Genain C.P., Parritz D.L., Canfield D., Letvin N. and Hauser S.L. (1995). Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann. Neurol., 37: 519-530.
20. Hohlfeld R., Londei M., Massacesi L. and Salvetti M. (1995).T-cell autoimmunity in multiple sclerosis. Immunology Today (now Trends in Immunology), 16:259-261.
21. Amato M.P., Massacesi L. and Amaducci L. (1996). Clinical outcome measurements in Multiple Sclerosis trials. MS Forum. Int. MS Journal 3 n(1) : 19-27.
22. Vergelli M., Olivotto J., Castigli E., Gran B., Raimondi L., Pirisino R., Amaducci L. and Massacesi L. (1997). Immunosuppressive activity of 13-cis-retinoic acid in rats: Aspects of pharmacokinetics and pharmacodynamics. Immunopharmacol., 37: 191-197.
23. Mazzanti B. , M. Vergelli, P. Riccio, R. Martin, H.F. McFarland, G.M. Liuzzi, L. Amaducci and Massacesi L. (1998). T cell response to Myelin Basic Protein in patients with Multiple Sclerosis and healthy donors. J. Neuroimmunol., 82: 96-100.
24. Gran B., Gestri D., Sottini A., Quiròs Roldàn E., Bettinardi A., Signorini S., Primi D., Ballerini C., Taiuti R., Amaducci L. and Massacesi L. (1998). Detection of skewed T-cell receptor V-beta gene usage in the peripheral blood of patients with multiple sclerosis. J. Neuroimmunol., 85: 22-32.
25. Cascino I., Ballerini C., Audino S., Rombolà G., Massacesi L., Colombo G., Scorza Smeraldi R., D’Alfonso S., Momigliano Richiardi P., Tosi R., Ruberti G. (1998). Fas Gene Polymorphisms are not associated with Systemic Lupus Erythematosus, Multiple Sclerosis and HIV Infection. Disease Markers, 13: 221-225.
26. Laman J.D., van Meurs M., Schellekens M.M., de Boer M., Melchers B., Massacesi L., Lassmann H., Klaassen E., ‘t Hart B. (1998). Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus). J. Neuroimmunol., 86: 30-45.
27. ‘t Hart B., Bauer J., Muller H.J., Melchers B., Nicolay K., Brok H., Bontrop R., Lassmann H. and Massacesi L. (1998) Histopathological characterization of magnetic resonance imaging-decectable brain white matter lesions in a primate model of multiple sclerosis. Am. J. Pathol., 153: 649-663.
28. Kappos, L; Polman, C; Pozzilli, C et al (1998). Placebo-controlled multicentre randomised trial of Interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet, 352: 1491-97.
29. Mazzucco S., Nardi E., Chelli M., Ginanneschi M., Rapi G., Papini A.M., Vergelli M., Mazzanti B., Massacesi L., Amaducci L. (1999). Synthesis of lipopeptides of the immunodominant epitope hMBP(83-99) containing amide or C-C bond linked hydrophobic chains for the study of T cell response. Letters in Peptide Sciences 6: 51-59.
30. Mazzucco S., Matà S., Vergelli M., Fioresi R., Nardi E., Mazzanti B., Chelli M., Lolli F., Ginanneschi M., Pinto F., Massacesi L. and Papini A.M. (1999). A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. Bioorg. Med. Chem. Lett. : 167-172.
31. Sabbadini M.G., Manfredi AA., Bozzolo E., Ferrario L., Rugarli C., Scorza R., Origgi L., Vanoli M., Gambini O., Vanzulli L., Croce D., Campana A., Messa C., Fazio F., Tincani A., Anzola G., Cattaneo R., Padovani A., Gasparotti R., Gerli R., Quartesan R., Piccirilli M., Farsi A., Emmi E., Domeneghetti M., Piccini C., Massacesi L., Pupi A., De Cristoforis M., Danieli M., Candela M., Fraticelli P., Bartolini M., Savolini U., Danieli G. and Passaleva A. (1999). Central Nervous system involvement in Systemic Lupus Eritematosus patients without overt neuropsychiatric manifestations. Lupus 8: 11-19.
32. D’Alfonso S., Nisticò L., Zavattari P., Marrosu M., Murru R., Lai M., Massacesi L., Ballerini C., Gestri D., Salvetti M., Ristori G., Bomprezzi R., Trojano M., Liguori M., Gambi D., Quattrone A., Fruci D., Cucca F., Momigliano Richiardi P. and Tosi R. (1999). A linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur. J Hum.Gen. 7 : 377-385.
33. Miller D.H., Molyneux P.D., Barker G.J., Mac Manus D.G., Moseley I.F., Wagner K.,and the European Study Group on Interferon-Beta1b in Secondary Progressive Multiple Sclerosis. (1999) Effect of Interferon-Beta1b on Magnetic Resonance Imaging Outcomes in Secondary Progressive Multiple Sclerosis: Results of a European Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Ann. Neurol., vol. 46, 850-859.
34. Ballerini C. Nacmias B., Rombolà G., Marcon G., Massacesi L., Sorbi S. (1999) HLA A2 Allele Is Associated with Age at Onset of Alzheimer’s Disease. Ann. Neurol., vol. 45: 397-400.
35. Mazzanti B., Hemmer B., Traggiai E., Ballerini C., McFarland H.F., Massacesi L., Martin R. and Vergelli M. (2000). Decrypting the Spectrum of Antigen-Specific T-Cell Responses: The Avidity Repertoire of MBP-Specific T-Cells. J. Neurosci. Res., 59:86-93.
36. ‘t Hart B.A., van Meurs M., Brok H.P.M., Massacesi L., Bauer J., Boon L., Bontrop R.E and Laman J.D. (2000). A new primate model for multiple sclerosis in the common marmoset. Immunology Today (ora Trends in Immunology), 21: 290-297.
37. Pupi A., Sestini S., De Cristofaro M.T., Emmi L., Marchione T., Salvati G., Li Gobbi F., Massacesi L., Meldolesi U. (2000). Use of technetium-99mhexametylpropyleneamine oxime single-photon emission tomography for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behcet’s disease. Eur. J. Nucl. Med. 27(6): 700-706.
38. D’Alfonso S., Nisticò L., Bocchio D., Bomprezzi R., Marrosu M.G., Murru M.R., Lai M., Massacesi L., Ballerini C., Repice A., Solvetti M., Montesperelli C., Ristori G., Trojano M., Liguori M., Gambi D., Quattrone A., Tosi R., Momigliano-Richiardi P. (2000). An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population. J. Neurovirol. 6 (S 2):18-22.
39. Molyneux P.D., Kappos L., Polman C., Pozzilli C., Barkhof F., Filippi M., Yousry T., Hahn D., Wagner K., Ghazi M., Beckmann K., Dalhke F., Losseff N., Barker G.J., Thompson A.J., Miller D.H. and the European Study Group on Interferon beta-1b in Secondary Progressive Multiple Sclerosis (2000). The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple Sclerosis. Brain 123: 2256-2263.
40. Ballerini C., Campani D., Rombolà G., Gran B., Nacmias B., Amato M.P., Siracusa G., Bartolozzi L., Sorbi S. and Massacesi L. (2000). Association of apolipoprotein E polymophism to clinical heterogeneity of multiple sclerosis. Neurosci. Lett. 296: 174-176.
41. Papini AM, Mulinacci B, Carotenuto A, Bonetti B, Sabatino G, Peron E, Nuti F, Alcaro MC Pozo-Carrero MC, Mazzanti, B, Pazzagli m, Massacesi L, Battistini L, Chelli, M, Rovero, P, Lolli, F, Chorev M, Sawyer, TK, 2001. MS PepKit: The first diagnostic test to follow-up multiple sclerosis. Peptide Revolution: Genomics, Proteomics & Therapeutics
42. Chiarugi A., Cozzi A., Ballerini C., Massacesi L. and Moroni F. (2001). Kynurenine 3-monoxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience 102: 687 - 695.
43. Mancardi G., t’Hart B., Roccatagliata L., Brok H., Giunti D., Bontrop R., Massacesi L., Capello E. and Uccelli A. (2001.) Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J. Neurol. Sciences 184: 41-49.
44. Gestri D., Baldacci L., Taiuti R., Galli E., Maggi E., Piccinni M.P., Vergelli M. and Massacesi L. (2001). Oligoclonal T-cell repertoire in cerebrospinal fluid of patients with nervous system inflammatory diseases. J. Neurol. Neurosurg. Psych. 70: 767- 772.
45. Broadley S., Sawcer S., D'Alfonso S., Henseik A., Coraddu F., Gray J., Roxburgh R., Clayton D., Buttinelli C., Quattrone A, Trojano M., Momigliano Richiardi P. , Massacesi L. and Compston A. (2001). A genome screen for multiple sclerosis in Italian families. Genes Immun. 2: 205-10.
46. Mancardi G.L., Saccardi, R., Filippi, M., Gualandi F., Murialdo A., Inglese M., Marrosu M.G., Meucci G., Massacesi L., Lugaresi A., Pagliai F., Sormani M.P., Sardanelli F., Marmont A. and the Italian Gitmo-Neuro Intergroup on Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis (2001). Autologous hematopoietic stem cell transplantation suppresses Gadolinium-enhanced MRI activity in multiple sclerosis. Neurology 57:62-68.
47. Papini A.M., Mazzanti B., Nardi E., Traggiai E., Ballerini C., Biagioli T., Kalbacher H., Beck H., Deeg M., Chelli M., Ginanneschi M., Massacesi L., Vergelli M. (2001). Palmitoyl Derivatives of GpMBP Epitopes: T-Cell Response and Peptidases Susceptibility. J. Med. Chem 44: 3504- 3510.
48. Soldan S. S., Fogdell-Hahn A., Brennan M. B., Mittleman B. B., Ballerini C., Massacesi L., Seya T., McFarland H. F. and Jacobson S. (2001). Elevated serum and CSF levels of soluble HHV-6 cellular receptor, membrane cofactor protein (MCP; CD46), in patients with multiple sclerosis. Ann. Neurol. 50: 486-93.
49. Vergelli M., B. Mazzanti, E. Traggiai, T. Biagioli, C. Ballerini, A Parigi, G. Pellicanò, A. Konze, Massacesi L (2001). Short-term evolution of autoreactive T-cell repertoire in multiple sclerosis. J Neurosci Res. 66:517-24.
50. Traggiai E., Biagioli T., Rosati E., Ballerini C., Mazzanti B., Ben Nun A., Massacesi L., Vergelli M. (2001). IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J. Neuroimmunol. 121:111-9.
51. Kappos L., Polman C., Pozzilli C., Thompson A., Beckmann K., Dalhke F., and the European Study Group on Interferon beta-1b in Secondary Progressive Multiple Sclerosis (2001). Final analysis of the European multicenter trial on IFNbeta-1b secondary progressive Multiple Sclerosis. Neurology 57: 1969-1975.
52. Freeman J, Thompson A., Fitzpatrick R., Hutchinson M., Miltenburger C., Beckmann K., Kappos L., Dalhke F., Polman C., Pozzilli C., and the European Study Group on Interferon beta-1b in Secondary Progressive Multiple Sclerosis (2001). IFNbeta-1b in the treatment of secondary progressive Multiple Sclerosis. Impact on quality of life. Neurology 57: 1870-1875.
53. Molyneux PD, Barker GJ, Barkhof F, Beckmann K, Dahlke F, Filippi M, Ghazi M, Hahn D, MacManus D, Polman C, Pozzilli C, Kappos L, Thompson AJ, Wagner K, Yousry T, Miller DH; European Study Group on Interferon Beta-1b in Secondary Progressive MS (2001). Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.Neurology 57: 2191-7.
54. D'Alfonso S., Mellai M., Giordano M., Pastore A., Malferrari G., Naldi P., Repice A., Liguori M., Cannoni S., Milanese C., Caputo D., Savettieri G., Momigliano-Richiardi P. and the Italian Group for the Study of Multiple Sclerosis Genetics(2002). Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene (MAG) and study of their association with multiple sclerosis. J. Neuroimmunol. 126 : 196-204.
55. Muraro, P.A., Bonanni, L., Mazzanti B., Pantalone, A., Traggiai, E., Massacesi L., Vergelli, M., Gambi, D. (2002). Short-term dynamics of circulating T cell receptor V beta repertoire in relapsing-remitting MS. J. Neuroimmunol. 127: 149-59.
56. Massacesi L. (2002). Compartmentalization of the immune response in the central nervous system and natural history of multiple sclerosis. Implications for therapy. Clin Neurol Neurosurg 104: 177-81.
57. Ballerini C., Rosati E., Salvetti M., Ristori G., Cannoni S., Biagioli T., Massacesi L., Sorbi S., Vergelli M. (2002). PTPRC exon 4 gene mutation distribution in a Italian MS population. Neuroscience Letters 328: 325-7.
58. Buzzetti R., Pozzilli P., Di Mario U., Ballerini C., and Massacesi L. (2002). Multiple sclerosis and Type I diabetes. Diabetologia 45: 1735-6.
59. Mellai M., Giordano M., D’Alfonso S., Marchini M., Scorza R., Danieli M.G., Leone M., Ferro I., Liguori M., Trojano M., Ballerini C., Massacesi L., Cannoni S., Bomprezzi R., Momigliano-Richiardi P. (2003). Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Human Immunol. 64: 274-284.
60. Polman C, Kappos L, White R, Dahlke F, Beckmann K, Pozzilli C, Thompson A, Petkau J, Miller D; European Study Group in Interferon Beta-1b in Secondary Progressive MS (2003). Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. Neurology 60: 37-43.
61. Sormani MP, Bruzzi P, Beckmann K, Wagner K, Miller DH, Kappos L, Filippi M; European Study Group on Interferon Beta-1b in Secondary Progressive MS (2003). MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b. Neurology 60: 1462-6.
62. Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, Genin E, Vasilescu A, Bougerie H, Trojano M, Martins Silva B, Maciel P, Clerget-Darpoux F, Clanet M, Edan G, Fontaine B, Semana G. (2003) and the Portuguese and Italian Group for MS genetics. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann Neurol. 54:119-22.
63. Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF, Oturai A, Trojano M, Momigliano-Richiardi P, Cocco E, Murru R, Hillert J, Compston A and Sawcer S (2003). Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis. J Neuroimmunol. 143: 31- 38.
64. Liguori M, Sawcer S, Setakis E, Compston A, Giordano M, D'Alfonso S, Mellai M, Malferrari G, Trojano M, Livrea P, De Robertis F, Massacesi L, Repice A, Ballerini C, Biagioli T, Bomprezzi R, Cannoni S, Ristori G, Salvetti M, Grimaldi LM, Biunno I, Comi G, Leone M, Ferro I, Naldi P, Milanese C, Gellera C, Loredana LM, Savettieri G, Salemi G, Aridon P, Caputo D, Rosa Guerini F, Ferrante P, and Momigliano-Richiardi P (2003). A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. J Neuroimmunol. 143: 97-100.
65. Ballerini C, Guerini F, Rombolà G, Rosati E, Massacesi L, Ferrante P, Caputo D, Figà Talamanca L, Naldi P, Liguori M, Alizadeh M, Momigliano-Richiardi P, D’Alfonso S (2004). HLA-Multiple Sclerosis association in Continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol. 150:178 -85.
66. IngleseM, G L Mancardi, E Pagani, M A Rocca, A Murialdo, R Saccardi, G Comiand M Filippi the Italian GITMO-NEURO Intergroup on Autologous Hemotopoietic Stem Cell Transplantation (2004).Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J. Neurol. Neurosurg. Psych. 75: 643-644.
67. Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P, Donelli A, Filippi M, Guerrasio A, Gualandi F, La Nasa G, Murialdo A, Pagliai F, Papineschi F, Scappini B, Marmont AM. and the Italian GITMO-NEURO Intergroup on Autologous Hemotopoietic Stem Cell Transplantation (2005). Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood. 105:2601-7.
68. MazzantiB, Biagioli T., Aldinucci A., Cavaletti G., CavalettiE., Crippa L., Oggioni N.,Sala F., Sala V., Frigo M., Rota S., Tagliabue E., Ballerini C., Massacesi L., Riccio P. and Lolli F. (2005). Effects of Pixantrone on T- and B-cell function in the course of acute rat experimental allergic encephalomyelitis. J. Neuroimmunol. 168: 111-117.
69. Capello E, Saccardi R, Murialdo A, Gualandi F, Pagliai F, Bacigalupo A, Marmont A, Uccelli A, Inglese M, Bruzzi P, Sormani MP, Cocco E, Meucci G, Massacesi L, Bertolotto A, Lugaresi A, Merelli E, Solari A, Filippi M, Mancardi GL; Italian GITMO-Neuro Intergroup on ASCT for Multiple Sclerosis (2005). Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Neurol Sci. 26: S200-3.
70. Massacesi L, Parigi A, Barilaro A, Repice AM, Pellicanò G, Konze A, Siracusa GF, Taiuti R and Amaducci L. (2005). Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated by Magnetic Resonance Imaging. Arch.Neurol.;62:1843-1847.
71. Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfo M, Pugliatti M, Sotgiu S, Solaro C, Bomprezzi R, Di Giovanni S, Figa Talamanca L, Nistico L, Fagnani C, Neale MC, Cascino I, Giorgi G, Battaglia MA, Buttinelli C, Tosi R, Salvetti M. and the Italian MS genetic collaborative group (2006). Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study. Ann Neurol.59(1):27-34.
72. The GAMES Collaborative Group, Ban M, Booth D, Heard R, Stewart G, Goris A, Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC, Brassat D, Clanet M, Cournu-Rebeix I, Fontaine B, Semana G, Goedde R, Epplen J, Weber A, Infante-Duarte C, Zipp F, Rajda C, Bencsik K, Vécsei L, Heggarty S, Graham C, Hawkins S, Liguori M, Momigliano-Richiardi P, Caputo D, Grimaldi LM, Leone M, Massacesi L, Milanese C, Salvetti M, Savettieri G, Trojano M, Bielecki B, Mycko MP, Selmaj K, Santos M, Maciel P, Pereira C, Silva A, Silva BM, Coraddu F, Marrosu MG, Akesson E, Hillert J, Datta P, Oturai A, Harbo HF, Spurkland A, Goertsches R, Villoslada P, Eraksoy M, Hensiek A, Compston A, Setakis E, Gray J, Yeo TW, Sawcer S. (2006). Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans. J. Neuroimmunol.179: 108-116.
73. Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, Carreras E, Saiz A, Löwenberg B, te Boekhorst P, GualandiF, Openshaw H, Longo G, Pagliai F, Massacesi L, Deconink E, Ouyang J, Zuazu Nagore F, Besalduch J, Lisukov I, Bonini A, Merelli E,Slavin S, Gratwohl A, Passweg J, Tyndall A, Steck A, Andolina M, Capobianco M, Diez Martin J, Lugaresi A,Meucci G, Sáez R,Clark R, Fernandez M, Fouillard L, Herstenstein B, Koza V, Cocco E, Baurmann H and Mancardi G on behalf of the Autoimmune Disease Working Party of EBMT (2006). Autologous stem cell transplantation for progressive multiple sclerosis: update of the European group for blood and marrow transplantation auto-immune diseases working party database. Mult. Sclerosis 12: 814-823.
74. Roccatagliata L, Rocca M, Valsasina P, Bonzano L, Sormani M, Saccardi R, Mancardi G, Filippi M; for the Italian GITMO-NEURO Intergroup on Autologous Stem Cell Transplantation.(2007). The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. Mult Sclerosis. 13: 1068-70.
75. Aldinucci A., Gerlini G., Fossati S., Cipriani G., Ballerini C., Biagioli T., Pimpinelli N., Borgognoni L., Massacesi L., Moroni F. and Chiarugi A. (2007). Requirement for PARP-1 activity during human dendritic cell maturation. J. Immunol. 179: 305-12.
76. D’Alfonso S., Bolognesi E., Guerini F., Barizzone N., Bocca S., Castelli L., Bergamaschi L., Agliardi C., Ferrante P., Naldi P., Leone M., Caputo D., Ballerini C., Salvetti M., Galimberti D., Massacesi L., Trojano M., Momigliano-Richiardi P. (2008). A sequence variation in the MOG gene is involved in Multiple Sclerosis susceptibility in Italy. Genes and Immun 9: 7-15.
77. Luccarini I., Ballerini C., Biagioli T., Biamonte F., Bellucci A., Rosi M.C., Grossi C., Massacesi L. and Casamenti F. (2008). Combined treatment with atorvastatin and minocycline suppresses severity of EAE. Exp. Neurol., 211: 214.
78. Mazzanti B., Aldinucci A., Biagioli T., Barilaro A., Urbani S., Dal Pozzo S., Amato MP, Siracusa GF., Crescioli C., Manuelli A., Bosi A., Saccardi R., Massacesi L. and Ballerini C. (2008). Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment. J. Neuroimmunol. 199:142-50.
79. ’t Hart B. and Massacesi L(2009). Clinical, pathological and immunological aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). J. Neuropath.Exp.Neurol. 68 (4): 341-355.
80. Bizzoco E, Lolli F, Repice A, Falcini M, Taiuti R, Siracusa GF, Amato MP, Biagioli T, Lori S, Moretti M, Vinattieri A, Nencini P, Massacesi L, Matà S. (2009). Prevalence of Neuromyelitis Optica Spectrum Disorder and Phenotype Distribution. J. Neurol. 256:1891-8
81. Aldinucci A, Biagioli T, Manuelli C, Repice A, Massacesi L, Ballerini C. (2010). Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP. J. Neuroimmunol, 218:28-35.
82. Aldinucci A, Rizzetto L, Pieri L, Nosi D, Romagnoli P, Biagioli T, Mazzanti B, Saccardi R, Beltrame L, Massacesi L, Cavalieri D, Ballerini C (2010). Inhibition of Immune Synapse by Altered Dendritic Cell Actin Distribution: A New Pathway of Mesenchymal Stem Cell Immune Regulation. J. Immunol. 185:5102-10.
83. Gaitán M, SheaC, Evangelou I, Stone R, Fenton K, Bielekova B, Massacesi L, Reich D. (2011). Evo-lution of the Blood-Brain Barrier in Newly Forming Multiple Sclerosis Lesions. Ann. Neurol. 70: 22-29.
84. Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, CerveraR, DentonC, HawkeyC, Labopin M, Mancardi G, MartinR, MooreJJ, PasswegJ, Peters C, RabusinM, RoviraM, van Laar JM & Farge D on behalf of the EBMT Autoimmune Disease, (2011). Haematopietic stem cells transplantation (HSCT) in severe autoimmune diseases: updated guidelines of the European group for bone marrow transplantation (EBMT). Bone marrow Transplantation
85. MancardiG, Sormani M, Di Gioia M, Vuolo L, Gualandi F, Amato M, Capello E, Currò D, Uccelli A, Bertolotto A, Gasperini C, Lugaresi A, Merelli E, Meucci G, Motti L, Tola M, Scarpini E, Repice A, Massacesi L, Saccardi R. (2012) Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler. J. 18: 835-842.
86. Lutterotti A, Jelcic I, Schulze C, Schippling S, Breiden P, Mazzanti B, Reinhard S, DiGioia M, Repice A, Massacesi L, Sputtek A, Salinas-Riester G, Kroeger N, Sospedra M, Saccardi R, Zander A and MartinR (2012). Gene expression and epigenetic profiling of CD34+ hematopoietic progenitor cells in multiple sclerosis patients – absence of proinflammatory signatures.Mult Scler. .
87. Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, Kraft G, Mancardi GL, Nash R, Pasquini M, Martin R, Muraro PA; European Blood and Marrow Transplantation Group; Center for International Blood and Marrow Research; HSCT in MS International Study Group (2012). A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler. Jun;18(6):825-34.
88. Zamboni P, Bertolotto A, Boldrini P, Cenni P, D'Alessandro R, D'Amico R, Del Sette M, Galeotti R, Galimberti S, Liberati A, Massacesi L, Papini D, Salvi F, Simi S, Stella A, Tesio L, Valsecchi MG, Filippini G. (2012). Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial. Trials 13: 183-196.
89. Carrai V, Donnini I, Mazzanti B, Alterini R, Amato MP, Barilaro A, Bosi A, Massacesi L, Portaccio E, Repice AM, Rotunno G and Saccardi R. (2013).Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous hematopoietic stem cells transplantarion. Clin. Neurol. and Neurosurg. 115: 1044 – 1048
90. Aldinucci A, Turco A, Biagioli T, Toma F, Bani D, Guasti D, Manuelli C, Rizzetto L, Cavalieri D, Massacesi L, Mello T, Scaini D, Bianco A, Ballerini L, Prato M, Ballerini C (2013). Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. Nano Letters 13(12):6098-105.
91. Paganini M, Biggeri A, Romoli AM, Mechi C, Ghelli E, Berti V, Pradella S, Bucciantini S, Catelan D, Saccardi R, Lombardini L, Mascalchi M, Massacesi L, Porfirio B, Di Lorenzo N, Vannelli GB, Gallina P (2014). Foetal striatal grafting slows motor and cognitive decline of Huntington’s disease. J.Neurol.Neurosurg.Psich. 85: 974-981.
92. Mascalchi M, Ginestroni A, Toschi N, Poggesi A, Cecchi P, Salvadori E,Tessa C, Cosottini M,De Stefano N, Pracucci G,Pantoni L, Inzitari D, Diciotti S and VMCI Tuscany investigators. (2014).
93. The burden of microstructural damage modulates cortical activation in elderly subjects with MCI and leuko-araiosis. A DTI and fMRI study. Human Brain Mapping35: 819–830.
94. Gaitan M, Maggi P, Wholer N, Leibowitch M, Sati P, Calandri B, Merkle L, Massacesi L, Silva A, Jacobson S, Rech D. (2014) Perivenular Brain lesions in a primate multiple sclerosis model at 7-tesla MRI. Mult. Scler. 20(1):64–71.
95. Maggi P, Cummings Macri S, Gaitán M, Leibovitch E, Wohler J, Knight H, Ellis M, Wu T, Silva A, Massacesi L, Jacobson S, Westmoreland S, Reich D (2014). The formation of inflammatory demyelinated lesions in cerebral white matter. Ann. Neurol. 76:594-608.
96. Massacesi L, Tramacere I, Amoroso S, Battaglia M, Benedetti MD, Filippini G, La Mantia L, Repice A M, Solari A, Tedeschi G, Milanese C (2014). Azathioprine versus Beta Interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial. PlosOne, 9(11):e113371; e-Pub, November 17 2014.
97. Bonechi E, Aldinucci A, Mazzanti B., DiGioia M, Repice A, Manuelli C, Saccardi R, Massacesi L, Ballerini C, (2014). Increased CXCL10 expression in Multiple Sclerosis MSCs and monocytes is unaffected by AHSCT. Ann Clin Transl Neurol, 1:650-8.
98. Laroni A, Brogi D, Morra VB, Guidi L, Pozzilli C, Comi G, Lugaresi A, Turrini R, Raimondi D, Uccelli A, Mancardi GL, EAP Investigators (2014). Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. BMC Neurol. 14:65.
99. Gallina P, Paganini M, Lombardini L, Biggeri A, Marini M, Morelli AM, Bucciantini S, Sarchielli E, Ambrosini S, Mechi C, Romoli AM, Ghelli E, Pradella S, Urbani S, Mazzanti B, Berti V, Giordano GP, Campolo M, Dal Pozzo S, Piacentini S, Saccardi R, Massacesi L, Mascalchi M, Bosi A, Conti R, Porfirio B, Di Lorenzo N, Vannelli GB,(2014). Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana. Trapianti 18: 5-11.
100. Salvadori E1, Poggesi A1, Valenti R1, Pracucci G1, Pescini F2, Pasi M1, Nannucci S1, Marini S1, Del Bene A1, Ciolli L1, Ginestroni A3, Diciotti S4, Orlandi G5, Di Donato I6, De Stefano N6, Cosottini M7, Chiti A5, Federico A6, Dotti MT6, Bonuccelli U5, Inzitari D1, Pantoni L8; VMCI-Tuscany Study Group. VMCI-Tuscany Study Group (2015). Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: the VMCI-Tuscany Study. J Alzheimers Dis. 43: 1313-23.
101. Maggi P, Mazzoni L, Moretti M, MassacesiL (2015). SWI enhances vein detection using gadolinium in multiple sclerosis. Acta Radiologica Open. 4:2047981614560938.
102. Clausi V, Giannecchini S,Magnani E, Repice A, Mechi C, Martelli F, Azzi A, Massacesi L. (2015).Markers of JC Virus Infection in Multiple Sclerosis Patients Under Natalizumab Therapy. Neurology Neuroimmunol Neuroinflamm. 2: e58.
103. Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, Donelli A, Lugaresi A, Di Bartolomeo P, Rottoli MR, Rambaldi A, Amato MP, Massacesi L, Di Gioia M, Vuolo V, Currò D, Roccatagliata L, Filippi M, Aguglia U, Iacopino P, Farge D, and Saccardi R. (2015). Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a phase II trial. Neurology. 84(10):981-8.
104. Giovannelli I, Martelli F, Repice AM, Massacesi L, Azzi A and Giannecchini S (2015). Detection of JCPyV microRNA in Blood and urine samples of multiple sclerosis patients under natalizumab therapy. J. of Neurovirology, 21: 666-70.
105. Capobianco M, Lo Re M, Sangalli F, Moiola L, Perini P, Gallo P, Danni M, Provinciali L, Repice AM, Massacesi L, Messina S, Patti F, Laroni A, Mancardi GL, Pucci E, Calabrese M and Bertolotto A (2015). Cyclophosphamide Pulse Therapy after Natalizumab Discontinuation for Multiple Sclerosis: a multicenter study. J Mult Scler (Foster City) 2:151.
106. Maggi P, Sati P, Massacesi L. (2016). Magnetic resonance imaging of experimental autoimmune encephalomyelitis in the common marmoset. J Neuroimmunol. 304:86-92¸ Epub 2016 Oct 8.
107. Lagi F, Bartalesi F, Pecile P, Biagioli T, Caldini AL, Fanelli A, Giannazzo G, Grifoni S, Massacesi L, Bartoloni A, Rossolini GM. (2016). Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults. J Clin Microbiol. 54(7):1851-4.
108. Montanari E, Rottoli M, Maimone D, Confalonieri P, Plewnia K, Frigo M, Francia A, Pala A, Losignore NA, Ragonese P, Veneziano A; POSIDONIA study group. (2016). A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study. J Neurol Sci. 15;364:105-9.
109. Salvadori E, Poggesi A, Valenti R, Pracucci G, Pescini F, Pasi M, Nannucci S, Marini S, Del Bene A, Ciolli L, Ginestroni A, Diciotti S, Orlandi G, Di Donato I, De Stefano N, Cosottini M, Chiti A, Federico A, Dotti MT, Bonuccelli U, Inzitari D, Pantoni L; VMCI-Tuscany Study Group (2016). Operationalizing mild cognitive impairment criteria in small vessel disease: the VMCI-Tuscany Study. Alzheimers Dement. 2016 Apr;12(4):407-18.
110. Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative (2016).The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 12:714-722.
111. Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, Frederiksen J, Skeen M, Jaffe GJ, Butzkueven H, Ziemssen F, Massacesi L, Chai Y, Xu L, Freeman S; RENEW Study Investigators (2017). Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 16:189-199.
112. Muraro P, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R. Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group (2017). Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. JAMA Neurol. 74:459-469.
113. Forci B, Mariottini A, Mechi C, Massacesi L, Repice A. (2017).Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. Mult Scler Relat Disord. 2017 Jul;15:24-26.
114. ZamboniP, TesioL, GalimbertiS, Massacesi L, SalviF, D’AlessandroR, CenniP, GaleottiR, PapiniD,D’AmicoR, SimiS, ValsecchiMG, FilippiniG and the Brave Dreams Research Group (2017). Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurol., e-pub 18 Novembre 2017.
115. Maggi P, Absinta M, GrammaticoM, Vuolo L, EmmiG, Carlucci G, Spagni G, Barilaro A, Repice AM, Emmi L, Prisco D, Martinelli V, Scotti R, Sadeghi N, Perrotta G, Sati P, Dachy B, Reich DS, Filippi M, Massacesi L. (2018). The central vein sign differentiates multiple sclsrosis from CNS inflammatory vasculopathies. Ann Neurol, 83 (2), 283-294.

Other publications

Amaducci L. e Massacesi L. (1981). Modificazioni neurochimiche e prospettive di farmacologia sperimentale e clinica nella sclerosi multipla. Atti del XXII° congresso della Società Italiana di Neurologia: 197-206.
Cambi F., Massacesi L. and Amaducci L. (1982). La sclerosi multipla malattia degli anticorpi senza senso. Aggiornamento del Medico 1 (5): 39-45.
Amaducci L., Massacesi L., Guarnieri B.M. (1983). Neurochemical aspects of multiple sclerosis. In "New trends of multiple sclerosis research", Cazzullo C. L., Caputo C.L., Ghezzi A. eds., pp. 125-130.
Amaducci L., Massacesi L., Guarnieri B.M., and Cambi F. (1984). Proteases, proteases inhibitors and diseases of the nervous system. In "Neuroimmunology", Behan P.O. and Spreafico F. eds., pp. 127-148. Raven Press (New York). Massacesi L. and Amaducci L. (1986). Selective immunosuppression in multiple sclerosis, in "Virology and immunology in multiple sclerosis", Cazzullo C.L., Caputo D., Ghezzi A., Zaffaroni M. editors, pp. 147-152. Springer-Verlag (Berlin).
Massacesi L., Abbamondi A.L., Castigli E., Sarlo F. and Amaducci L.(1987). Encefalomielite allergica sperimentale e acido retinoico. In "La neuroimmunologia clinica oggi", Annunziata P. and Guazzi G. eds.: 47-56, Piccin (Padova).
Massacesi L., Abbamondi A.L., Sarlo F. and Amaducci L. (1987). The control of experimental allergic encephalomyelitis with retinoic acid. Further studies. Riv. Neurol. 57:166-169.
Massacesi L., Abbamondi A.L., Castigli E. and Amaducci L. (1988). Immunosuppression in experimental allergic encephalomyelitis. In "A multidisciplinary approach to myelin diseases", Serlupi Crescenzi G. ed. Plenum Press (New York) pp. 251-258.
Massacesi L., Abbamondi A.L., Castigli E., Sarlo F. and Amaducci L. (1988). Immunohistochemical study of the suppressive effect of retinoic acid (RA) on experimental allergic encephalomyelitis. In "Trends in European multiple sclerosis research", Confavreux C., Aimard G. and Devic M. eds. Excerpta Medica (Amsterdam), pp. 147-152.
Massacesi L., Abbamondi A.L., Sarlo S., Castigli E., Olivotto J., Vergelli M. and Amaducci L. (1989). Role of astroglial cells in experimental allergic encephalomyelitis. In “Trends in neuroimmunology”, Marrosu M.G., Cianchetti C. and Tavolato B. eds., Plenum Press (New York), pp. 97-102.
Massacesi L., Sarlo F., Abbamondi A.L., Castigli E., Olivotto J., Vergelli M., Raimondi L., Medica A. and Amaducci L. (1989). Immunosuppressive activity of Retinoic Acid (RA). In “Multiple Sclerosis Research”, M.A. Battaglia ed., Elsevier Science Publishers B.V., pp. 215-224.
Massacesi L., Sarlo F., Castigli E., Vergelli M., Olivotto J., Raimondi L., Medica A. and Amaducci L. (1989). Concentration related effects of Retinoic Acid on lymphoproliferative response in EAE. In “Recent advances in multiple sclerosis therapy”, R.E. Gonsette, P. Delmotte, eds., Elsevier Science Publishers B.V., pp. 377-378.
Massacesi L., Sarlo F., Castigli E., Olivotto J., Vergelli M., Abbamondi A.L. and Amaducci L. (1989). Effects of retinoic acid on passive transfer EAE. In “Recent advances in multiple sclerosis therapy”, R.E. Gonsette, P. Delmotte, eds., Elsevier Science Publishers B.V., pp. 195-198.
Zehetbauer B., Massacesi L., Liuzzi G. M., Vergelli M., Olivotto J., Grassi L., Riccio P. and Amaducci L. (1991). Myelin Basic Protein in lipid-bound form induces experimental allergic encephalomyelitis and demyelination in Lewis rat. Acta Neurologica 13: 121-132.
Vergelli M., Sorrentino G. and Massacesi L. (1993). Malattie degenerative. In “Neuroimmunologia Clinica”, Bruno Tavolato ed. Il pensiero Scientifico ed. (Roma), pp. 213-228.
Massacesi L., Amato M.P. and Amaducci L. (1994). Immunosuppression in Multiple Sclerosis: state of the art and future perspectives. In "A multidisciplinary approach to myelin diseases. II", S. Salvati ed. Plenum Press (New York), pp. 255-259.
Fonda C., Amato M.P., Massacesi L., Falcini M. Bartolozzi L. and Amaducci L. (1995). Confronto fra RM dopo somministrazione di gadolinio, senza e dopo applicazione del “trasferimento di magnetizzazione” nella sclerosi multipla. In “Neuroradiologia”, L.Bozzao editor, Centauro (Udine), pp.273-280.
Massacesi L. (1996). L’encefalomielite autoimmune sperimentale. In “Neurobiologia e Neuroimmunologia Clinica”, a cura di Federico A. e Annunziata P. CIC edizioni Internazionali (Roma), pp 85-93.
Amato M.P., Massacesi L. and Amaducci L. (1996). Clinical outcome measurements in Multiple Sclerosis trials. MS Forum. Int. MS Journal 3 n(1) : 19-27.
Mazzanti B., Traggiai E., Hemmer B., Martin R., Massacesi L., Vergelli M. (1999). The affinity spectrum of myelin basic protein reactive T cells. In “Advances in the immunopathogenesis of multiple sclerosis”. Gambi D., Muraro P.A.and Lugaresi A. eds. Sprinter (Milano, Italy), pp 3-10.
Vergelli M., Massacesi L., McFarland H. (2000). Immunopathogenesis of Multiple Sclerosis In “T cell autoimmunity in Multiple Sclerosis”. M. Londei ed., Landes Bioscience (Georgetown, Texas, USA), pp.133-148.
Massacesi L. (2000). Patogenesi della sclerosi multipla: meccanismo di cronicizzazione delle lesioni infiammatorie. In “Aspetti Immunologici e Terapeutici della Sclerosi Multipla”- C. Fieschi ed., UTET Periodici Scientifici (Milano), pp. 2-6.
Massacesi L. (2000). Correlati biologici e di laboratorio della patologia neuroimmune. In Atti del Convegno “Impiego delle Immunoglobuline E.V. in neurologia: attualità e prospettive”.
Mancardi GL, Murialdo A, Saccardi R, Pagliai F, Gualandi F, Marmont A, Inglese M, Bruzzi P, Sormiani MP, Filippi, M., Marrosu M.G., Meucci G., Massacesi L, Bertolotto A, Lugaresi A., Morelli E., Filippi M e l’Italian GITMO-NEURO Intergroup sul Trapiantato Autologo di cellule staminali ematopoietiche nella sclerosi multipla(2005). Il trapianto autologo di midollo osseo Intensa immunosoppressione seguita da trapianto autologo di cellule staminali in pazienti con forma grave di SM: dati clinici e RM. In L’interferone beta ed altre possibilità terapeutiche. L Durelli Ed., Excerpta Medica Elsevier (Milano), pp 97-106.
Mancardi G.L., R. Saccardi, A. Murialdo, F. Pagliai, F. Gualandi, A. Marmont, M. Inglese, P. Bruzzi, M.P. Sormani, M.G. Marrosu, G. Meucci, L. Massacesi, A. Bertolotto, A. Lugaresi, E. Merelli, M. Filippi. (2007). Intense Immunosuppression Followed by Autologous Stem Cell Transplantation in Severe Multiple Sclerosis Cases: MRI and Clinical Data. In Stem Cell Therapy for Autoimmune Disease, Richard K. Burt ed.
Massacesi L. Ed. (2013). Percorsi assistenziali del paziente con Sclerosi Multipla. Maya Idee, Verona.
Massacesi L (2013). Ruolo delle Agenzie regolatorie nel percorso autorizzativo dei farmaci neurologici in Europa. Sclerosi Multipla news 4 (14): 4-7.

Luca MASSACESI

Luca MASSACESI

Luca MASSACESI

Luca MASSACESI

Luca MASSACESI

Luca MASSACESI

Insegnamenti relativi all'Anno Accademico 2023-2024 2022-2023 2021-2022 2020-2021 2019-2020 2018-2019 2017-2018 2016-2017 2015-2016 2014-2015 2013-2014 2012-2013 2011-2012 2010-2011 2009-2010 2008-2009 2007-2008

Luca MASSACESI

Luca MASSACESI

Insegnamenti relativi all'Anno Accademico